UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported): September 16, 2014
 
VENTAS, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
1-10989
 
61-1055020
(State or Other Jurisdiction
 
(Commission
 
(IRS Employer
of Incorporation)
 
File Number)
 
Identification No.)
 
353 N. Clark Street, Suite 3300, Chicago, Illinois
 
60654
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant’s Telephone Number, Including Area Code: (877) 483-6827
 
Not Applicable
Former Name or Former Address, if Changed Since Last Report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
x         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 





Item 8.01.                                         Other Events.
 
As previously announced, in June 2014, Ventas, Inc. (“Ventas” or the “Company”) entered into a definitive agreement to acquire all of the outstanding shares of American Realty Capital Healthcare Trust, Inc. (“HCT”) in a stock and cash transaction valued at approximately $2.9 billion, or $11.33 per HCT share, including investments expected to be made by HCT prior to completion of the acquisition, the majority of which have now been completed. The Company expects to fund the transaction through the issuance of its common stock, valued at $67.13 per share (for aggregate consideration of between $1.8 billion and $2.0 billion), the assumption of debt and cash. Completion of the transaction is subject to the approval of HCT stockholders and customary closing conditions. Ventas expects to complete the HCT transaction during the fourth quarter of 2014, although there can be no assurance as to whether or when the transaction will be completed.

Additional Information about the Proposed Transaction and Where to Find It

In connection with the proposed transaction, the Company expects to prepare and file with the Securities and Exchange Commission a registration statement on Form S-4, which will contain a proxy statement of HCT and a prospectus of the Company, and each party will file other documents with respect to the Company’s proposed acquisition of HCT. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE PROPOSED TRANSACTION, INVESTORS ARE URGED TO READ THE REGISTRATION STATEMENT AND THE PROXY STATEMENT/PROSPECTUS (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Investors may obtain free copies of the registration statement, the proxy statement/prospectus and other relevant documents filed by the Company and HCT with the SEC (when they become available) through the website maintained by the SEC at www.sec.gov. Copies of the documents filed by the Company with the SEC are also available free of charge on the Company’s website at www.ventasreit.com, and copies of the documents filed by HCT with the SEC are available free of charge on HCT’s website at www.archealthcaretrust.com.

Participants in Solicitation Relating to the Merger

The Company and HCT and their respective directors and executive officers may be deemed participants in the solicitation of proxies from HCT’s stockholders in respect of the proposed transaction. Information regarding the Company’s directors and executive officers can be found in the Company’s definitive proxy statement for the Company’s 2014 annual meeting of stockholders, filed with the SEC on April 4, 2014. Information regarding HCT’s directors and executive officers can be found in HCT’s definitive proxy statement for HCT’s 2014 annual meeting of stockholders, filed with the SEC on April 28, 2014. Additional information regarding the interests of such potential participants will be included in the registration statement and the proxy statement/prospectus and other relevant documents filed with the SEC in connection with the proposed transaction when they become available. These documents are available free of charge on the SEC’s website and from the Company or HCT, as applicable, using the sources indicated above.

  
Item 9.01.                                         Financial Statements and Exhibits.
 
(a)  Financial Statements of Businesses Acquired.
 
The unaudited consolidated financial statements of HCT as of June 30, 2014 and for the three and six months ended June 30, 2014 and 2013 are filed herewith as Exhibit 99.1 and incorporated in this Item 9.01(a) by reference.

The audited consolidated financial statements of HCT as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013 are filed herewith as Exhibit 99.2 and incorporated in this Item 9.01(a) by reference.
 
(b)  Pro Forma Financial Information.
 
The unaudited pro forma condensed consolidated financial statements of Ventas as of and for the six months ended June 30, 2014 and for the year ended December 31, 2013, giving effect to the HCT transaction, are filed herewith as Exhibit 99.3 and incorporated in this Item 9.01(b) by reference.
 





(c)  Shell Company Transactions.
 
Not applicable.
 
(d)        Exhibits:
 
Exhibit
 Number
 
Description
 
 
 
23.1
 
Consent of Grant Thornton LLP.
 
 
 
99.1
 
Unaudited consolidated financial statements of HCT as of June 30, 2014 and for the three and six months ended June 30, 2014 and 2013.
 
 
 
99.2
 
Audited consolidated financial statements of HCT as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013.
 
 
 
99.3
 
Unaudited pro forma condensed consolidated financial statements of Ventas as of and for the six months ended June 30, 2014 and for the year ended December 31, 2013.
 

 






 





SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
VENTAS, INC.
 
 
 
 
 
 
Date: September 16, 2014
By:
/s/ Kristen M. Benson
 
 
Kristen M. Benson
 
 
Senior Vice President, Associate General Counsel
and Corporate Secretary
 







EXHIBIT INDEX

Exhibit
 Number
 
Description
 
 
 
23.1
 
Consent of Grant Thornton LLP.
 
 
 
99.1
 
Unaudited consolidated financial statements of HCT as of June 30, 2014 and for the three and six months ended June 30, 2014 and 2013.
 
 
 
99.2
 
Audited consolidated financial statements of HCT as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013.
 
 
 
99.3
 
Unaudited pro forma condensed consolidated financial statements of Ventas as of and for the six months ended June 30, 2014 and for the year ended December 31, 2013.








Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated February 26, 2014, with respect to the consolidated financial statements and schedule of American Realty Capital Healthcare Trust, Inc. and subsidiaries, included in this Current Report on Form 8-K of Ventas, Inc. We hereby consent to the incorporation by reference of said report in the Registration Statements of Ventas, Inc. on Forms S-3 (File No. 333-180521, File No.333-178185, File No. 333-173434) and Forms S-8 (File No. 333-183121, File No. 333-61552, File No. 333-97251, File No. 333-107951, File No. 333-118944, File No. 333-126639, File No. 333-136175, File No. 333-173434).
/s/ GRANT THORNTON LLP

New York, New York
September 15, 2014






Exhibit 99.1


AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2014
 
TABLE OF CONTENTS

 
Page
Consolidated Balance Sheets as of June 30, 2014 (Unaudited) and December 31, 2013
Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2014 and 2013 (Unaudited)
Consolidated Statement of Changes in Equity for the Six Months Ended June 30, 2014 (Unaudited)
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2014 and 2013 (Unaudited)
Notes to Consolidated Financial Statements (Unaudited)



1

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share data)


 
June 30,
2014
 
December 31,
2013
 
(Unaudited)
 
 
ASSETS
 
 
 
Real estate investments, at cost:
 
 
 
Land
$
143,505

 
$
107,719

Buildings, fixtures and improvements
1,729,130

 
1,363,858

Construction in progress
19,262

 
11,112

Acquired intangible lease assets
228,963

 
181,264

Total real estate investments, at cost
2,120,860

 
1,663,953

Less: accumulated depreciation and amortization
(148,543
)
 
(87,350
)
Total real estate investments, net
1,972,317

 
1,576,603

Cash and cash equivalents
28,695

 
103,447

Restricted cash
2,135

 
1,381

Investment securities, at fair value
19,427

 
14,670

Preferred equity investment
8,800

 

Prepaid expenses and other assets
26,080

 
17,431

Deferred costs, net
20,071

 
21,041

Total assets
$
2,077,525

 
$
1,734,573

LIABILITIES AND EQUITY
 
 
 
Mortgage notes payable
$
304,207

 
$
259,348

Mortgage premiums, net
4,000

 
2,769

Credit facility
507,500

 

Below-market lease liabilities, net
5,146

 
5,543

Derivatives, at fair value
58,490

 
333

Accounts payable and accrued expenses
28,277

 
17,460

Deferred rent and other liabilities
5,261

 
2,949

Dividends payable

 
10,427

Total liabilities
912,881

 
298,829

Preferred stock, $0.01 par value per share, 50,000,000 shares authorized, none issued or outstanding at June 30, 2014 and December 31, 2013

 

Common stock, $0.01 par value per share, 300,000,000 authorized, 169,316,257 and 180,463,898 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively
1,691

 
1,805

Additional paid-in capital
1,462,108

 
1,591,941

Accumulated other comprehensive loss
(987
)
 
(3,243
)
Accumulated deficit
(312,655
)
 
(158,378
)
Total stockholders' equity
1,150,157

 
1,432,125

Non-controlling interests
14,487

 
3,619

Total equity
1,164,644

 
1,435,744

Total liabilities and equity
$
2,077,525

 
$
1,734,573


The accompanying notes are an integral part of these statements.


2

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share data)
(Unaudited)

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2014
 
2013
 
2014
 
2013
Revenues:
 
 
 
 
 
 
 
Rental income
$
55,584

 
$
20,885

 
$
103,101

 
$
36,872

Operating expense reimbursements
4,267

 
2,474

 
8,451

 
4,663

Resident services and fee income
4,918

 
578

 
9,206

 
1,080

Total revenues
64,769

 
23,937

 
120,758

 
42,615

Operating expenses:
 
 
 
 
 
 
 
Property operating and maintenance
26,238

 
7,444

 
49,717

 
12,636

Operating fees to affiliates
2,352

 

 
2,352

 

Acquisition and transaction related
22,456

 
2,713

 
25,878

 
4,751

Vesting of Class B units for asset management services
12,917

 

 
12,917

 

Fair value of listing note
58,150

 

 
58,150

 

General and administrative
2,674

 
1,240

 
4,592

 
1,481

Equity-based compensation
97

 
10

 
107

 
18

Depreciation and amortization
31,713

 
12,714

 
60,656

 
24,408

Total operating expenses
156,597

 
24,121

 
214,369

 
43,294

Operating loss
(91,828
)
 
(184
)
 
(93,611
)
 
(679
)
Other income (expenses):
 
 
 
 
 
 
 
Interest expense
(7,108
)
 
(3,315
)
 
(12,651
)
 
(6,404
)
Income from preferred equity investment and investment securities and interest income
495

 
255

 
795

 
255

Gain on sale of investment securities
335

 

 
335

 

Total other expense
(6,278
)
 
(3,060
)
 
(11,521
)
 
(6,149
)
Net loss
(98,106
)
 
(3,244
)
 
(105,132
)
 
(6,828
)
Net loss (income) attributable to non-controlling interests
817

 
(14
)
 
808

 
(36
)
Net loss attributable to stockholders
(97,289
)
 
(3,258
)
 
(104,324
)
 
(6,864
)
 
 
 
 
 
 
 
 
Other comprehensive income:
 
 
 
 
 
 
 
Designated derivatives, fair value adjustment
(26
)
 
298

 
(7
)
 
343

Unrealized gain on investment securities, net
636

 
(985
)
 
2,263

 
(985
)
Comprehensive loss attributable to stockholders
$
(96,679
)
 
$
(3,945
)
 
$
(102,068
)
 
$
(7,506
)
 
 
 
 
 
 
 
 
Basic and diluted weighted average shares outstanding
175,129,424

 
170,124,871

 
178,357,402

 
123,834,119

Basic and diluted net loss per share attributable to stockholders
$
(0.56
)
 
$
(0.02
)
 
$
(0.58
)
 
$
(0.06
)

The accompanying notes are an integral part of these statements.


3

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
Six months ended June 30, 2014
(In thousands, except share data)
(Unaudited)

 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
Number
of
Shares
 
Par
Value
 
Additional
Paid-In
Capital
 
Accumulated Other Comprehensive Loss
 
Accumulated
Deficit
 
Total
Stockholders'
Equity
 
Non-controlling Interests
 
Total Equity
Balance, December 31, 2013
180,463,898

 
$
1,805

 
$
1,591,941

 
$
(3,243
)
 
$
(158,378
)
 
$
1,432,125

 
$
3,619

 
$
1,435,744

Common stock issued through distribution reinvestment plan
2,344,631

 
23

 
22,231

 

 

 
22,254

 

 
22,254

Common stock repurchases, inclusive of fees and expenses
(13,718,177
)
 
(137
)
 
(151,995
)
 

 

 
(152,132
)
 

 
(152,132
)
Dividends declared

 

 

 

 
(49,953
)
 
(49,953
)
 

 
(49,953
)
Contributions from non-controlling interest holders

 

 

 

 

 

 
750

 
750

Vesting of Class B units for asset management services

 

 

 

 

 

 
12,917

 
12,917

Equity-based compensation
225,905

 

 
239

 

 

 
239

 

 
239

Distributions to non-controlling interest holders

 

 

 

 

 

 
(299
)
 
(299
)
Increase in interest in Reliant Rehabilitation - Dallas, TX

 

 
(308
)
 

 

 
(308
)
 
(1,692
)
 
(2,000
)
Other comprehensive income

 

 

 
2,256

 

 
2,256

 

 
2,256

Net loss

 

 

 

 
(104,324
)
 
(104,324
)
 
(808
)
 
(105,132
)
Balance, June 30, 2014
169,316,257

 
$
1,691

 
$
1,462,108

 
$
(987
)
 
$
(312,655
)
 
$
1,150,157

 
$
14,487

 
$
1,164,644


The accompanying notes are an integral part of this statement.

4

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Six Months Ended June 30,
 
2014
 
2013
Cash flows from operating activities:
 
 
 
Net loss attributable to stockholders
$
(104,324
)
 
$
(6,864
)
Adjustment to reconcile net loss to net cash provided by operating activities:
 
 
 
Depreciation
36,628

 
17,065

Amortization of intangibles
24,028

 
7,343

Amortization of deferred financing costs
3,190

 
1,253

Amortization of mortgage premiums
(648
)
 
(368
)
Accretion of below-market lease liabilities and amortization of above-market lease assets, net
189

 
186

Vesting of Class B units for asset management services
12,917

 

Net loss (income) attributable to non-controlling interests
(808
)
 
36

Equity-based compensation
239

 
33

Fair value of listing note
58,150

 

Gain on sale of investment securities
(335
)
 

Changes in assets and liabilities:
 
 
 
Prepaid expenses and other assets
(6,097
)
 
(3,045
)
Accounts payable and accrued expenses
10,792

 
3,437

Deferred rent and other liabilities
2,312

 
(91
)
Net cash provided by operating activities
36,233

 
18,985

Cash flows from investing activities:
 
 
 
Investment in real estate and preferred equity investment
(411,875
)
 
(183,621
)
Deposits for real estate
(6,500
)
 
(5,152
)
Capital expenditures
(2,302
)
 
(104
)
Purchase of investment securities
(3,000
)
 
(18,966
)
Proceeds from sale of investment securities
841

 

Net cash used in investing activities
(422,836
)
 
(207,843
)
Cash flows from financing activities:
 
 
 
Payments of note payable

 
(2,500
)
Payments of mortgage notes payable
(671
)
 
(87
)
Proceeds from credit facility
507,500

 

Payments on credit facility

 
(26,000
)
Payments of deferred financing costs
(1,913
)
 
(584
)
Proceeds from issuance of common stock

 
1,196,951

Proceeds from the issuance of OP units
750

 

Common stock repurchases, inclusive of fees and expenses
(152,636
)
 
(990
)
Payments of offering costs and fees related to stock issuances

 
(122,161
)
Dividends paid
(38,126
)
 
(17,162
)
Due from/to affiliate

 
190

Payments to non-controlling interest holders
(2,000
)
 

Distributions to non-controlling interests holders
(299
)
 
(190
)
Restricted cash
(754
)
 
(238
)
Net cash provided by financing activities
311,851

 
1,027,229

Net change in cash
(74,752
)
 
838,371

Cash, beginning of period
103,447

 
13,869

Cash, end of period
$
28,695

 
$
852,240


5

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Six Months Ended June 30,
 
2014
 
2013
Supplemental Disclosures:
 
 
 
Cash paid for interest
$
10,096

 
$
5,508

Cash paid for income taxes
1,223

 
84

 
 
 
 
Non-Cash Investing and Financing Activities:
 
 
 
Mortgage notes payable assumed or used to acquire investments in real estate
$
45,530

 
$
15,776

Premiums on assumed mortgage notes payable
1,879

 
340

Common stock issued through distribution reinvestment plan
22,254

 
17,801


The accompanying notes are an integral part of these statements.

6

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)


Note 1 — Organization
American Realty Capital Healthcare Trust, Inc. (the "Company") invests primarily in real estate serving the healthcare industry in the United States. The Company owns a diversified portfolio of healthcare-related real estate, focusing predominantly on medical office buildings ("MOBs") and seniors housing communities. Additionally, the Company selectively invests across the healthcare continuum in hospitals, post-acute care facilities and other properties. As of June 30, 2014, the Company owned 147 properties and one preferred equity investment, located in 30 states with an aggregate purchase price of $2.1 billion, comprised of 7.5 million rentable square feet.
In February 2011, the Company commenced its initial public offering (the "IPO") on a "reasonable best efforts" basis of up to 150.0 million shares of common stock, $0.01 par value per share, at a price of $10.00 per share, subject to certain volume and other discounts. The Company closed its IPO in April 2013 and operated as a non-traded real estate investment trust ("REIT") through April 6, 2014. On April 7, 2014, the Company listed its common stock on the NASDAQ Global Select Market (“NASDAQ”) under the symbol “HCT” (the "Listing"). Concurrent with the Listing, the Company offered to purchase up to 13.6 million of its common stock at a price of $11.00 per share (the "Tender Offer"). As a result of the Tender Offer, on May 2, 2014, the Company purchased 13.6 million shares of its common stock at a price of $11.00 per share, for an aggregate of $150.1 million, excluding fees and expenses relating to the Tender Offer and including fractional shares repurchased thereafter.
The Company, which was incorporated on August 23, 2010, is a Maryland corporation that qualified as a REIT for U.S. federal income tax purposes beginning with the taxable year ended December 31, 2011. Substantially all of the Company's business is conducted through American Realty Capital Healthcare Trust Operating Partnership, L.P., a Delaware limited partnership (the "OP"). The Company has no direct employees. The Company has retained American Realty Capital Healthcare Advisors, LLC (the "Advisor") to manage its affairs on a day-to-day basis. The Company has retained American Realty Capital Healthcare Properties, LLC (the "Property Manager") to serve as the Company's property manager.  Realty Capital Securities, LLC (the "Dealer Manager") served as the dealer manager of the IPO and continues to provide the Company with various services. The Advisor, Property Manager and Dealer Manager are under common control with the parent of the Company's sponsor, American Realty Capital V, LLC (the "Sponsor"), as a result of which, they are related parties and each has received or may receive compensation and fees for services related to the IPO, the Listing and for the investment and management of the Company's assets.
Note 2 — Merger Agreement
On June 1, 2014, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Ventas, Inc., a Delaware corporation ("Ventas"), Stripe Sub, LLC a Delaware limited liability company and wholly owned subsidiary of Ventas ("Merger Sub"), Stripe OP, LP, a Delaware limited partnership of which Merger Sub is the sole general partner ("OP Merger Sub"), and the OP. The Merger Agreement provides for the merger of the Company with and into Merger Sub, with Merger Sub surviving as a wholly-owned subsidiary of Ventas (the "Merger"), and for the merger of OP Merger Sub with and into the OP, with the OP continuing as the surviving partnership (the "Partnership Merger"). The board of directors of the Company has unanimously approved the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement, including the Partnership Merger.
Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each outstanding share of common stock, par value $0.01 per share, of the Company will be converted into the right to receive, pursuant to an election made by each holder of the Company's common stock, (i) $11.33 in cash, limited to 10% of the shares outstanding of the Company's common stock, or (ii) 0.1688 (the "Exchange Ratio") shares of common stock, par value $0.25 per share, of Ventas ("Ventas Common Stock").

7

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

In addition, pursuant to the Partnership Merger, at the Effective Time: (i) the Company’s interest as the general partner of the OP will remain outstanding and constitute the only outstanding general partnership interest in the OP; and (ii) each unit of limited partnership interests in the OP (the “OP units”) issued and outstanding immediately prior to the Effective Time of the Partnership Merger, including the 5,613,374 OP units to be issued in respect of the termination of the Listing Note Agreement (as defined in Note 10 — Subordinated Listing Distribution Derivative), will be converted into such number of Ventas Class C units (as defined in the limited partnership agreement of the OP as contemplated to be amended and restated by the Merger Agreement) of the OP as is equal to the Exchange Ratio. In addition, unless otherwise notified by Ventas, prior to the Effective Time, the Company has agreed to terminate the Company’s Employee and Director Incentive Restricted Share Plan, the Company’s 2011 Stock Option Plan and the 2014 Advisor Multi-Year Outperformace Agreement (the "OPP"), all, however, contingent on the occurrence of the Effective Time.
The completion of the Merger is subject to various customary conditions. The Merger Agreement includes certain termination rights for both the Company and Ventas and provides that, in connection with the termination of the Merger Agreement, under specified circumstances, the Company may be required to pay to Ventas expense reimbursement in an amount equal to $10.0 million. The Merger Agreement also provides for the payment of a termination fee by the Company in the amount of $55.0 million (net of the expense reimbursement, if previously paid) if the Merger Agreement is terminated under specified circumstances. The Merger is expected to close during the fourth quarter of 2014.
Pursuant to the Merger Agreement, all Merger related fees, other than fees and expenses arising from any litigation, the obtainment of consents, debt prepayment penalties, defeasance costs, breakage costs, indemnification of liabilities (excluding liabilities to the Advisor or American Realty Capital Healthcare Special Limited Partnership, LLC, (the "SLP")) and accounting expenses are capped at $23.6 million. During the three and six months ended June 30, 2014, the Company has incurred $5.3 million related to the Merger.
Note 3 — Summary of Significant Accounting Policies
The accompanying consolidated financial statements of the Company included herein were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to this Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The information furnished includes all adjustments and accruals of a normal recurring nature, which, in the opinion of management, are necessary for a fair presentation of results for the interim periods. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three and six months ended June 30, 2014 are not necessarily indicative of the results for the entire year or any subsequent interim period.
These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of, and for the year ended December 31, 2013, which are included in the Company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on February 26, 2014. There have been no significant changes to the Company's significant accounting policies during the six months ended June 30, 2014, other than the updates described below.
Listing Note
Concurrently with the Listing, the Company caused the OP to issue the Listing Note (see Note 10 — Subordinated Listing Distribution Derivative). Except as provided below, the Listing Note's value will be determined, in part, based on the average market value of the Company’s outstanding common stock for the period 180 days to 210 days after the Listing. Until the principal amount of the Listing Note is determined, the Listing Note is treated as a derivative and the Company estimates the contingent consideration using a valuation model and records the fair value of the Listing Note on the consolidated balance sheets. The initial fair value and subsequent changes in fair value are recorded in the consolidated statements of operations and comprehensive loss. Concurrently with the execution of the Merger Agreement, the OP and the SLP entered into an amendment to the Listing Note agreement. Pursuant to the amended Listing Note agreement, contingent upon the occurrence of the Merger at the Effective Time, 5,613,374 OP units will be issued in respect of the termination of the Listing Note.

8

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Multi-Year Outperformance Agreement
On April 7, 2014 (the "OPP Effective Date") in connection with the Listing, the Company entered into the OPP with the OP and the Advisor. Because the Advisor can terminate at any time and receive the value of the award at the next anniversary date, the estimated value of the award as of the first anniversary was expensed on the OPP Effective Date and the estimated value of the award on the second and third anniversaries is being amortized over the first year and first two years of the OPP, respectively and adjusted to reflect the probability of the closing of the Merger. The award and related expense is adjusted each reporting period for changes in the estimated value. Concurrently with the execution of the Merger Agreement, the Company, the OP and the Advisor entered into an agreement terminating the OPP, pursuant to which the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger (see Note 17 — Equity-Based Compensation).
Tender Offer
The Company recorded the excess of the cost of the tendered shares over its par value to additional paid-in capital.
Recently Issued Accounting Pronouncements
In February 2013, the Financial Accounting Standards Board ("FASB") issued new accounting guidance clarifying the accounting and disclosure requirements for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new guidance was effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
In April 2014, the FASB amended the requirements for reporting discontinued operations. Under the revised guidance, in addition to other disclosure requirements, a disposal of a component of an entity or a group of components of an entity is required to be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results when the component or group of components meets the criteria to be classified as held for sale, disposed of by sale or other than by sale. The Company has adopted the provisions of this guidance effective January 1, 2014, and has applied the provisions prospectively. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
In May 2014, the FASB issued revised guidance relating to revenue recognition. Under the revised guidance, an entity is required to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The revised guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is not permitted under GAAP. The revised guidance allows entities to apply the full retrospective or modified retrospective transition method upon adoption. The Company has not yet selected a transition method and is currently evaluating the impact of the new guidance.

9

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Note 4 — Real Estate Investments 
The following table presents the allocation of the assets acquired and liabilities assumed during the six months ended June 30, 2014 and 2013:
 
 
Six Months Ended June 30,
(Dollar amounts in thousands)
 
2014
 
2013
Real estate investments, at cost:
 
 
 
 
Land
 
$
34,786

 
$
11,677

Buildings, fixtures and improvements
 
363,968

 
167,407

Construction in progress
 
8,150

 

Total tangible assets
 
406,904

 
179,084

Acquired intangibles:
 
 
 
 
In-place leases
 
47,699

 
19,082

Above-market lease assets
 

 
3,163

Below-market lease liabilities
 

 
(639
)
Total assets acquired, net
 
454,603

 
200,690

Preferred equity investment (see Note 5 — Preferred Equity Investment)
 
8,800

 

Deposits for real estate
 
(3,590
)
 

Mortgage notes payable assumed or used to acquire real estate investments
 
(45,530
)
 
(15,776
)
Premiums on mortgages assumed
 
(1,879
)
 
(340
)
Other liabilities assumed
 
(529
)
 
(953
)
Cash paid for acquired real estate and preferred equity investments
 
$
411,875

 
$
183,621

Number of properties purchased
 
32

 
20

The allocations to buildings, fixtures and improvements have been provisionally assigned to each class, pending receipt of additional information from a third party specialist.
The following table presents unaudited pro forma information as if the acquisitions during the six months ended June 30, 2014, had been consummated on January 1, 2013. Additionally, the unaudited pro forma net loss attributable to stockholders was adjusted to exclude acquisition related expense of $6.6 million from the six months ended June 30, 2014.
 
 
Six Months Ended June 30,
(In thousands)
 
2014
 
2013
Pro forma revenues
 
$
137,887

 
$
75,311

Pro forma net loss attributable to stockholders
 
$
(96,390
)
 
$
(3,224
)

10

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

The following table presents future minimum base rental cash payments due to the Company over the next five years and thereafter. These amounts exclude contingent rent payments, as applicable, that may be collected from certain tenants based on provisions related to sales thresholds and increases in annual rent based on exceeding certain economic indexes among other items.
(In thousands)
 
Future Minimum
Base Rent Payments
July 1, 2014 — December 31, 2014
 
$
56,300

2015
 
113,885

2016
 
114,770

2017
 
113,880

2018
 
108,851

Thereafter
 
801,879

 
 
$
1,309,565

As of June 30, 2014 and 2013, the Company did not have any tenants whose annualized rental income on a straight-line basis represented approximately 10% or greater of total annualized rental income for all portfolio properties on a straight-line basis.
The following table lists the states where the Company has concentrations of properties where annualized rental income on a straight-line basis represents approximately 10% or more of consolidated annualized rental income on a straight-line basis for all properties as of June 30, 2014 and 2013:
 
 
June 30,
State
 
2014
 
2013
Florida
 
10.0%
 
*
Georgia
 
12.8%
 
16.7%
Illinois
 
*
 
10.6%
Oregon
 
*
 
16.1%
Texas
 
10.5%
 
16.8%
____________________________
*
State's annualized rental income on a straight-line basis was not 10% or more of total annualized rental income for all portfolio properties as of the date specified.
Note 5 — Preferred Equity Investment
As of June 30, 2014, the Company owned a preferred equity investment in an entity that owns the 80th Street Residence, a senior housing community located at 430 East 80th Street in the Upper East Side of Manhattan. As of June 30, 2014, the preferred equity investment had a carrying amount of $8.8 million. The investment has a ten-year term maturing in March 2024, a 0.5% origination fee, a 10.0% current pay rate distributed on a semi-annual basis. The Company's preferred equity investment includes a right of first refusal to acquire the 80th Street Residence in the event the owner elects to sell the property in the future. As of December 31, 2013, the Company did not have any preferred equity investments.
The preferred equity investment has a fixed return based on contributed capital and no participation in profits or losses of the real estate activities.  As such, the Company accounts for the returns earned in income from preferred equity investment and investment securities on the consolidated statements of operations.  The Company assesses the investment for impairment on a periodic basis.

11

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Note 6 — Investment Securities
As of June 30, 2014, the Company had investments in common stock, redeemable preferred stock, a real estate income fund and a senior note with an aggregate fair value of $19.4 million. The real estate income fund is managed by an affiliate of the Sponsor (see Note 15 — Related Party Transactions and Arrangements). These investments are considered available-for-sale securities and therefore increases or decreases in the fair value of these investments are recorded in accumulated other comprehensive loss as a component of equity on the consolidated balance sheets unless the securities are considered to be other than temporarily impaired at which time the losses would be reclassified to expense.
The following table details the unrealized gains and losses on investment securities as of June 30, 2014 and December 31, 2013:
(In thousands)
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
June 30, 2014
 
 
 
 
 
 
 
 
Investment securities
 
$
20,075

 
$
123

 
$
(771
)
 
$
19,427

December 31, 2013
 
 
 
 
 
 
 
 
Investment securities
 
$
17,580

 
$
202

 
$
(3,112
)
 
$
14,670

Unrealized losses as of June 30, 2014 were considered temporary and therefore no impairment was recorded during the three and six months ended June 30, 2014. During the six months ended June 30, 2014, the Company sold investments in common stock with a cost of $0.5 million for $0.8 million, resulting in a realized gain on sale of investment securities of $0.3 million.
The Company's preferred stock investments are redeemable at the respective issuer's option after five years from issuance. The senior note matures in 28.7 years and bears interest at 5.45% as of June 30, 2014.
Note 7 — Credit Facility
On May 25, 2012, the Company entered into a senior revolving credit facility in the aggregate principal amount of $50.0 million (the "Credit Facility") with KeyBank National Association ("KeyBank"). On October 25, 2012, the Company entered into an amendment, which increased the maximum commitments under the Credit Facility to $200.0 million.
On July 24, 2013, the Company entered into an unsecured amended and restated credit agreement (the "Amended Facility"), which allows for total borrowings of up to $755.0 million, comprised of a $500.0 million term loan component and a $255.0 million revolving loan component. The Amended Facility also contains a subfacility for letters of credit of up to $25.0 million. The Amended Facility contains an “accordion feature” to allow the Company, under certain circumstances, to increase the aggregate term loan borrowings under the Amended Facility to up to $750.0 million and the aggregate revolving loan borrowings to up to $450.0 million, or up to $1.2 billion of total borrowings.
Pursuant to the Amended Facility, the Company has the option, based upon its corporate leverage, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 1.60% to 2.20%; or (b) the Base Rate, plus an applicable margin that ranges from 0.35% to 0.95%. Base Rate is defined in the Amended Facility as the greatest of (i) the fluctuating annual rate of interest announced from time to time by KeyBank as its “prime rate,” (ii) 0.5% above the federal funds effective rate or (iii) 1.0% above the applicable one-month LIBOR. Upon such time as the Company receives an investment grade credit rating as determined by major credit rating agencies, the Company will have the option, based upon its credit rating, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 0.95% to 1.70%; or (b) the Base Rate, plus an applicable margin that ranges from 0.00% to 0.70%. The Amended Facility includes an unused fee per annum equal to (a) 0.25% of any unused balance of the revolving facility, if such unused balance exceeds 50% of the available revolving facility, (b) 0.15% of any unused balance of the revolving credit facility, if such unused balance is equal to or less than 50% of the available revolving facility and (c) 0.25% of any unused balance of the term facility.

12

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

The Amended Facility provides for monthly interest payments for each Base Rate loan and periodic payments for each LIBOR loan, based upon the applicable LIBOR loan period, with all principal outstanding being due on the maturity date. The term loan component of the Amended Facility matures in July 2018 and the revolving loan component of the Amended Facility matures in July 2016. The revolving loan component of the Amended Facility contains two, one-year extension options. The Amended Facility may be prepaid from time to time and at any time, in whole or in part, without premium or penalty, subject to reimbursement of certain costs and expenses. In the event of a default, the lenders have the right to terminate its obligations under the Amended Facility and to accelerate the payment on any unpaid principal amount of all outstanding loans.
On January 23, 2014, the Company entered into the first amendment to the Amended Facility (the "First Amendment"), which permits the Company to make a maximum of five borrowings of term loans from the period beginning July 24, 2013 to July 24, 2014 (the “Term Loan Commitment Period”) in an aggregate principal amount which decreases over time as follows: for the period beginning July 24, 2013 to January 24, 2014, $500.0 million; for the period beginning January 25, 2014 to April 24, 2014, $400.0 million; and for the period beginning April 25, 2014 to July 24, 2014, $200.0 million. Additionally, under the First Amendment, the Company may from time to time, at its option, increase the total term loan commitment up to an amount not to exceed the sum of $750.0 million plus the amount of the initial term loan commitment not borrowed during the Term Loan Commitment Period.
On April 7, 2014, the Company entered into the second amendment to the Amended Facility (the “Second Amendment”). The Second Amendment, among other things, (i) permits the issuance of the Listing Note to the SLP following the Listing, (ii) modifies the distribution covenant to account for the suspension of the Company’s distribution reinvestment plan (the "DRIP"); (iii) permits the issuance of long term incentive plan units ("LTIP units") to the Advisor and (iv) modifies certain other terms of the Amended Facility to allow the Company to make additional restricted payments, including the Tender Offer.
As of June 30, 2014, the balance outstanding under the Amended Facility was $507.5 million, with a weighted average interest rate of 1.8%. The Company's unused borrowing capacity was $96.9 million, based on the assets assigned to the Amended Facility as of June 30, 2014. Availability of borrowings is based on a pool of eligible unencumbered real estate assets. There were no advances outstanding as of December 31, 2013.
The Amended Facility requires the Company to meet certain financial covenants, including the maintenance of certain financial ratios (such as specified debt to equity and debt service coverage ratios) as well as the maintenance of a minimum net worth. As of June 30, 2014, the Company was in compliance with the financial covenants under the Amended Facility.
Note 8 — Note Payable
In September 2011, the Company entered into an unsecured $4.5 million note payable with an unaffiliated third party investor. The note bore interest at a fixed rate of 8.0% per annum and was due to mature in September 2014. The note had two one-year extension options. The note required monthly interest payments with the principal balance due at maturity. The note could be repaid at any time, in whole or in part, without premium or penalty. Notwithstanding the foregoing, after the initial maturity date, the lender had a right to require the repayment in full of any outstanding principal and interest under the note upon 60 days' notice. The note was repaid in full in January 2013 at the Company's election.

13

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Note 9 — Mortgage Notes Payable
The Company's mortgage notes payable as of June 30, 2014 and December 31, 2013 consist of the following:
 
 
 
 
Outstanding Loan Amount as of
 
 
 
 
 
 
Portfolio
 
Encumbered Properties
 
June 30, 2014
 
December 31, 2013
 
Effective Interest Rate
 
Interest Rate
 
Maturity
 
 
 
 
(In thousands)
 
(In thousands)
 
 
 
 
 
 
Texarkana ASC - Texarkana, TX
 
1
 
$
2,119

 
$
2,143

 
5.58
%
 
Fixed
 
Jun. 2016
Carson Tahoe Specialty Medical Center - Carson City, NV (1)
 
3
 
21,751

 
21,751

 
5.08
%
 
Fixed
 
Sep. 2015
Durango Medical Plaza - Las Vegas, NV (1)
 
1
 
17,172

 
17,172

 
5.08
%
 
Fixed
 
Sep. 2015
CareMeridian Rehabilitation - Phoenix, AZ (1)
 
1
 
6,936

 
6,936

 
5.08
%
 
Fixed
 
Sep. 2015
Reliant Rehabilitation - Dallas, TX (1)
 
1
 
24,850

 
24,850

 
5.15
%
 
Fixed
 
Sep. 2015
Select Rehabilitation - San Antonio, TX (1)
 
1
 
12,714

 
12,714

 
5.15
%
 
Fixed
 
Sep. 2015
Spring Creek Medical Plaza - Tomball, TX (1)
 
1
 
7,477

 
7,477

 
5.15
%
 
Fixed
 
Sep. 2015
Odessa Regional MOB - Odessa, TX
 
1
 
4,047

 
4,047

 
4.09
%
(2)
Fixed
 
Dec. 2016
Methodist North MOB - Peoria, IL
 
1
 
13,544

 
13,544

 
3.99
%
(2)
Fixed
 
Dec. 2016
University of Wisconsin Health MOB - Monona, WI
 
1
 
5,039

 
5,039

 
4.00
%
 
Fixed
 
Apr. 2017
Reliant Rehabilitation - Houston, TX (1)
 
1
 
13,437

 
13,437

 
4.98
%
 
Fixed
 
Sep. 2015
Village Healthcare Center - Santa Ana (1)
 
1
 
1,906

 
1,906

 
4.98
%
 
Fixed
 
Sep. 2015
Sisters of Mercy Building - Springfield, MO
 
1
 
5,500

 
5,500

 
4.11
%
 
Fixed
 
Sep. 2017
East Pointe Medical Plaza - Lehigh Acres, FL
 
1
 
5,260

 
5,260

 
4.11
%
 
Fixed
 
Sep. 2017
Unitron Hearing Building - Plymouth, MN
 
1
 
4,000

 
4,000

 
4.11
%
 
Fixed
 
Sep. 2017
Carson Tahoe MOB West - Carson City, NV
 
1
 
4,675

 
4,675

 
3.88
%
(2)
Fixed
 
Jun. 2017
Aurora Health Care Portfolio
 
3
 
49,600

 
49,600

 
5.60
%
 
Fixed
 
Jan. 2017
Princeton Village - Clackamas, OR
 
1
 
3,068

 
3,114

 
7.48
%
 
Fixed
 
Jan. 2031
Pelican Pointe - Klamath Falls, OR
 
1
 
12,365

 
12,460

 
5.16
%
 
Fixed
 
Apr. 2022
Fayette MOB - Fayetteville, GA
 
1
 
6,902

 
6,986

 
5.18
%
 
Fixed
 
Sep. 2015
Garden House - Anderson, SC
 
1
 
8,082

 
8,149

 
4.86
%
 
Fixed
 
Dec. 2018
Benton House - Covington, GA
 
1
 
8,060

 
8,121

 
5.26
%
 
Fixed
 
May 2019
Arbor Terrace - Asheville, SC
 
1
 
9,433

 
9,497

 
5.58
%
 
Fixed
 
Feb. 2018
Arbor Terrace - Decatur, GA
 
1
 
10,896

 
10,970

 
5.57
%
 
Fixed
 
Jan. 2018
Casa de Santa Fe - Rocklin, CA
 
1
 
20,579

 

 
4.71
%
 
Fixed
 
Oct. 2021
Bay Medical Plaza - Lynn Haven, FL
 
1
 
9,579

 

 
6.61
%
 
Fixed
 
Aug. 2017
Bay Medical Center - Panama City, FL
 
1
 
9,321

 

 
6.61
%
 
Fixed
 
Aug. 2017
Legacy Heart Center - Plano, TX
 
1
 
5,895

 

 
5.76
%
 
Fixed
 
Oct. 2015
Total
 
32
 
$
304,207

 
$
259,348

 
5.17
%
(3)
 
 
 
_____________________________________
(1)
These mortgages, aggregating $106.2 million, represent the first, second and third tranches of a multi-tranche mortgage loan agreement to provide funding for a portfolio of eight properties. The mortgages for each of the properties are cross-collateralized with one another and in the event that the Company defaults on one of the mortgages, the lender may look to the other properties as collateral.
(2)
Fixed as a result of entering into a swap agreement.
(3)
Calculated on a weighted average basis for all mortgages outstanding as of June 30, 2014.

14

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

The following table summarizes the scheduled aggregate principal payments on mortgage notes payable for the five years subsequent to June 30, 2014:
(In thousands)
 
Future Principal
Payments
July 1, 2014 — December 31, 2014
 
$
769

2015
 
120,179

2016
 
20,936

2017
 
94,353

2018
 
27,778

Thereafter
 
40,192

 
 
$
304,207

Some of the Company's mortgage notes payable agreements require compliance with certain property-level financial covenants including debt service coverage ratios. As of June 30, 2014 and December 31, 2013, the Company was in compliance with the financial covenants under its mortgage notes payable agreements.
Note 10 — Subordinated Listing Distribution Derivative
Upon occurrence of the Listing, the SLP became entitled to begin receiving distributions of net sales proceeds pursuant to its special limited partner interest in the OP (the “SLP Interest”) in an aggregate amount that is evidenced by the issuance of a note by the OP (the “Listing Note”). The Listing Note is equal to 15.0% of the amount, if any, by which (a) the average market value of the Company’s outstanding common stock for the period 180 days to 210 days after the Listing, plus dividends paid by the Company prior to Listing, exceeds (b) the sum of the total amount of capital raised from stockholders during the Company’s prior offering and the amount of cash flow necessary to generate a 6.0% annual cumulative, non-compounded return to such stockholders. Concurrently with the Listing, the Company, as general partner of the OP, caused the OP to enter into the Listing Note Agreement dated April 7, 2014 by and between the OP and the SLP (the "Listing Note Agreement"), and caused the OP to issue the Listing Note. The Listing Note is evidence of the SLP’s right to receive distributions of net sales proceeds from the sale of the Company’s real estate and real estate-related assets up to an aggregate amount equal to the principal balance of the Listing Note. Pursuant to the terms of the limited partnership agreement of the OP, the SLP has the right, but not the obligation, to convert all or a portion of the SLP Interest into OP units which are convertible into shares of the Company's common stock.
Except as provided below, the principal amount of the Listing Note will be determinable based on the actual market value of the Company’s outstanding common stock for the period 180 days to 210 days after the Listing and therefore the principal amount of the Listing Note is not yet definitive. Until the amount of the Listing Note can be determined, the Listing Note is considered a derivative, which is marked to fair value at each reporting date, with changes in the estimated value recorded in the consolidated statements of operations and comprehensive loss. The Listing Note fair value, as of June 30, 2014, was estimated using a Monte Carlo simulation, which uses a combination of observable and unobservable inputs and was adjusted to reflect the probability of the closing of the Merger (see Note 11 — Fair Value of Financial Instruments). As of June 30, 2014, the Listing Note had a fair value of $58.2 million. The final value of the Listing Note could differ materially from the current estimate.
However, concurrently with the execution of the Merger Agreement, the OP and the SLP entered into an amendment to the Listing Note Agreement (the "Listing Note Amendment"), to provide that: (i) immediately prior to, and contingent upon, the closing of the Merger, the SLP will be deemed to have contributed its right to distributions from the OP pursuant to its SLP Interest, the amount of which distributions are evidenced by the Listing Note, to the OP in exchange for 5,613,374 OP units in the OP; and (ii) the Listing Note Agreement will terminate upon receipt by the SLP of such OP units. The Listing Note Amendment will, pursuant to its terms, automatically terminate and be of no further force or effect if the Merger Agreement is terminated in accordance with its terms.


15

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Note 11 — Fair Value of Financial Instruments
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the instrument. This alternative approach also reflects the contractual terms of the instrument, as applicable, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities, and unobservable inputs, such as expected volatility. The guidance defines three levels of inputs that may be used to measure fair value:
Level 1 — Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset and liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.
Level 3 — Unobservable inputs that reflect the entity's own assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.
The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. However, the Company expects that changes in classifications between levels will be rare.
Although the Company has determined that the majority of the inputs used to value its interest rate swaps fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with those interest rate swaps utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. However, as of June 30, 2014 and December 31, 2013, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its interest rate swap positions and has determined that the credit valuation adjustments are not significant to the overall valuation of the Company's interest rate swaps. As a result, the Company has determined that its interest rate swap valuations in their entirety are classified in Level 2 of the fair value hierarchy.
The valuation of interest rate swaps is determined using a discounted cash flow analysis on the expected cash flows. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, as well as observable market-based inputs, including interest rate curves and implied volatilities. In addition, credit valuation adjustments, are incorporated into the fair values to account for the Company's potential nonperformance risk and the performance risk of the counterparties.
The valuation of the OPP was determined using a Monte Carlo simulation. This analysis reflects the contractual terms of the OPP, including the vesting periods and total return hurdles, as well as observable market-based inputs, including interest rate curves, and unobservable inputs, such as expected volatility and a probability of the closing of the Merger. As a result, the Company has determined that its OPP valuation in its entirety is classified in Level 3 of the fair value hierarchy.
The valuation of the Listing Note is determined using a Monte Carlo simulation. This analysis reflects the known inputs of the valuation of the Listing Note, including the gross share proceeds received and the sum of dividends paid prior to the Listing, as well as observable market-based inputs, including interest rate curves, implied probability of the closing of the Merger and unobservable inputs, such as expected volatility. As a result, the Company has determined that its Listing Note valuation in its entirety is classified in Level 3 of the fair value hierarchy.
The Company has investments in common stock, redeemable preferred stock, a real estate income fund and senior notes that are traded in active markets and therefore, due to the availability of quoted market prices in active markets, the Company has classified these investments as Level 1 in the fair value hierarchy.

16

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

The following table presents information about the Company's assets and liabilities (including derivatives that are presented net) measured at fair value on a recurring basis as of June 30, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those instruments fall:
(In thousands)
 
Quoted Prices in Active Markets
Level 1
 
Significant Other Observable Inputs
Level 2
 
Significant Unobservable Inputs
Level 3
 
Total
June 30, 2014
 
 
 
 
 
 
 
 
Interest rate swaps
 
$

 
$
(340
)
 
$

 
$
(340
)
Investment securities
 
$
19,427

 
$

 
$

 
$
19,427

OPP (1)
 
$

 
$

 
$
(1,350
)
 
$
(1,350
)
Listing Note
 
$

 
$

 
$
(58,150
)
 
$
(58,150
)
December 31, 2013
 
 
 
 
 
 
 
 
Interest rate swaps
 
$

 
$
(333
)
 
$

 
$
(333
)
Investment securities
 
$
14,670

 
$

 
$

 
$
14,670

(1) The amount presented represents the fair value of all LTIP units issued under the OPP, of which $0.5 million has been recorded in general and administrative expense on the consolidated statement of operations and presented as a liability on the consolidated balance sheet in accounts payable and accrued expenses.
A review of the fair value hierarchy classification is conducted on a quarterly basis. Changes in the type of inputs may result in a reclassification for certain assets. There were no transfers between levels of the fair value hierarchy during the six months ended June 30, 2014.
Level 3 valuations
The following is a reconciliation of the beginning and ending balance for the changes in instruments with Level 3 inputs in the fair value hierarchy for the six months ended June 30, 2014:
(In thousands)
 
OPP
 
Listing Note
Beginning balance as of December 31, 2013
 
$

 
$

Fair value at issuance
 
33,200

 
27,400

Fair value adjustments
 
(31,850
)
 
30,750

Ending balance as of June 30, 2014
 
$
1,350

 
$
58,150

The following table provides quantitative information about the significant Level 3 inputs used:
Financial Instrument
 
Fair Value at June 30, 2014
 
Principal Valuation Technique
 
Unobservable Inputs
 
Input Value
 
 
(In thousands)
 
 
 
 
 
 
Listing Note
 
$
58,150

 
Monte Carlo Simulation
 
Expected volatility
 
17.0%
 
 
 
 
 
 
Merger Probability
 
95.0%
OPP
 
$
1,350

 
Monte Carlo Simulation
 
Expected volatility
 
29.0%
 
 
 
 
 
 
Merger Probability
 
95.0%
The following discussion provides a description of the impact on a fair value measurement of a change in each unobservable input in isolation. For the relationship described below, the inverse relationship would also generally apply.
Expected volatility is a measure of the variability in possible returns for an instrument, parameter or market index given how much the particular instrument, parameter or index changes in value over time. Generally, the higher the expected volatility of the underlying, the wider the range of potential future returns. An increase in expected volatility, in isolation, would generally result in an increase in the fair value measurement of an instrument.

17

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Pursuant to the OPP Termination Agreement, the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger (see Note 17 — Equity-Based Compensation). As such, all LTIP units previously issued under the OPP may be forfeited and any value associated with the OPP would be eliminated. The closing of the Merger also requires the Listing Note to be settled through the issuance of 5,613,374 OP units pursuant to the Listing Note Amendment, which will be converted into Ventas Class C units that are convertible into shares of Ventas Common Stock (see Note 2 — Merger Agreement). The probability input is a measure of the likelihood that the Merger will occur given legal and due diligence requirements that exist in order to close the Merger. An increase in the probability of the Merger, in isolation, would generally result in a decrease in the fair value of the OPP and an increase in the fair value of the Listing Note.
Financial instruments not carried at fair value
The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate that value. The fair value of short-term financial instruments such as cash and cash equivalents, restricted cash, investment securities, other receivables, due to affiliates, accounts payable and dividends payable approximates their carrying value on the consolidated balance sheets due to their short-term nature. The fair values of the Company's remaining financial instruments that are not reported at fair value on the consolidated balance sheets are reported below:
(In thousands)
 
Level
 
Carrying Amount at June 30, 2014
 
Fair Value at June 30, 2014
 
Carrying Amount at December 31, 2013
 
Fair Value at December 31, 2013
Mortgage notes payable and premiums, net (1)
 
3
 
$
308,207

 
$
313,932

 
$
262,117

 
$
266,242

Credit facility
 
3
 
$
507,500

 
$
507,500

 
$

 
$

Preferred equity investment
 
3
 
$
8,800

 
$
8,800

 
$

 
$

(1) Carrying value includes $304.2 million and $259.3 million mortgage notes payable and $4.0 million and $2.8 million net mortgage premiums as of June 30, 2014 and December 31, 2013, respectively.
The fair value of the mortgage notes payable are estimated using a discounted cash flow analysis, based on the Advisor's experience with similar types of borrowing arrangements. Advances under the credit facility are considered to be reported at fair value, since its interest rate varies with changes in LIBOR.
Note 12 — Interest Rate Derivatives and Hedging Activities
Risk Management Objective of Using Derivatives
The Company may use derivative financial instruments, including interest rate swaps, caps, collars, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and costs associated with the Company's operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements will not be able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships.
Cash Flow Hedges of Interest Rate Risk
The Company's objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company may use interest rate swaps and collars as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with forecasted variable-rate debt. Interest rate collars designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract and payments of variable-rate amounts if interest rates fall

18

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

below the floor strike rate on the contract.
The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings.
Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. During the next 12 months, the Company estimates that an additional $0.2 million will be reclassified from other comprehensive loss as an increase to interest expense.
As of June 30, 2014 and December 31, 2013, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:
 
 
June 30, 2014
 
December 31, 2013
Interest Rate Derivative
 
Number of
Instruments
 
Notional Amount
 
Number of
Instruments
 
Notional Amount
 
 
 
 
(In thousands)
 
 
 
(In thousands)
Interest rate swaps
 
3
 
$
22,266

 
3
 
$
22,266

The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of June 30, 2014 and December 31, 2013:
(In thousands)
 
Balance Sheet Location
 
June 30, 2014
 
December 31, 2013
Derivatives designated as hedging instruments:
 
 
 
 
 
 
Interest rate swaps
 
Derivatives, at fair value
 
$
(340
)
 
$
(333
)
Derivatives in Cash Flow Hedging Relationships
The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2014 and 2013:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(In thousands)
 
2014
 
2013
 
2014
 
2013
Amount of income (loss) recognized in accumulated other comprehensive loss from interest rate derivatives (effective portion)
 
$
(90
)
 
$
237

 
$
(134
)
 
$
222

Amount of loss reclassified from accumulated other comprehensive loss into income as interest expense (effective portion)
 
$
(64
)
 
$
(61
)
 
$
(127
)
 
$
(121
)
Amount of gain (loss) recognized in income on derivative instruments (ineffective portion and amount excluded from effectiveness testing)
 
$

 
$

 
$

 
$


19

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Offsetting Derivatives
The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's interest rate derivatives as of June 30, 2014 and December 31, 2013. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The table below provides the location that the fair value of derivative assets and liabilities are presented on the accompanying consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross Amounts Not Offset on the Balance Sheet
 
 
Derivatives (In thousands)
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset on the Balance Sheet
 
Net Amounts of Liabilities presented on the Balance Sheet
 
Financial Instruments
 
Cash Collateral Posted
 
Net Amount
June 30, 2014
 
$
(340
)
 
$

 
$
(340
)
 
$

 
$

 
$
(340
)
December 31, 2013
 
$
(333
)
 
$

 
$
(333
)
 
$

 
$

 
$
(333
)
Derivatives Not Designated as Hedges
Derivatives not designated as hedges are not speculative. These derivatives may be used to manage the Company's exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements to be classified as hedging instruments. The Company does not have any hedging instruments that do not qualify for hedge accounting.
Credit-risk-related Contingent Features
The Company has agreements with its derivative counterparties that contain a provision whereby if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligation.
As of June 30, 2014, the fair value of derivatives in a liability position related to these agreements, including accrued interest, but excluding any adjustment for nonperformance risk related to these agreements, was $0.4 million. As of June 30, 2014, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreement at its aggregate termination value of $0.4 million at June 30, 2014.
Note 13 — Common Stock
The Company listed its common stock on the NASDAQ under the symbol "HCT" on April 7, 2014. As of June 30, 2014 and December 31, 2013, the Company had 169.3 million and 180.5 million shares of common stock outstanding, respectively, including unvested restricted stock and shares issued under the DRIP.
On April 7, 2014, the Company commenced the Tender Offer. The Tender Offer was completed on May 2, 2014 with the Company purchasing approximately 13.6 million shares of its common stock at a price of $11.00 per share, for an aggregate of $150.1 million, excluding fees and expenses relating to the Tender Offer and including fractional shares repurchased thereafter. The Company funded the Tender Offer using a drawn on its Amended Facility.
On April 11, 2014, the Company filed a universal shelf registration statement that was declared effective. The Company intends to maintain the universal shelf registration statement.
On December 10, 2011, the board of directors authorized, and the Company declared, dividends payable to stockholders of record each day during the applicable period at a rate equal to $0.0018630137 per day, or $0.68 annually, per share of common stock beginning January 1, 2012. Following the Listing, dividends are paid to stockholders of record at the close of business on the 8th day of each month and payable on the 15th day of such month. Dividend payments are dependent on the availability of funds. The board of directors may reduce the amount of dividends paid or suspend dividend payments at any time and therefore dividend payments are not assured.

20

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

On April 1, 2014, the Company provided notice to its stockholders that, pursuant to the terms of the DRIP, the board of directors approved an amendment to the DRIP that enables the Company to suspend the DRIP. Subsequently, the board of directors approved the suspension of the DRIP, effective March 30, 2014. The final issuance of shares of common stock pursuant to the DRIP in connection with the Company’s March 2014 dividend was paid in April 2014.
On March 30, 2014, the board of directors approved the termination of the Company’s Share Repurchase Program (“SRP”). The Company processed all of the requests received under the SRP for the first quarter of 2014 and will not process further requests. The following table reflects the cumulative number of shares repurchased under the Company's SRP cumulatively through June 30, 2014:
 
 
Number of Requests
 
Number of Shares Repurchased
 
Average Price per Share
Cumulative repurchase requests as of December 31, 2013
 
122

 
386,968

 
$
9.77

Six months ended June 30, 2014
 
22

 
69,476

 
9.85

Cumulative repurchase requests as of June 30, 2014
 
144

 
456,444

 
$
9.79

Note 14 — Commitments and Contingencies
Future Minimum Lease Payments
The Company has entered into lease agreements related to certain acquisitions under leasehold interest arrangements. The following table reflects the minimum base cash rental payments due from the Company over the next five years and thereafter under these arrangements.  These amounts exclude contingent rent payments, as applicable, that may be payable based on provisions related to increases in annual rent based on exceeding certain economic indexes among other items.
(In thousands)
 
Future Minimum
Lease Payments
July 1, 2014 — December 31, 2014
 
$
335

2015
 
627

2016
 
634

2017
 
641

2018
 
664

Thereafter
 
23,553

 
 
$
26,454

Purchase Commitments
In July 2013, the Company entered into a construction advance agreement and purchase and sale agreement to initially fund the construction of, and subsequently purchase upon construction completion and rent commencement, a medical office building in Kenosha, Wisconsin for $24.5 million. As of June 30, 2014, the Company has funded $1.8 million and $19.3 million for the land and construction in progress, respectively.

21

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Litigation
In connection with the proposed acquisition by Ventas of all of the outstanding stock of the Company, purported shareholders of the Company have filed thirteen class action lawsuits in the Circuit Court for Baltimore City, Maryland and the Supreme Court of the State of New York and federal district court in Maryland naming the Company and its board of directors, among others, as defendants. The filed actions are: Holzer v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003553 (Md. Cir. Ct.), filed June 6, 2014; Romano v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003534 (Md. Cir. Ct.) filed June 6, 2014; Brenner v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003540 (Md. Cir. Ct.) filed June 9, 2014; Schindler v. Burns, et al., Index No. 671761/2014 (N.Y. Sup. Ct.), filed June 10, 2014; Frey v. American Realty Capital Healthcare Trust, Inc. et al., Index No. 651772/2014 (N.Y. Sup. Ct.), filed June 10, 2014; Hamill v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003636, (Md. Cir. Ct.), filed June 11, 2014; Stanley v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003664 (Md. Cir. Ct.), filed June 12, 2014; Shine v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003707 (Md. Cir. Ct.), filed June 13, 2014; Uhl v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003710 (Md. Cir. Ct.), filed June 13, 2014; Kuo v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003765 (Md. Cir. Ct), filed June 17, 2014; Flor v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003817 (Md. Cir. Ct.), filed June 19, 2014, Rosenzweig v. Schorsch et al., Case No. 1:14-CV-02019-GLR (U.S.D.C. - Dist. Md.) (Russell, D.J.), filed June 23, 2014 and Abbassi, et al. v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-004104 (Md. Cir. Ct.), filed July 9, 2014. The Stanley, Shine, Kuo, Rosenzweig and Abbassi complaints also assert derivative claims on behalf of the Company against the individual defendants. The filed actions allege, inter alia, breach of fiduciary duty and breach of contract claims arising from the proposed acquisition of the Company by Ventas and seek (i) to enjoin the proposed acquisition and (ii) recover damages if the proposed acquisition is completed. There have been no other court filings in any of these matters.
The Company believes that such lawsuits are without merit, but the ultimate outcome of such matter cannot be predicted with certainty. Because the lawsuits are in their early stages, neither the outcome of the lawsuits nor an estimate of a probable loss or any reasonable possible losses are determinable at this time. No provisions for such losses have been recorded in the accompanying consolidated financial statements for the three and six months ended June 30, 2014. An adverse judgment for monetary damages could have a material adverse effect on the operations and liquidity of the Company. A preliminary injunction could delay or jeopardize the completion of the Merger, and an adverse judgment granting permanent injunctive relief could indefinitely enjoin completion of the Merger. All defendants believe that the claims are without merit and are defending against them vigorously. Additional lawsuits arising out of or related to the Merger Agreement may be filed in the future. As of June 30, 2014, there were no other material legal proceedings pending or known to be contemplated against the Company.
Environmental Matters
In connection with the ownership and operation of real estate, the Company may potentially be liable for costs and damages related to environmental matters. As of June 30, 2014, the Company maintains environmental insurance for its properties that provides coverage for potential environmental liabilities, subject to the policy's coverage conditions and limitations. The Company has not been notified by any governmental authority of any non-compliance, liability or other claim, and is not aware of any other environmental condition that it believes will have a material adverse effect on the consolidated results of operations and comprehensive loss.
Note 15 — Related Party Transactions and Arrangements
The SLP, an entity wholly owned by the Sponsor, owned 20,000 shares of the Company's outstanding common stock as of June 30, 2014 and December 31, 2013.
The Advisor, as the holder of Class B units, had the right to make a capital contribution to the OP in exchange for OP units. Pursuant to a contribution and exchange agreement entered into between the Advisor and the OP dated April 7, 2014 (the "Contribution and Exchange Agreement"), the Advisor contributed $0.8 million in cash to the OP in exchange for 83,333 OP units of the OP (see Note 19  — Non-Controlling Interests).

22

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

During the six months ended June 30, 2014, the Company invested $3.0 million in a real estate income fund managed by an affiliate of the Sponsor (see Note 6 — Investment Securities). There is no obligation to purchase any additional shares and the shares can be sold at any time.
Fees Paid in Connection with the IPO
The Dealer Manager was paid fees and compensation in connection with the sale of the Company's common stock in the IPO. The Dealer Manager received a selling commission of up to 7.0% of gross offering proceeds before reallowance of commissions earned by participating broker-dealers. In addition, the Dealer Manager received up to 3.0% of the gross proceeds, from the sale of common stock, before reallowance to participating broker-dealers, as a dealer manager fee. The Dealer Manager was permitted to reallow its dealer manager fee to participating broker-dealers, based on such factors as the volume of shares sold by respective participating broker-dealers and marketing support incurred as compared to those of other participating broker-dealers. The following table details total selling commissions and dealer manager fees incurred and receivable from the Dealer Manager as of and for the periods presented:
 
 
Three Months Ended
 
Six Months Ended
 
Receivable (1) as of
 
 
June 30,
 
June 30,
 
June 30,
 
December 31,
(In thousands)
 
2014
 
2013
 
2014
 
2013
 
2014
 
2013
Total commissions and fees incurred from the Dealer Manager
 
$
(19
)
 
$
60,913

 
$

 
$
117,425

 
$
(18
)
 
$
(18
)
_____________________
(1) Includes reimbursements received for selling commissions and dealer manager fees as a result of share purchase cancellations related to common stock sales prior to the close of the IPO
The Advisor and its affiliates received compensation and reimbursement for services provided in connection with the IPO. Effective March 1, 2013, the Company utilized transfer agent services provided by an affiliate of the Dealer Manager. All offering costs related to the IPO incurred by the Company, or its affiliated entities, on behalf of the Company were charged to additional paid-in capital on the accompanying consolidated balance sheets during the IPO. The following table details offering costs and reimbursements incurred from and payable to the Advisor and Dealer Manager as of and for the periods presented:
 
 
Three Months Ended
 
Six Months Ended
 
Payable as of
 
 
June 30,
 
June 30,
 
June 30,
 
December 31,
(In thousands)
 
2014
 
2013
 
2014
 
2013
 
2014
 
2013
Fees and expense reimbursements incurred from the Advisor and Dealer Manager
 
$

 
$
622

 
$

 
$
1,901

 
$

 
$

Fees Paid in Connection With the Operations of the Company
The Advisor is paid an acquisition fee equal to 1.0% of the contract purchase price of each acquired property and 1.0% of the amount advanced for a loan or other investment and is reimbursed for acquisition costs incurred in the process of acquiring properties, which is expected to be approximately 0.5% of the contract purchase price of each acquired property and 0.5% of the amount advanced for a loan or other investment. The total of all acquisition fees, acquisition expenses and financing coordination fees (as defined below), with respect to the Company's portfolio of investments, did not exceed 4.5% of the contract purchase price of the Company's portfolio as measured at the close of the acquisition phase. On April 7, 2014, in connection with the Listing, the Company entered into the Third Amended and Restated Advisory Agreement (the "Amended Advisory Agreement") by and among the Company, the OP and the Advisor, which, among other things, terminates the acquisition fee 180 days after the Listing, or October 4, 2014 (the "Termination Date"), except for fees with respect to properties under contract, letter of intent or under negotiation as of the Termination Date.

23

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

If the Advisor provides services in connection with the origination or refinancing of any debt that the Company obtains and uses to acquire properties or to make other permitted investments, or that is assumed, directly or indirectly, in connection with the acquisition of properties, the Company pays the Advisor a financing coordination fee equal to 1.0% of the amount available or outstanding under such financing, subject to certain limitations. In accordance with the Amended Advisory Agreement, the financing coordination fee terminates on the Termination Date, except for fees with respect to properties under contract, letter of intent or under negotiation as of the Termination Date.
In connection with providing strategic advisory services related to certain portfolio acquisitions, the Company has entered into arrangements in which the investment banking division of the Dealer Manager receives a transaction fee of 0.25% of the transaction value for such portfolio acquisition transactions. Should the Dealer Manager provide strategic advisory services related to additional portfolio acquisition transactions, the Company will enter into new arrangements with the Dealer Manager on such terms as may be agreed upon between the two parties.
Until the Listing, in respect of the asset management subordination, the Advisor was entitled to Class B units equal to: (i) the excess of (A) the product of (y) the cost of assets multiplied by (z) 0.1875% over (B) any amounts payable as an oversight fee (as described below) for such calendar quarter; divided by (ii) the per share price in the primary portion of the IPO, excluding commissions and dealer manager fees. In respect of this arrangement, the Company caused the OP to issue (subject to periodic approval by the board of directors) to the Advisor performance-based restricted partnership units of the OP designated as "Class B units," which were intended to be profit interests and vest, and no longer be subject to forfeiture, at such time as: (x) the value of the OP's assets plus all dividends made equaled or exceeded the total amount of capital contributed by investors plus a 6% cumulative, pre-tax, non-compounded annual return thereon (the "economic hurdle"); (y) any one of the following occurs: (1) the termination of the advisory agreement by an affirmative vote of a majority of the Company's independent directors without cause; (2) a listing; or (3) another liquidity event; and (z) the Advisor is still providing advisory services to the Company (the "performance condition"). The value of issued Class B units was determined and expensed when the Company deemed the achievement of the performance condition to be probable, which occurred as of the Listing. As of April 7, 2014, in aggregate, the board of directors had approved the issuance of 1,360,362 Class B units to the Advisor in connection with this arrangement. The Advisor received dividends on unvested Class B units equal to the dividend rate received on the Company's common stock. Such dividends on issued Class B units are included in general and administrative expenses in the consolidated statement of operations and comprehensive loss. The performance condition related to these Class B units was satisfied upon completion of the Listing, which resulted in $12.9 million of expense on April 7, 2014, which is included in vesting of Class B units for asset management services expense on the consolidated statement of operations and comprehensive loss. On April 7, 2014, the Class B units were converted to OP units on a one-to-one basis.
In accordance with the Amended Advisory Agreement, the asset management fee was amended to 0.50% per annum of average invested assets up to $3.0 billion and 0.40% per annum of average invested assets above $3.0 billion. The Amended Advisory Agreement also permits the asset management fee to be paid in the form of cash, OP units and shares of restricted common stock of the Company, or a combination thereof, at the Advisor's election.
Concurrently with the execution of the Merger Agreement, the Company entered into an amendment, whereby the parties have agreed to terminate the Amended Advisory Agreement immediately prior to, and contingent upon, the closing of the Merger.
Unless the Company contracts with a third party, the Company pays the Property Manager a property management fee of up to 1.5% of gross revenues from the Company's stand-alone single-tenant net leased properties and up to 2.5% of gross revenues from all other types of properties, respectively, plus market-based leasing commission applicable to the geographic location of each property.  The Company also reimburses the affiliate for property level expenses. If the Company contracts directly with third parties for such services, the Company pays them customary market fees and pays the Property Manager an oversight fee of up to 1.0% of the gross revenues of the applicable property. In no event will the Company pay the Property Manager or any affiliate both a property management fee and an oversight fee with respect to any particular property. Concurrently with the execution of the Merger Agreement, the Company entered into an amendment (the “Property Management Agreement Amendment”). Under the Property Management Agreement Amendment, the parties have agreed to terminate the property

24

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

management agreement immediately prior to, and contingent upon, the closing of the Merger. The Property Management Agreement Amendment will, pursuant to its terms, automatically terminate and be of no further force or effect if the Merger Agreement is terminated in accordance with its terms.
Effective March 1, 2013, the Company entered into an agreement with the Dealer Manager to provide strategic advisory and investment banking services required in the ordinary course of the Company's business, such as performing financial analysis, evaluating publicly traded comparable companies and assisting in developing a portfolio composition strategy, a capitalization structure to optimize future liquidity options and structuring operations. Strategic advisory fees were amortized over the term of the IPO and included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. The Dealer Manager and its affiliates also provide transfer agency services, as well as transaction management and other professional services. After the close of the IPO, these fees were included in general and administrative expenses on the consolidated statement of operations and comprehensive loss during the period the service was provided.
The following table details amounts incurred, forgiven and payable to related parties in connection with the Company's operations-related services described above as of and for the periods presented:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Payable as of
 
2014
 
2013
 
2014
 
2013
 
June 30,
 
December 31,
(In thousands)
Incurred
 
Forgiven
 
Incurred
 
Forgiven
 
Incurred
 
Forgiven
 
Incurred
 
Forgiven
 
2014
 
2013
One-time fees and reimbursements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisition fees and related cost reimbursements
$
2,218

 
$

 
$
1,852

 
$

 
$
4,533

 
$

 
$
2,880

 
$

 
$

 
$

Financing coordination fees
59

 

 

 

 
361

 

 
158

 

 

 

Other expense reimbursements

 

 
19

 

 

 

 
19

 

 

 

Ongoing fees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset management services (1)
2,352

 

 

 

 
2,352

 

 

 

 
2,352

 

Property management and leasing fees

 
704

 

 
268

 

 
1,311

 

 
491

 

 

Transfer agent and other professional fees
615

 

 
226

 

 
1,197

 

 
226

 

 
377

 
235

Strategic advisory fees

 

 
460

 

 

 

 
920

 

 

 

Dividends on Class B Units
12

 

 
37

 

 
151

 

 
54

 

 

 

Total related party operation fees and reimbursements
$
5,256

 
$
704

 
$
2,594

 
$
268

 
$
8,594

 
$
1,311

 
$
4,257

 
$
491

 
$
2,729

 
$
235

___ ____________
(1) Prior to the Listing, the Company caused the OP to issue the Advisor restricted performance based Class B units for asset management services, which vested with the Listing. Amounts reflected in the table reflect asset management services following the Listing as described above.
The Company reimburses the Advisor's costs of providing administrative services, subject to the limitation that it will not reimburse the Advisor for any amount by which its operating expenses (including the asset management fee) at the end of the four preceding fiscal quarters exceeds the greater of (a) 2% of average invested assets, or (b) 25% of net income other than any additions to reserves for depreciation, bad debt or other similar non-cash reserves and excluding any gain from the sale of assets for that period. Additionally, the Company will not reimburse the Advisor for personnel costs in connection with services for which the Advisor receives acquisition fees or real estate commissions. No reimbursement was incurred from the Advisor for providing administrative services, including any reimbursement for compensation to named officers of the Company, for the three and six months ended June 30, 2014 or 2013.
In order to improve operating cash flows and the ability to pay dividends from operating cash flows, the Advisor and the Property Manager agreed to waive certain fees including property management fees during the three and six months ended June 30, 2014. Because the Advisor and the Property Manager waived certain fees, cash flows from operations that would have been paid to the Advisor and the Property Manager were available to pay dividends to stockholders. The fees that were forgiven

25

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

are not deferrals and accordingly, will not be paid to the Advisor or the Property Manager in any subsequent periods. In certain instances, to improve the Company's working capital, the Advisor may elect to absorb a portion of the Company's general and administrative costs. No such fees were absorbed during the three and six months ended June 30, 2014 or the three months ended June 30, 2013. For the six months ended June 30, 2013, the Advisor absorbed $0.3 million of the Company's general and administrative costs. The Company did not have a receivable due from the Advisor related to absorbed general and administrative costs as of June 30, 2014 and December 31, 2013. These absorbed costs are presented net in the accompanying consolidated statements of operations and comprehensive loss.
Fees Incurred in Connection with the Liquidation or Listing of the Company's Real Estate Assets
Fees Incurred in Connection with the Listing
In December 2013, the Company entered into a transaction management agreement with RCS Advisory Services, LLC, an entity owned by the Dealer Manager, to provide strategic alternatives transaction management services through the occurrence of a liquidity event and a-la-carte services thereafter. The Company agreed to pay $3.0 million pursuant to this agreement. During the three and six months ended June 30, 2014, the Company incurred $1.5 million in fees pursuant to this agreement, which includes amounts for services provided in preparation for the Listing, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. No such amounts were incurred during the three and six months ended June 30, 2013. The Company incurred $1.5 million in fees pursuant to this arrangement during the year ended December 31, 2013 which were included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss. Thus the Company does not owe the Dealer Manager any more fees pursuant to this agreement.
In December 2013, the Company entered into an information agent and advisory services agreement with the Dealer Manager and American National Stock Transfer, LLC, an entity owned by the Dealer Manager, to provide in connection with a liquidity event, advisory services, educational services to external and internal wholesalers, communication support as well as proxy, tender offer or redemption and solicitation services. The Company agreed to pay $1.9 million pursuant to this agreement. During the three and six months ended June 30, 2014, the Company incurred $1.3 million of these fees pursuant to this agreement, which includes amounts for services provided in preparation for the Tender Offer, and is included in additional paid in capital on the consolidated balance sheet. No such amounts were incurred during the three and six months ended June 30, 2013. The Company incurred $0.6 million in fees pursuant to this arrangement during the year ended December 31, 2013 which were included in acquisition and transaction related costs in the consolidated statement of operations.
The investment banking division of the Dealer Manager provided the Company with strategic and financial advice and assistance in connection with (i) a possible sale transaction involving the Company (ii) the possible listing of the Company's securities on a national securities exchange, and (iii) a possible acquisition transaction involving the Company. The Dealer Manager received a listing advisory fee equal to an amount equal to 0.25% of the transaction value. During the three and six months ended June 30, 2014, the Company incurred $6.4 million in connection with this agreement, which is included in acquisition and transaction related expenses on the consolidated statement of operations and comprehensive loss.
During the three and six months ended June 30, 2014, the Company also incurred $1.5 million of expenses with affiliated entities relating to general legal, marketing and sales services provided in connection with the Listing and other non-recurring transactions. These expenses are included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss.

26

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Fees Incurred in Connection with the Merger
In May 2014, the Company entered into a transaction management agreement with RCS Advisory Services, LLC, an entity owned by the Dealer Manager, to provide, in connection with the Merger, strategic alternatives transaction management services through the occurrence of a sale transaction and a-la-carte services thereafter. The Company agreed to pay $3.0 million pursuant to this agreement. During the three and six months ended June 30, 2014, the Company incurred $2.0 million in fees pursuant to this agreement, which includes amounts for services provided in preparation for the Merger, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. This amount is included in accounts payable and accrued expenses on the consolidated balance sheet as of June 30, 2014. No such amounts were incurred during three and six months ended June 30, 2013.
In May 2014, the Company entered into an information agent and advisory services agreement with the Dealer Manager and American National Stock Transfer, LLC, an entity owned by the Dealer Manager, to provide in connection with the Merger, advisory services, educational services to external and internal wholesalers and communication support. The Company agreed to pay $1.9 million pursuant to this agreement. During the three and six months ended June 30, 2014, the Company incurred $0.6 million of these fees pursuant to this agreement, which includes amounts for services provided in preparation for the Merger, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. This amount is included in accounts payable and accrued expenses on the consolidated balance sheet as of June 30, 2014. No such amounts were incurred during three and six months ended June 30, 2013.
The investment banking division of the Dealer Manager provides the Company with strategic and financial advice and assistance in connection with a possible sale transaction involving the Company. The Dealer Manager will receive a transaction advisory fee equal to the greatest (i) an amount equal to 0.25% of the transaction value, (ii) $1.0 million and (iii) the highest fee payable to any co-bookrunner (or comparable person) in connection with the transaction. If the possible sale transaction does not occur, the Dealer Manger will receive a base advisor services fee of $1.0 million on the earlier of (a) the date the Dealer Manager resigns or is terminated for cause and (b) 18 months from the date of any other termination of this agreement by the Company. No such amounts were incurred during the three and six months ended June 30, 2014 or 2013.
During the three and six months ended June 30, 2014, the Company also incurred $0.1 million of expenses with affiliated entities relating to legal, consulting and other expenses provided in connection with the Merger. These expenses are included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss.
Other Liquidation Related Fees
The Company will pay a brokerage commission on the sale of property, not to exceed the lesser of 2.0% of the contract sale price of the property and 50.0% of the total brokerage commission paid if a third party broker is also involved; provided, however, that in no event may the real estate commissions paid to the Advisor, its affiliates and unaffiliated third parties exceed the lesser of 6.0% of the contract sales price and a reasonable, customary and competitive real estate commission, in light of the size, type and location of the property, in each case, payable to the Advisor or its affiliates, as determined by a majority of the independent directors. No such fees were incurred during the three and six months ended June 30, 2014 or 2013.
Concurrent with the Listing, the OP entered into the Listing Note (see Note 10 — Subordinated Listing Distribution Derivative) and the OPP (see Note 17 — Equity-Based Compensation).
In connection with the Listing and the Amended Advisory Agreement, the Company terminated the subordinated termination fee that would be due to the Advisor in the event of termination of the advisory agreement.
Note 16 — Economic Dependency
Under various agreements, the Company has engaged or will engage the Advisor and its affiliates and entities under common control with our Advisor, to provide certain services that are essential to the Company, including asset management services, supervision of the management and leasing of properties owned by the Company, asset acquisition and disposition decisions, transfer agency services, as well as other administrative responsibilities for the Company including accounting services, transaction management services and investor relations.

27

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

As a result of these relationships, the Company is dependent upon the Advisor and its affiliates. In the event that these companies are unable to provide the Company with the respective services, the Company will be required to find alternative providers of these services.
Note 17 — Equity-Based Compensation
Stock Option Plan
The Company has a stock option plan (the "Plan") which authorizes the grant of nonqualified stock options to the Company's independent directors, officers, advisors, consultants and other personnel subject to the absolute discretion of the board of directors and the applicable limitations of the Plan. The exercise price for all stock options granted under the Plan was fixed at $10.00 per share until the Listing, and thereafter the exercise price for stock options granted to the independent directors will be equal to the fair market value of a share on the last business day preceding the annual meeting of stockholders. Upon a change in control, unvested options will become fully vested and any performance conditions imposed with respect to the options will be deemed to be fully achieved. A total of 0.5 million shares have been authorized and reserved for issuance under the Plan. As of June 30, 2014 and December 31, 2013, no stock options were issued under the Plan. In connection with the Merger Agreement, the Company has agreed to terminate the Plan, contingent on the closing of the Merger.
Restricted Share Plan
The Company's employee and director incentive restricted share plan ("RSP") provides the Company with the ability to grant awards of restricted shares to the Company's directors, officers and employees (if the Company ever has employees), employees of the Advisor and its affiliates, employees of entities that provide services to the Company, directors of the Advisor or of entities that provide services to the Company, certain consultants to the Company and the Advisor and its affiliates or to entities that provide services to the Company.
Prior to April 28, 2014, the RSP provided for the automatic grant of 3,000 restricted shares of common stock to each of the independent directors, without any further action by the Company's board of directors or the stockholders, on the date of initial election to the board of directors and on the date of each annual stockholder's meeting. Restricted stock issued to independent directors vested over a five-year period following the first anniversary of the date of grant in increments of 20% per annum. On April 28, 2014, the Company amended the RSP to, among other things, remove the fixed amount of shares that are automatically granted to the independent directors and remove the fixed vesting period of five years. Under the amended RSP, the annual amount granted to the independent directors is determined by the board of directors. Under the amended RSP, restricted share awards entitle the recipient to receive shares of common stock from the Company under terms that provide for vesting over a specified period of time or upon attainment of pre-established performance objectives. Such awards would typically be forfeited with respect to the unvested shares upon the termination of the recipient's employment or other relationship with the Company.
Prior to March 30, 2014, the total number of common shares granted under the RSP could not exceed 5.0% of the Company's outstanding shares of common stock on a fully diluted basis at any time, and in any event could not exceed 7.5 million shares (as such number may be adjusted for stock splits, stock dividends, combinations and similar events). On March 30, 2014, the Company adopted an amendment to the Company’s RSP to increase the number of shares of the Company capital stock, par value $0.01 per share, available for awards thereunder to 10.0% of the Company’s outstanding shares of stock on a fully diluted basis at any time. The amendment also eliminated the RSP limit of 7.5 million shares of stock.
Restricted shares may not, in general, be sold or otherwise transferred until restrictions are removed and the shares have vested. Holders of restricted shares may receive cash dividends prior to the time that the restrictions on the restricted shares have lapsed. Any dividends payable in shares of common stock shall be subject to the same restrictions as the underlying restricted shares. In connection with the Merger Agreement, the Company has agreed to terminate the RSP, contingent on the closing of the Merger.

28

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

The following table reflects restricted share award activity to the Company's board of directors for the six months ended June 30, 2014:
 
Number of Restricted Shares
 
Weighted-Average Issue Price
Unvested, December 31, 2013
18,000

 
$
9.23

Granted
225,905

 
9.07

Vested (1)
(18,000
)
 
9.23

Unvested, June 30, 2014
225,905

 
$
9.07

______________________
(1) Previously granted unvested restricted stock outstanding vested as of the Listing.
As of June 30, 2014, the Company had $2.0 million of unrecognized compensation cost related to unvested restricted share awards granted under the Company's RSP.
The fair value of the restricted shares, based on the price per share in the IPO or the per share closing price on the NASDAQ subsequent to the IPO, is expensed over the vesting period of three or five years. Compensation expense related to restricted stock was $0.2 million and approximately $9,000 for the three months ended June 30, 2014 and June 30, 2013, respectively. Compensation expense related to restricted stock was $0.2 million and approximately $18,000 for the six months ended June 30, 2014 and June 30, 2013, respectively. Compensation expense of $0.1 million related to the vesting of restricted stock in connection with the Listing is recorded in acquisition and transaction costs and compensation expense of $0.1 million related to the amortization of restricted stock in connection with shares granted during the three and six months ended June 30, 2014 is recorded in equity-based compensation in the consolidated statement of operations.
Multi-Year Outperformance Plan
On the OPP Effective Date in connection with the Listing, the Company entered into the OPP with the OP and the Advisor. Under the OPP, the Advisor was issued 9,219,108 LTIP units in the OP with a maximum award value on the issuance date equal to 5.0% of the Company’s market capitalization (the “OPP Cap”). The LTIP units are structured as profits interest in the OP. Concurrently with the execution of the Merger Agreement, the Company, the OP and the Advisor entered into an agreement (the “OPP Termination Agreement”) terminating the OPP. Under the OPP Termination Agreement, the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger.

29

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

If the Merger is not completed, the Advisor may be eligible to earn a number of LTIP units with a value equal to a portion of the OPP Cap upon the first, second and third anniversaries of the OPP Effective Date based on the Company’s achievement of certain levels of total return to its stockholders (“Total Return”), including both share price appreciation and common stock dividends, as measured against a peer group of companies, as set forth below, for the three-year performance period commencing on the OPP Effective Date (the “Three-Year Period”); each 12-month period during the Three-Year Period (each, a “One-Year Period”); and the initial 24-month period of the Three-Year Period (the “Two-Year Period”), as follows:
 
 
Performance Period
 
Annual Period
 
Interim Period
Absolute Component: 4% of any excess Total Return attained above an absolute hurdle measured from the beginning of such period:
21%
 
7%
 
14%
Relative Component: 4% of any excess Total Return attained above the Total Return for the performance period of the Peer Group*, subject to a ratable sliding scale factor as follows based on achievement of cumulative Total Return measured from the beginning of such period:
 
 
 
 
 
100% will be earned if cumulative Total Return achieved is at least:
18%
 
6%
 
12%
50% will be earned if cumulative Total Return achieved is:
—%
 
—%
 
—%
0% will be earned if cumulative Total Return achieved is less than:
—%
 
—%
 
—%
a percentage from 50% to 100% calculated by linear interpolation will be earned if the cumulative Total Return achieved is between:
0% - 18%
 
0% - 6%
 
0%- 12%
____________________
*The “Peer Group” is comprised of the companies in the SNL US REIT Healthcare Index.
The potential outperformance award is calculated at the end of each One-Year Period, the Two-Year Period and the Three-Year Period. The award earned for the Three-Year Period is based on the formula in the table above less any awards earned for the Two-Year Period and One-Year Periods, but not less than zero; the award earned for the Two-Year Period is based on the formula in the table above less any award earned for the first and second One-Year Period, but not less than zero. Any LTIP units that are unearned at the end of the performance period will be forfeited.
Until such time as the LTIP units are fully vested in accordance with the provisions of the OPP, the LTIP units are entitled to dividends equal to 10% of the dividends made on OP units. After the LTIP units are fully vested, they are entitled to a catch-up dividends and then the same dividends as the OP units. At the time the Advisor’s capital account with respect to the LTIP units is economically equivalent to the average capital account balance of the OP units and has been earned and has been vested for 30 days, the applicable LTIP units will automatically convert into OP units on a one-to-one basis. The OPP provides for early calculation of LTIP units earned and for the accelerated vesting of any earned LTIP units in the event Advisor is terminated or in the event the Company incurs a change in control, in either case prior to the end of the Three-Year Period.
Because the Advisor can terminate at any time and receive the value of the award at the next anniversary date, the estimated value of the award as of the first anniversary was expensed on the OPP Effective Date and the estimated value of the award on the second and third anniversaries is being amortized over the first year and first two years of the OPP, respectively. The estimated fair value of the award at each anniversary date is determined using a Monte Carlo simulation with certain inputs including probability of the Merger (see Note 11 — Fair Value of Financial Instruments). The fair value of the award and related expense is adjusted each reporting period for changes in the estimated value. The Company recorded an expense related to the OPP of $0.5 million for the three and six months ended June 30, 2014, which is included in general and administrative expenses on the consolidated statement of operations. Because the award can be settled in cash, the related liability is included in accounts payable and accrued expenses on the consolidated balance sheet.

30

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Other Share-Based Compensation
Until the Listing, the Company could issue common stock in lieu of cash to pay fees earned by the Company's directors at the respective director's election. There are no restrictions on the shares issued. There were no such shares issued during the six months ended June 30, 2014. During the six months ended June 30, 2013, the Company issued 1,667 shares in lieu of payment of approximately $15,000 in cash.
Note 18 — Net Loss Per Share
The following is a summary of the basic and diluted net loss per share computation for the three and six months ended June 30, 2014 and 2013:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2014
 
2013
 
2014
 
2013
Net loss attributable to stockholders (in thousands)
$
(97,289
)
 
$
(3,258
)
 
$
(104,324
)
 
$
(6,864
)
Basic and diluted weighted average shares outstanding
175,129,424

 
170,124,871

 
178,357,402

 
123,834,119

Basic and diluted net loss per share attributable to stockholders
$
(0.56
)
 
$
(0.02
)
 
$
(0.58
)
 
$
(0.06
)
The Company had the following common share equivalents as of June 30, 2014 and 2013, which were excluded from the calculation of diluted loss per share attributable to stockholders as the effect would have been antidilutive:
 
June 30,
 
2014
 
2013
Unvested restricted stock
225,905
 
22,200
OP units
1,443,897
 
202
Class B units

 
275,135
Total common stock equivalents
1,669,802
 
297,537
Note 19  — Non-Controlling Interests
The Company is the sole general partner of the OP and holds the majority of OP units. The Advisor, a limited partner, held 202 OP units as of December 31, 2013, which represent a nominal percentage of the aggregate OP ownership. On April 7, 2014, 1,360,362 Class B units that were previously issued to the Advisor for asset management services were converted to OP units on a one-to-one basis. Additionally, the Advisor, as the holder of Class B units, had the right to make a capital contribution to the OP in exchange for OP units. Pursuant to the Contribution and Exchange Agreement, the Advisor contributed $0.8 million in cash to the OP in exchange for 83,333 OP units of the OP. As of June 30, 2014, the Advisor held 1,443,897 OP units. There were $0.2 million of OP unit dividends to the Advisor during the three and six months ended June 30, 2014.
A holder of OP units has the right to convert OP units for the cash value of a corresponding number of shares of the Company's common stock or a corresponding number of shares of the Company's common stock, at the Company's election, in accordance with the limited partnership agreement of the OP. The remaining rights of the holders of OP units are limited, however, and do not include the ability to replace the general partner or to approve the sale, purchase or refinancing of the OP's assets.
The Company has investment arrangements with unaffiliated third parties whereby such investors receive an ownership interest in certain of the Company's property-owning subsidiaries and are entitled to receive a proportionate share of the net operating cash flow derived from the subsidiaries' property. Upon disposition of a property subject to non-controlling interest, the investor will receive a proportionate share of the net proceeds from the sale of the property. The investor has no recourse to any other assets of the Company. Due to the nature of the Company's involvement with each of the arrangements described in the table below and the significance of its investment in relation to the investment of the third parties, the Company has determined that it controls each entity in each of these arrangements and, therefore, the entities related to these arrangements

31

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

are consolidated within the Company's financial statements. A non-controlling interest is recorded for each investors' ownership interest in the property.
The following table summarizes the activity related to investment arrangements with unaffiliated third parties:
 
 
 
 
 
 
 
 
As of June 30, 2014
 
Distributions
 
 
 
 
 Net Investment
 
 Non-Controlling Ownership
 
Net Real Estate Assets Subject to
 
Mortgage Payables
Subject to
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Property Name (Dollar amounts in thousands)
 
Investment
Date
 
Amount as of June 30, 2014
 
Percentage as of June 30, 2014
 
Investment
Arrangement
 
Investment
Arrangement
 
2014
 
2013
 
2014
 
2013
Reliant Rehabilitation - Dallas, TX
 
Nov. 2011
 
$

 
%
 
$

 
$

 
$

 
$
41

 
$
40

 
$
81

Odessa Regional MOB - Odessa, TX (1)
 
Dec. 2011
 

 
%
 

 

 

 
4

 

 
4

Methodist North MOB - Peoria, IL (1)
 
Dec. 2011
 

 
%
 

 

 

 
12

 

 
12

University of Wisconsin Health MOB - Monona, WI
 
Mar. 2012
 
2,300

 
25
%
 
8,118

 
5,039

 
48

 
47

 
93

 
93

Total
 
 
 
$
2,300

 
 
 
$
8,118

 
$
5,039

 
$
48

 
$
104

 
$
133

 
$
190

_________________
(1) During the year ended December 31, 2013, the Company fully redeemed the third parties' interest in Odessa Regional MOB and Methodist North MOB for an aggregate of $0.1 million.
(2) During the three months ended March 31, 2014, Company fully redeemed the third parties' interest in Reliant Rehabilitation - Dallas, TX for an aggregate of $2.0 million.
Note 20 — Segment Reporting
During the six months ended June 30, 2014 and 2013, the Company operated in three reportable business segments for management and internal financial reporting purposes: medical office buildings; triple-net buildings; and seniors housing communities.
These operating segments are the segments of the Company for which separate financial information is available and for which segment results are evaluated in deciding how to allocate resources and in assessing performance. The medical office buildings primarily consists of medical office buildings leased to healthcare-related tenants under long-term leases, which may require such tenants to pay a pro-rata share of property-related expenses. The seniors housing communities segment primarily consists of investments in assisted living, independent living and memory care facilities located in the United States which the Company operates through engaging independent third-party managers. The triple-net buildings segment primarily consists of investments in hospitals, inpatient rehabilitation facilities and seniors housing communities under long-term leases, under which tenants are responsible to directly pay property-related expenses. The Company evaluates performance of the combined properties in each segment based on net operating income. Net operating income is defined as total revenues less property operating and maintenance expenses. There are no intersegment sales or transfers. The Company uses net operating income to evaluate the operating performance of real estate investments and to make decisions concerning the operation of the properties. The Company believes that net operating income is useful to investors in understanding the value of income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as operating fees to affiliates, acquisition and transaction related expenses, general and administrative expenses, depreciation and amortization expense and interest expense. Additionally, net operating income as defined by the Company may not be comparable to net operating income as defined by other REITs or companies.
For federal income tax purposes, we have elected to be taxed as a REIT beginning with our taxable year ended December 31, 2011. REIT status imposes limitations related to seniors housing communities. Generally, to qualify as a REIT, we cannot directly operate seniors housing communities. However, such facilities may generally be operated by a taxable REIT subsidiary ("TRS") pursuant to a lease with the Company. Therefore, the Company has formed multiple TRS subsidiaries under the OP to operate the seniors housing communities pursuant to contracts with unaffiliated management companies. The Company's TRS entities incurred $0.2 million and approximately $44,000 in federal and state income taxes for the three months ended June 30,

32

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

2014 and 2013. The Company's TRS entities incurred $0.6 million and $0.1 million in federal and state income taxes for the six months ended June 30, 2014 and 2013. Federal and state income taxes are included in general and administrative expenses on the accompanying consolidated statements of operations and comprehensive loss.
The following tables reconcile the segment activity to consolidated net income for the three and six months ended June 30, 2014 and 2013. The segment information for the three and six months ended June 30, 2013 have been restated to conform to the presentation applicable to the three and six months ended June 30, 2014.
 
 
Three Months Ended June 30, 2014
 
Six Months ended June 30, 2014
(In thousands)
 
Medical Office Buildings
 
Triple-Net Buildings
 
Seniors Housing Communities
 
Consolidated
 
Medical Office Buildings
 
Triple-Net Buildings
 
Seniors Housing Communities
 
Consolidated
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rental income
 
$
20,753

 
$
8,738

 
$
26,093

 
$
55,584

 
$
40,721

 
$
13,372

 
$
49,008

 
$
103,101

Operating expense reimbursements
 
4,192

 
75

 

 
4,267

 
8,218

 
233

 

 
8,451

Resident services and fee income
 

 

 
4,918

 
4,918

 

 

 
9,206

 
9,206

Total revenues
 
24,945

 
8,813

 
31,011

 
64,769

 
48,939

 
13,605

 
58,214

 
120,758

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property operating and maintenance
 
4,916

 
163

 
21,159

 
26,238

 
9,688

 
387

 
39,642

 
49,717

Net operating income
 
$
20,029

 
$
8,650

 
$
9,852

 
$
38,531

 
$
39,251

 
$
13,218

 
$
18,572

 
$
71,041

Operating fees to affiliate
 
 
 
 
 
 
 
2,352

 
 
 
 
 
 
 
2,352

Acquisition and transaction related
 
 
 
 
 
 
 
22,456

 
 
 
 
 
 
 
25,878

Vesting of Class B units for asset management services
 
 
 
 
 
 
 
12,917

 
 
 
 
 
 
 
12,917

Fair value of listing note
 
 
 
 
 
 
 
58,150

 
 
 
 
 
 
 
58,150

General and administrative
 
 
 
 
 
 
 
2,674

 
 
 
 
 
 
 
4,592

Equity-based compensation
 
 
 
 
 
 
 
97

 
 
 
 
 
 
 
107

Depreciation and amortization
 
 
 
 
 
 
 
31,713

 
 
 
 
 
 
 
60,656

Interest expense
 
 
 
 
 
 
 
7,108

 
 
 
 
 
 
 
12,651

Income from preferred equity investment, investment securities and other income
 
 
 
 
 
 
 
(495
)
 
 
 
 
 
 
 
(795
)
Gain on sale of investment securities
 
 
 
 
 
 
 
(335
)
 
 
 
 
 
 
 
(335
)
Net loss attributable to non-controlling interests
 
 
 
 
 
 
 
(817
)
 
 
 
 
 
 
 
(808
)
Net loss attributable to stockholders
 
 
 
 
 
 
 
$
(97,289
)
 
 
 
 
 
 
 
$
(104,324
)

33

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

 
 
Three Months Ended June 30, 2013
 
Six Months ended June 30, 2013
(In thousands)
 
Medical Office Buildings
 
Triple-Net Buildings
 
Seniors Housing Communities
 
Consolidated
 
Medical Office Buildings
 
Triple-Net Buildings
 
Seniors Housing Communities
 
Consolidated
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rental income
 
$
11,325

 
$
3,001

 
$
6,559

 
$
20,885

 
$
21,027

 
$
5,806

 
$
10,039

 
$
36,872

Operating expense reimbursements
 
2,336

 
138

 

 
2,474

 
4,523

 
140

 

 
4,663

Resident services and fee income
 

 

 
578

 
578

 

 

 
1,080

 
1,080

Total revenues
 
13,661

 
3,139

 
7,137

 
23,937

 
25,550

 
5,946

 
11,119

 
42,615

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property operating and maintenance
 
2,649

 
146

 
4,649

 
7,444

 
5,265

 
155

 
7,216

 
12,636

Net operating income
 
$
11,012

 
$
2,993

 
$
2,488

 
$
16,493

 
$
20,285

 
$
5,791

 
$
3,903

 
$
29,979

Operating fees to affiliate
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Acquisition and transaction related
 
 
 
 
 
 
 
2,713

 
 
 
 
 
 
 
4,751

General and administrative
 
 
 
 
 
 
 
1,240

 
 
 
 
 
 
 
1,481

Equity-based compensation
 
 
 
 
 
 
 
10

 
 
 
 
 
 
 
18

Depreciation and amortization
 
 
 
 
 
 
 
12,714

 
 
 
 
 
 
 
24,408

Interest expense
 
 
 
 
 
 
 
3,315

 
 
 
 
 
 
 
6,404

Income from preferred equity investment, investment securities and other income
 
 
 
 
 
 
 
(255
)
 
 
 
 
 
 
 
(255
)
Net loss attributable to non-controlling interests
 
 
 
 
 
 
 
14

 
 
 
 
 
 
 
36

Net loss attributable to stockholders
 
 
 
 
 
 
 
$
(3,258
)
 
 
 
 
 
 
 
$
(6,864
)
The following table reconciles the segment activity to consolidated total assets as of June 30, 2014 and December 31, 2013:
 
 
June 30,
 
December 31,
(In thousands)
 
2014
 
2013
Assets
 
 
 
 
Investments in real estate:
 
 
 
 
Medical office buildings
 
$
976,264

 
$
948,122

Triple-net buildings
 
383,692

 
205,367

Seniors Housing Communities
 
612,361

 
423,114

Total reportable segments, net
 
1,972,317

 
1,576,603

Cash
 
28,695

 
103,447

Restricted cash
 
2,135

 
1,381

Investment securities, at fair value
 
19,427

 
14,670

Preferred equity investment
 
8,800

 

Prepaid expenses and other assets
 
26,080

 
17,431

Deferred costs, net
 
20,071

 
21,041

Total assets
 
$
2,077,525

 
$
1,734,573


34

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2014
(Unaudited)

Note 21 — Subsequent Events
The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q, and determined that there have not been any events that have occurred that would require adjustments to disclosures in the consolidated financial statements except for the following transactions:
Acquisitions
The following table presents certain information about the properties and other real estate investments that the Company acquired from July 1, 2014 to August 12, 2014:
 
Number of Properties
 
Rentable
Square Feet
Total portfolio as of June 30, 2014
147

 
7,522,338

Acquisitions
3

 
331,042

Total portfolio as of August 12, 2014
150

 
7,853,380


35


Exhibit 99.2


AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2013 AND 2012 AND FOR
THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
 
TABLE OF CONTENTS

 
Page
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2013 and 2012
Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2013, 2012 and 2011
Consolidated Statements of Changes in Equity for the Years Ended December 31, 2013, 2012 and 2011
Consolidated Statements of Cash Flows for the Years Ended December 31, 2013, 2012 and 2011
Notes to Consolidated Financial Statements
Financial Statement Schedules:
 
Schedule III - Real Estate and Accumulated Depreciation


1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders
American Realty Capital Healthcare Trust, Inc.
We have audited the accompanying consolidated balance sheets of American Realty Capital Healthcare Trust, Inc. (a Maryland Corporation) and subsidiaries (the "Company") as of December 31, 2013 and 2012 and the related consolidated statements of operations and comprehensive loss, changes in equity and cash flows for each of the three years in the periods ended December 31, 2013. Our audits of the basic financial statements included the financial statement schedules listed in the index appearing under Item 15(a). These financial statements and financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of American Realty Capital Healthcare Trust, Inc. and subsidiaries as of December 31, 2013 and 2012 and the results of their operations and their cash flows for each of the three years in the periods ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

/s/ GRANT THORNTON LLP

Philadelphia, Pennsylvania
February 26, 2014




2

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)

 
December 31,
 
2013
 
2012
ASSETS
 
 
 
Real estate investments, at cost:
 
 
 
Land
$
107,719

 
$
48,409

Buildings, fixtures and improvements
1,363,858

 
552,085

Construction in progress
11,112

 

Acquired intangible lease assets
181,264

 
77,095

Total real estate investments, at cost
1,663,953

 
677,589

Less: accumulated depreciation and amortization
(87,350
)
 
(21,262
)
Total real estate investments, net
1,576,603

 
656,327

Cash and cash equivalents
103,447

 
13,869

Restricted cash
1,381

 
127

Investment securities, at fair value
14,670

 

Receivable for sale of common stock

 
6,943

Prepaid expenses and other assets
17,431

 
5,826

Due from affiliate

 
190

Deferred costs, net
21,041

 
7,386

Total assets
$
1,734,573

 
$
690,668

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
Mortgage notes payable
$
259,348

 
$
200,095

Mortgage premium, net
2,769

 
2,903

Credit facility

 
26,000

Note payable

 
2,500

Below-market lease liabilities, net
5,543

 
1,692

Derivatives, at fair value
333

 
643

Accounts payable and accrued expenses
17,460

 
5,669

Deferred rent and other liabilities
2,949

 
917

Distributions payable
10,427

 
2,962

Total liabilities
298,829

 
243,381

Preferred stock, $0.01 par value per share, 50,000,000 shares authorized, none issued or outstanding at December 31, 2013 and 2012

 

Common stock, $0.01 par value per share, 300,000,000 authorized, 180,463,898 and 55,584,641 shares issued and outstanding at December 31, 2013 and 2012, respectively
1,805

 
556

Additional paid-in capital
1,591,941

 
476,157

Accumulated other comprehensive loss
(3,243
)
 
(643
)
Accumulated deficit
(158,378
)
 
(32,832
)
Total stockholders' equity
1,432,125

 
443,238

Non-controlling interests
3,619

 
4,049

Total equity
1,435,744

 
447,287

Total liabilities and equity
$
1,734,573

 
$
690,668

The accompanying notes are an integral part of these statements.


3

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share data)

 
Year Ended December 31,
 
2013
 
2012
 
2011
Revenues:
 
 
 
 
 
Rental income
$
107,754

 
$
30,379

 
$
2,561

Operating expense reimbursements
11,148

 
5,194

 
753

Resident services and fee income
6,451

 
165

 

Total revenues
125,353

 
35,738

 
3,314

Operating expenses:
 
 
 
 
 
Property operating and maintenance
46,665

 
6,564

 
863

Operating fees to affiliate

 
987

 

Acquisition and transaction related
13,606

 
9,433

 
3,415

General and administrative
4,613

 
905

 
429

Depreciation and amortization
67,456

 
19,320

 
1,535

Total operating expenses
132,340

 
37,209

 
6,242

Operating loss
(6,987
)
 
(1,471
)
 
(2,928
)
Other income (expenses):
 
 
 
 
 
Interest expense
(15,843
)
 
(9,184
)
 
(1,191
)
Other income
89

 
18

 
2

Income from investment securities
869

 

 

Loss on sale of investment securities
(300
)
 

 

Total other expense
(15,185
)
 
(9,166
)
 
(1,189
)
Net loss
(22,172
)
 
(10,637
)
 
(4,117
)
Net loss (income) attributable to non-controlling interests
(58
)
 
2

 
32

Net loss attributable to stockholders
(22,230
)
 
(10,635
)
 
(4,085
)
 
 
 
 
 
 
Other comprehensive loss:
 
 
 
 
 
Designated derivatives, fair value adjustment
310

 
(397
)
 
(246
)
Unrealized loss on investment securities, net
(2,910
)
 

 

Comprehensive loss attributable to stockholders
$
(24,830
)
 
$
(11,032
)
 
$
(4,331
)
 
 
 
 
 
 
Basic and diluted weighted average shares outstanding
151,683,551

 
25,008,063

 
1,649,649

Basic and diluted net loss per share attributable to stockholders
$
(0.15
)
 
$
(0.43
)
 
$
(2.48
)
The accompanying notes are an integral part of these statements.


4

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands, except share data)

 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
Number
of
Shares
 
Par
Value
 
Additional
Paid-In
Capital
 
Accumulated Other Comprehensive Loss
 
Accumulated
Deficit
 
Total
Stockholders'
Equity
 
Non-controlling Interests
 
Total Equity
Balance, December 31, 2010
20,000

 
$

 
$
200

 
$

 
$
(1
)
 
$
199

 
$

 
$
199

Issuance of common stock
6,924,696

 
70

 
68,811

 

 

 
68,881

 

 
68,881

Common stock offering costs, commissions and dealer
manager fees

 

 
(12,308
)
 

 

 
(12,308
)
 

 
(12,308
)
Common stock issued through distribution reinvestment plan
31,438

 

 
299

 

 

 
299

 

 
299

Common stock repurchases
(6,241
)
 

 
(62
)
 

 

 
(62
)
 

 
(62
)
Share-based compensation
13,556

 

 
57

 

 

 
57

 

 
57

Distributions declared

 

 

 

 
(1,022
)
 
(1,022
)
 

 
(1,022
)
Contributions from non-controlling interest holders

 

 

 

 

 

 
2,144

 
2,144

Other comprehensive loss

 

 

 
(246
)
 

 
(246
)
 

 
(246
)
Net loss

 

 

 

 
(4,085
)
 
(4,085
)
 
(32
)
 
(4,117
)
Balance, December 31, 2011
6,983,449

 
70

 
56,997

 
(246
)
 
(5,108
)
 
51,713

 
2,112

 
53,825

Issuance of common stock
47,997,987

 
480

 
477,532

 

 

 
478,012

 

 
478,012

Common stock offering costs, commissions and dealer
manager fees

 

 
(63,990
)
 

 

 
(63,990
)
 

 
(63,990
)
Common stock issued through distribution reinvestment plan
690,994

 
7

 
6,557

 

 

 
6,564

 

 
6,564

Common stock repurchases
(108,361
)
 
(1
)
 
(1,065
)
 

 

 
(1,066
)
 

 
(1,066
)
Share-based compensation
20,572

 

 
126

 

 

 
126

 

 
126

Distributions declared

 

 

 

 
(17,089
)
 
(17,089
)
 

 
(17,089
)
Contributions from non-controlling interest holders

 

 

 

 

 

 
2,300

 
2,300

Distributions to non-controlling interest holders

 

 

 

 

 

 
(361
)
 
(361
)
Other comprehensive loss

 

 

 
(397
)
 

 
(397
)
 

 
(397
)
Net loss

 

 

 

 
(10,635
)
 
(10,635
)
 
(2
)
 
(10,637
)
Balance, December 31, 2012
55,584,641

 
556

 
476,157

 
(643
)
 
(32,832
)
 
443,238

 
4,049

 
447,287

Issuance of common stock
119,784,507

 
1,199

 
1,188,762

 

 

 
1,189,961

 

 
1,189,961

Common stock offering costs, commissions and dealer
manager fees

 

 
(121,209
)
 

 

 
(121,209
)
 

 
(121,209
)
Common stock issued through distribution reinvestment plan
5,353,449

 
53

 
50,804

 

 

 
50,857

 

 
50,857

Common stock repurchases
(272,366
)
 
(3
)
 
(2,651
)
 

 

 
(2,654
)
 

 
(2,654
)
Share-based compensation
13,667

 

 
114

 

 

 
114

 

 
114

Distributions declared

 

 

 

 
(103,316
)
 
(103,316
)
 

 
(103,316
)
Distributions to non-controlling interest holders

 

 

 

 

 

 
(380
)
 
(380
)
Increase in interest in Odessa Regional MOB and Methodist North MOB

 

 
(36
)
 

 

 
(36
)
 
(108
)
 
(144
)
Other comprehensive loss

 

 

 
(2,600
)
 

 
(2,600
)
 

 
(2,600
)
Net income (loss)

 

 

 

 
(22,230
)
 
(22,230
)
 
58

 
(22,172
)
Balance, December 31, 2013
180,463,898

 
$
1,805

 
$
1,591,941

 
$
(3,243
)
 
$
(158,378
)
 
$
1,432,125

 
$
3,619

 
$
1,435,744

The accompanying notes are an integral part of these statements.


5

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

 
Year Ended December 31,
 
2013
 
2012
 
2011
Cash flows from operating activities:
 
 
 
 
 
Net loss attributable to stockholders
$
(22,230
)
 
$
(10,635
)
 
$
(4,085
)
Adjustment to reconcile net loss attributable to stockholders to net cash provided by (used in) operating activities:
 
 
 
 
 
Depreciation
42,526

 
15,066

 
1,174

Amortization of intangible assets
24,930

 
4,254

 
361

Amortization of deferred financing costs
3,982

 
1,267

 
122

Amortization of mortgage premium
(826
)
 
(315
)
 

Accretion of below-market lease liabilities and amortization of above-market lease assets, net
444

 
306

 
59

Net loss attributable to non-controlling interests
58

 
(2
)
 
(32
)
Bad debt expense
735

 

 

Share-based compensation
114

 
126

 
57

Loss on sale of investment securities
300

 

 

Changes in assets and liabilities:
 
 
 
 
 
Prepaid expenses and other assets
(9,248
)
 
(5,076
)
 
(750
)
Due from affiliate
190

 

 

Accounts payable and accrued expenses
10,004

 
2,046

 
772

Deferred rent and other liabilities
2,032

 
756

 
161

Net cash provided by (used in) operating activities
53,011

 
7,793

 
(2,161
)
Cash flows from investing activities:
 
 
 
 
 
Investment in real estate and other assets
(920,541
)
 
(452,546
)
 
(53,348
)
Deposits for real estate
(3,590
)
 

 

Capital expenditures
(707
)
 

 

Purchase of investment securities
(19,593
)
 

 

Proceeds from sale of investment securities
1,713

 

 

Net cash used in investing activities
(942,718
)
 
(452,546
)
 
(53,348
)
Cash flows from financing activities:
 
 
 
 
 
Proceeds from notes payable

 

 
4,500

Payments of note payable
(2,500
)
 

 
(2,000
)
Proceeds from mortgage notes payable

 
34,777

 

Payments of mortgage notes payable
(474
)
 
(42
)
 
(20
)
Proceeds from credit facility

 
65,000

 

Payments on credit facility
(26,000
)
 
(39,000
)
 

Payments of deferred financing costs
(17,160
)
 
(5,996
)
 
(2,779
)
Proceeds from issuance of common stock
1,196,904

 
471,474

 
68,476

Common stock repurchases
(2,404
)
 
(701
)
 
(37
)
Payments of offering costs and fees related to stock issuances
(122,309
)
 
(63,372
)
 
(11,549
)
Distributions paid
(44,994
)
 
(7,910
)
 
(376
)
Due from/to affiliate

 
(190
)
 
(80
)
Contributions from non-controlling interest holders

 

 
4,444

Payments to non-controlling interest holders
(144
)
 

 

Distributions to non-controlling interest holders
(380
)
 
(361
)
 

Restricted cash
(1,254
)
 
(95
)
 
(32
)
Net cash provided by financing activities
979,285

 
453,584

 
60,547

Net change in cash
89,578

 
8,831

 
5,038

Cash and cash equivalents, beginning of period
13,869

 
5,038

 

Cash and cash equivalents, end of period
$
103,447

 
$
13,869

 
$
5,038


6

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)


 
Year Ended December 31,
 
2013
 
2012
 
2011
Supplemental Disclosures:
 
 
 
 
 
Cash paid for interest
$
12,031

 
$
7,801

 
$
629

 
 
 
 
 
 
Non-Cash Investing and Financing Activities:
 
 
 
 
 
Mortgage notes payable assumed or used to acquire investments in real estate
$
59,727

 
$
54,639

 
$
110,741

Premiums on assumed mortgage notes payable
692

 
3,218

 

Liabilities assumed in real estate acquisitions
2,637

 
968

 
396

Common stock issued through distribution reinvestment plan
50,857

 
6,564

 
299

Reclassification of deferred offering costs

 

 
844


The accompanying notes are an integral part of these statements.


7

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013



Note 1 — Organization
American Realty Capital Healthcare Trust, Inc. (the "Company"), incorporated on August 23, 2010, is a Maryland corporation that qualified as a real estate investment trust ("REIT") for U.S. federal income tax purposes beginning with the taxable year ended December 31, 2011. On February 18, 2011, the Company commenced its initial public offering (the "IPO") on a "reasonable best efforts" basis of up to 150.0 million shares of common stock, $0.01 par value per share, at a price of $10.00 per share, subject to certain volume and other discounts, pursuant to a registration statement on Form S-11, as amended (File No. 333-169075) (the "Registration Statement"), filed with the U.S. Securities and Exchange Commission (the "SEC") under the Securities Act of 1933, as amended.  The Registration Statement also covered up to 25.0 million shares of common stock available pursuant to a distribution reinvestment plan (the "DRIP") under which the Company's common stockholders may elect to have their distributions reinvested in additional shares of the Company's common stock at a price initially equal to $9.50 per share, which was 95% of the offering price in the IPO.
On April 12, 2013, the Company registered an additional 25.0 million shares to be used under the DRIP (as amended to include a direct stock purchase component) pursuant to a registration statement on Form S-3 (File No. 333-187900). In April 2013, the Company completed the issuance of the 150.0 million shares of common stock registered in connection with its IPO, plus 1.2 million DRIP shares, and as permitted, reallocated the remaining 23.8 million DRIP shares, available under the Registration Statement to the primary offering. On April 26, 2013, the Company closed the IPO following the successful achievement of its target equity raise, including the shares reallocated from the DRIP. As of December 31, 2013, the Company had 180.5 million shares of common stock outstanding, including unvested restricted shares and shares issued under the DRIP, and had received total proceeds of $1.8 billion, including proceeds from shares issued under the DRIP. As of December 31, 2013, the aggregate value of all the common stock outstanding was $1.8 billion based on a per share value of $10.00 (or $9.50 for shares issued under the DRIP).
The Company was formed to primarily acquire a diversified portfolio of income producing real estate properties, focusing predominantly on medical office buildings and healthcare-related facilities. All such properties may be acquired and operated by the Company alone or jointly with another party. The Company may also originate or acquire first mortgage loans secured by real estate. The Company purchased its first property and commenced real estate operations in June 2011. As of December 31, 2013, the Company owned 114 properties with an aggregate purchase price of $1.6 billion, comprised of 5.8 million rentable square feet.
Substantially all of the Company's business is conducted through American Realty Capital Healthcare Trust Operating Partnership, L.P., a Delaware limited partnership (the "OP"). The Company has no direct employees. The Company has retained American Realty Capital Healthcare Advisors, LLC (the "Advisor") to manage its affairs on a day-to-day basis. The Company has retained American Realty Capital Healthcare Properties, LLC (the "Property Manager") to serve as the Company's property manager.  Realty Capital Securities, LLC (the "Dealer Manager") served as the dealer manager of the IPO. The Advisor and Property Manager are wholly owned entities of, and the Dealer Manager is under common ownership with, the Company's sponsor, American Realty Capital V, LLC (the "Sponsor") and, as a result of which, they are related parties and each has received or may receive compensation and fees for services related to the IPO and for the investment and management of the Company's assets. Such entities have received or may receive fees during the offering, acquisition, operational and liquidation stages.
Note 2 — Summary of Significant Accounting Policies
Basis of Accounting and Presentation
The accompanying consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States ("GAAP").
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and consolidated joint venture arrangements in which the Company has controlling financial interests. The portions of the consolidated joint venture arrangements not owned by the Company were presented as noncontrolling interests as of and during the period consolidated. All inter-company accounts and transactions have been eliminated in consolidation.

8

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The Company evaluates its relationships and investments to determine if it has variable interests. A variable interest is an investment or other interest that will absorb portions of an entity's expected losses or receive portions of the entity's expected residual returns. If the Company determines that it has a variable interest in an entity, it evaluates whether such interest is in a variable interest entity ("VIE"). A VIE is broadly defined as an entity where either (1) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of an entity that most significantly impact the entity's economic performance or (2) the equity investment at risk is insufficient to finance that entity's activities without additional subordinated financial support. The Company consolidates any VIEs when it is determined to be the primary beneficiary of the VIE's operations.
A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities of a VIE that most significantly impact the entity's economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE. The Company qualitatively assesses whether it is (or is not) the primary beneficiary of a VIE. Consideration of various factors include, but are not limited to, the Company's ability to direct the activities that most significantly impact the entity's economic performance, its form of ownership interest, its representation on the entity's governing body, the size and seniority of its investment, its ability and the rights of other investors to participate in policy making decisions and to replace the manager of and/or liquidate the entity.
The Company continually evaluates the need to consolidate joint ventures based on standards set forth in GAAP. In determining whether the Company has a controlling interest in a joint venture and the requirement to consolidate the accounts of that entity, management considers factors such as ownership interest, power to make decisions and contractual and substantive participating rights of the partners/members as well as whether the entity is a VIE for which the Company is the primary beneficiary.
In addition, the Company evaluates its investments in marketable securities to determine if they represent variable interests in VIEs. As of December 31, 2013, the Company determined that investments in marketable securities are variable interests in VIEs, of which the Company is not the primary beneficiary because it does not have the ability to direct the activities of the VIEs that most significantly impact each entity's economic performance. The Company's maximum exposure to loss from these investments does not exceed the carrying value on the accompanying consolidated balance sheet.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, real estate taxes and derivative financial instruments and hedging activities, as applicable.
Real Estate Investments
Investments in real estate are recorded at cost. Improvements and replacements are capitalized when they extend the useful life of the asset. Costs of repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of up to 40 years for buildings, 15 years for land improvements, five years for fixtures and the shorter of the useful life or the remaining lease term for tenant improvements and leasehold interests.
The Company is required to make subjective assessments as to the useful lives of the Company's properties for purposes of determining the amount of depreciation to record on an annual basis with respect to the Company's investments in real estate. These assessments have a direct impact on the Company's net income because if the Company were to shorten the expected useful lives of the Company's investments in real estate, the Company would depreciate these investments over fewer years, resulting in more depreciation expense and lower net income on an annual basis.
The Company is required to present the operations related to properties that have been sold or properties that are intended to be sold as discontinued operations in the statement of operations for all periods presented. Properties that are intended to be sold are to be designated as "held for sale" on the consolidated balance sheet.

9

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Impairment of Long Lived Assets
When circumstances indicate the carrying value of a property may not be recoverable, the Company reviews the asset for impairment. This review is based on an estimate of the future undiscounted cash flows, excluding interest charges, expected to result from the property's use and eventual disposition. These estimates consider factors such as expected future operating income, market and other applicable trends and residual value, as well as the effects of leasing demand, competition and other factors. If impairment exists, due to the inability to recover the carrying value of a property, an impairment loss is recorded to the extent that the carrying value exceeds the estimated fair value of the property for properties to be held and used. For properties held for sale, the impairment loss is the adjustment to fair value less estimated cost to dispose of the asset. These assessments have a direct impact on net income because recording an impairment loss results in an immediate negative adjustment to net income.
Allocation of Purchase Price of Acquired Assets
The Company allocates the purchase price of acquired properties to tangible and identifiable intangible assets acquired based on their respective fair values. Tangible assets include land, land improvements, buildings, fixtures and tenant improvements on an as-if vacant basis. The Company utilizes various estimates, processes and information to determine the as-if vacant property value. Estimates of value are made using customary methods, including data from appraisals, comparable sales, discounted cash flow analysis and other methods. Amounts allocated to land, land improvements, buildings, fixtures and tenant improvements are based on cost segregation studies performed by independent third-parties or the Company's analysis of comparable properties in its portfolio. Identifiable intangible assets include amounts allocated to acquire leases for above- and below-market lease rates, the value of in-place leases, and the value of customer relationships.
The aggregate value of intangible assets related to in-place leases is primarily the difference between the property valued with existing in-place leases adjusted to market rental rates and the property valued as if vacant. Factors considered in the analysis of the in-place lease intangibles include an estimate of carrying costs during the expected lease-up period for each property, taking into account current market conditions and costs to execute similar leases. In estimating carrying costs, the Company includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at contract rates during the expected lease-up period, which typically ranges from six to 12 months. Estimates of costs to execute similar leases including leasing commissions, legal and other related expenses are also utilized.
Above-market and below-market in-place lease values for owned properties are recorded based on the present value (using an interest rate which reflects the risks associated with the leases acquired) of the difference between the contractual amounts to be paid pursuant to the in-place leases and management's estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. The capitalized above-market lease intangibles are amortized as a decrease to rental income over the remaining term of the lease.  The capitalized below-market lease values are amortized as an increase to rental income over the remaining term and any fixed rate renewal periods provided within the respective leases. In determining the amortization period for below-market lease intangibles, the Company initially will consider, and periodically evaluate on a quarterly basis, the likelihood that a lessee will execute the renewal option.  The likelihood that a lessee will execute the renewal option is determined by taking into consideration the tenant's payment history, the financial condition of the tenant, business conditions in the industry in which the tenant operates and economic conditions in the area in which the property is located.
The aggregate value of intangible assets related to customer relationships is measured based on the Company's evaluation of the specific characteristics of each tenant's lease and its overall relationship with the tenant. Characteristics considered in determining these values include the nature and extent of the existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant's credit quality and expectations of lease renewals, among other factors.
The value of in-place leases is amortized to expense over the initial term of the respective leases, which is approximately one to 25 years. The value of customer relationship intangibles is amortized to expense over the initial term and any renewal periods in the respective leases, but in no event does the amortization period for intangible assets exceed the remaining depreciable life of the building. If a tenant terminates its lease, the unamortized portion of the in-place lease value and customer relationship intangibles is charged to expense.

10

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


In making estimates of fair values for purposes of allocating purchase price, the Company utilizes a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. The Company also considers information obtained about each property as a result of pre-acquisition due diligence, as well as subsequent marketing and leasing activities, in estimating the fair value of the tangible and intangible assets acquired and intangible liabilities assumed.
Acquired intangible assets and lease liabilities consist of the following as of the periods presented:
 
 
December 31,
(In thousands)
 
2013
 
2012
Intangible assets:
 
 
 
 
In-place leases, net of accumulated amortization of $28,763 and $4,568 at December 31, 2013 and 2012, respectively
 
$
143,819

 
$
68,247

Above-market leases, net of accumulated amortization of $1,239 and $516 at December 31, 2013 and 2012, respectively
 
7,443

 
3,764

Total intangible lease assets, net
 
$
151,262

 
$
72,011

Intangible liabilities:
 
 
 
 
Below-market leases, net of accumulated accretion of $564 and $143 at December 31, 2013 and 2012, respectively
 
$
5,543

 
$
1,692

Total intangible lease liabilities, net
 
$
5,543

 
$
1,692

The following table provides the weighted-average amortization and accretion periods for intangible assets and liabilities as of December 31, 2013 and the projected amortization expense and adjustments to revenues for the next five years:
(In thousands)
 
Weighted-
Average
Amortization
Period
 
2014
 
2015
 
2016
 
2017
 
2018
In-place leases
 
8.8
 
$
32,916

 
$
14,976

 
$
14,286

 
$
13,425

 
$
11,727

 
 
 
 
 
 
 
 
 
 
 
 
 
Above-market lease assets
 
8.6
 
$
(1,171
)
 
$
(1,127
)
 
$
(1,063
)
 
$
(942
)
 
$
(687
)
Below-market lease liabilities
 
6.9
 
795

 
785

 
752

 
522

 
356

Total to be deducted from rental income
 
 
 
$
(376
)
 
$
(342
)
 
$
(311
)
 
$
(420
)
 
$
(331
)
Construction in Progress
Construction in progress represents the ground-up development of a medical office building which the Company plans to hold as long-term investment in real estate.  These properties are carried at cost.  The cost of land and buildings under development includes specifically identifiable costs. The capitalized costs include pre-construction costs essential to the development of the property, development costs, construction costs, interest costs, real estate taxes, salaries and related costs of personnel directly involved and other costs incurred during the period of development. The Company will cease cost capitalization when the property is deemed available for occupancy and a lease has commenced for the property.
Cash and Cash Equivalents
Cash and cash equivalents include cash in bank accounts as well as investments in highly-liquid money market funds with original maturities of three months or less. As of December 31, 2012, $0.3 million was held in an overnight repurchase agreement with the Company's financial institution, in which excess funds over an established threshold were being swept daily. No funds were held in an overnight purchase agreement, as of December 31, 2013.
The Company deposits cash with high quality financial institutions. These deposits are guaranteed by the Federal Deposit Insurance Company ("FDIC") up to an insurance limit. At December 31, 2013 and 2012, the Company had deposits of $103.4 million and $13.9 million, of which $93.8 million and $4.3 million, respectively, were in excess of the amount insured by the FDIC. Although the Company bears risk to amounts in excess of those insured by the FDIC, it does not anticipate any losses as a result.

11

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Restricted Cash
Restricted cash primarily consists of reserves related to lease expirations as well as maintenance, structural, and debt service reserves.
Deferred Costs, Net
Deferred costs, net, consists of deferred financing costs and deferred leasing costs. Deferred financing costs represent commitment fees, legal fees, and other costs associated with obtaining commitments for financing. These costs are amortized over the terms of the respective financing agreements using the effective interest method and included in interest expense on the accompanying consolidated statements of operations and comprehensive loss. Unamortized deferred financing costs are expensed when the associated debt is refinanced or repaid before maturity.  Costs incurred in seeking financial transactions that do not close are expensed in the period in which it is determined that the financing will not close.
Deferred leasing costs, consisting primarily of lease commissions and costs incurred in connection with new leases, are deferred and amortized over the term of the lease.
Share Repurchase Program
 The Company's board of directors has adopted a Share Repurchase Program ("SRP") that enables stockholders to sell their shares to the Company in limited circumstances.  The SRP permits investors to sell their shares back to the Company after they have held them for at least one year, subject to the significant conditions and limitations described below.
Prior to the time that the Company's shares are listed on a national securities exchange and until the Company establishes an estimated value for the shares, the purchase price per share will depend on the length of time investors have held such shares as follows: after one year from the purchase date — the lower of $9.25 or 92.5% of the amount they actually paid for each share; after two years from the purchase date —the lower of $9.50 or 95.0% of the amount they actually paid for each share; after three years from the purchase date — the lower of $9.75 or 97.5% of the amount they actually paid for each share; and after four years from the purchase date — the lower of $10.00 or 100% of the amount they actually paid for each share (in each case, as adjusted for any stock distributions, combinations, splits and recapitalizations). The Company will begin establishing an estimated value for its shares based on the value of its real estate and real estate-related investments beginning 18 months after the close of its offering. Beginning 18 months after the completion of the Company's offering (excluding common shares issued under the DRIP), the board of directors will determine the value of the properties and the other assets based on such information as the board determines appropriate, which is expected to include independent valuations of properties or of the Company as a whole, prepared by third-party service providers.
The Company is only authorized to repurchase shares pursuant to the SRP up to the value of the shares issued under the DRIP and will limit the amount spent to repurchase shares in a given quarter to the value of the shares issued under the DRIP in that same quarter. In addition, the board of directors may reject a request for redemption, at any time. Due to these limitations, the Company cannot guarantee that it will be able to accommodate all repurchase requests. Purchases under the SRP by the Company will be limited in any calendar year to 5% of the weighted average number of shares outstanding during the prior year (or 1.25% per calendar quarter).

12

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


When a stockholder requests repurchases and the repurchases are approved by the Company's board of directors, it will reclassify such obligation from equity to a liability based on the settlement value of the obligation. The following table reflects the number of shares repurchased for the years ended December 31, 2013, 2012 and 2011.
 
Number of Requests
 
Number of Shares Repurchased
 
Average Price per Share
Year ended December 31, 2011
3
 
6,241

 
$
10.00

Year ended December 31, 2012
27
 
108,361

 
9.83

Year ended December 31, 2013 (1)
92
 
272,366

 
9.75

Cumulative repurchase requests as of December 31, 2013 (1)
122
 
386,968

 
$
9.77

_________________
(1)
Includes 25 unfulfilled repurchase requests consisting of 66,553 shares at an average price per share of $9.62, which were approved for repurchase as of December 31, 2013 and completed in February 2014. This liability is included in accounts payable and accrued expenses on the Company's consolidated balance sheet.
Distribution Reinvestment Plan
Pursuant to the DRIP, stockholders may elect to reinvest distributions by purchasing shares of common stock in lieu of receiving cash.  No dealer manager fees or selling commissions are paid with respect to shares purchased under the DRIP.  Participants purchasing shares pursuant to the DRIP have the same rights and are treated in the same manner as if such shares were issued pursuant to the IPO. The board of directors may designate that certain cash or other distributions be excluded from the DRIP.  The Company has the right to amend any aspect of the DRIP or terminate the DRIP with ten days' notice to participants. Shares issued under the DRIP are recorded to equity in the accompanying consolidated balance sheet in the period distributions are declared.  During the years ended December 31, 2013 and 2012, the Company issued 5.4 million and 0.7 million shares of common stock with a value of $50.9 million and $6.6 million, respectively, and a par value per share of $0.01, under the DRIP.
Derivative Instruments
The Company may use derivative financial instruments to hedge all or a portion of the interest rate risk associated with its borrowings. Certain of the techniques used to hedge exposure to interest rate fluctuations may also be used to protect against declines in the market value of assets that result from general trends in debt markets. The principal objective of such agreements is to minimize the risks and/or costs associated with the Company's operating and financial structure as well as to hedge specific anticipated transactions.
The Company records all derivatives on the consolidated balance sheets at fair value.  The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.

13

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The accounting for subsequent changes in the fair value of these derivatives depends on whether each has been designed and qualifies for hedge accounting treatment. If the Company elects not to apply hedge accounting treatment, any changes in the fair value of these derivative instruments is recognized immediately in gains (losses) on derivative instruments in the consolidated statement of operations. If the derivative is designated and qualifies for hedge accounting treatment the change in the estimated fair value of the derivative is recorded in other comprehensive income (loss) to the extent that it is effective. Any ineffective portion of a derivative's change in fair value will be immediately recognized in earnings.
Revenue Recognition
The Company's rental income is primarily related to rent received from tenants in medical office buildings and other healthcare-related facilities and residents in seniors housing communities. Rent paid by each tenant in the Company's three operating segments, excluding seniors housing communities under the RIDEA structure, are recorded in accordance with the terms of each lease on a straight-line basis over the initial term of the lease. Since many of the leases provide for rental increases at specified intervals, straight-line basis accounting requires the Company to record a receivable, and include in revenues, unbilled rent receivables that the Company will only receive if the tenant makes all rent payments required through the expiration of the initial term of the lease. When the Company acquires a property, the terms of existing leases are considered to commence as of the acquisition date for the purposes of this calculation. Rental income from residents in the Company's seniors housing communities are recognized as earned. Residents pay a monthly rent that covers occupancy of their unit and basic services, including utilities, meals and some housekeeping services. The terms of the rent are short term in nature, primarily month-to-month. The Company defers the revenue related to lease payments received from tenants and residents in advance of their due dates.
Cost recoveries from tenants are included in operating expense reimbursement in the period the related costs are incurred, as applicable.
Resident services and fee income relates to ancillary services performed for residents in the Company's seniors housing communities. Fees for ancillary services are recorded in the period in which the services are performed.
The Company continually reviews receivables related to rent and unbilled rent receivables and determines collectability by taking into consideration the tenant's payment history, the financial condition of the tenant, business conditions in the industry in which the tenant operates and economic conditions in the area in which the property is located. In the event that the collectability of a receivable is in doubt, the Company will record an increase in the allowance for uncollectible accounts or record a direct write-off of the receivable in the consolidated statements of operations.
Offering and Related Costs
Offering and related costs include all expenses incurred in connection with the Company's IPO. Offering costs (other than selling commissions and the dealer manager fee) include costs that may be paid by the Advisor, the Dealer Manager or their affiliates on behalf of the Company. These costs include but not limited to (i) legal, accounting, printing, mailing, and filing fees; (ii) escrow related fees; (iii) reimbursement of the Dealer Manager for amounts it may pay to reimburse the bona fide diligence expenses of broker-dealers; and (iv) reimbursement to the Advisor for the salaries of its employees and other costs in connection with preparing supplemental sales materials and related offering activities. The Company was obligated to reimburse the Advisor or its affiliates, as applicable, for organization and offering costs paid by them on behalf of the Company, provided that the Advisor was obligated to reimburse the Company to the extent organization and offering costs (excluding selling commissions and the dealer manager fee) incurred by the Company in its offering exceed 1.5% of gross offering proceeds. As a result, these costs were only a liability of the Company to the extent selling commissions, the dealer manager fee and other organization and offering costs did not exceed 11.5% of the gross proceeds determined at the end of the IPO. As of the end of the IPO in April 2013, offering costs were less than 11.5% of the gross proceeds received in the IPO. (See Note 12 — Related Party Transactions and Arrangements).
Share-Based Compensation
The Company has a stock-based incentive award plan for its directors, which is accounted for under the guidance of share based payments.  The expense for such awards is included in general and administrative expenses and is recognized over the vesting period or when the requirements for exercise of the award have been met. (See Note 14 — Share-Based Compensation).

14

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Income Taxes
The Company elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code commencing with the tax year ended December 31, 2011. If the Company qualifies for taxation as a REIT, it generally will not be subject to federal corporate income tax to the extent it distributes its REIT taxable income to its stockholders, and so long as it distributes at least 90% of its REIT taxable income. The Company distributed to its stockholders 100% of its ordinary taxable income for each of the years ended December 31, 2013, 2012 and 2011. Accordingly, no provision for federal or state income taxes related to such ordinary taxable income was recorded in the Company's financial statements. REITs are subject to a number of other organizational and operational requirements. Even if the Company qualifies for taxation as a REIT, it may be subject to certain state and local taxes on its income and property, and federal income and excise taxes on its undistributed income.
The following table details the composition of the Company's tax expense for the year ended December 31, 2013, which includes federal and state income taxes incurred by the Company's TRS entities. These income taxes are reflected in general and administrative expenses on the accompanying consolidated statement of operations and comprehensive loss. The Company did not incur any federal or state tax expenses during the year ended December 31, 2012 and 2011.
 
 
Year Ended December 31, 2013
(In thousands)
 
Expense
 
Deferred
Federal
 
$
296

 
$
90

State
 
228

 
20

 
 
$
524

 
$
110

As of December 31, 2013, the Company owned 26 seniors housing communities, that are owned by a taxable REIT subsidiary ("TRS"), which are owned by the OP. A TRS is subject to federal, state and local income taxes. Each TRS is a tax paying component for purposes of classifying deferred tax assets and liabilities. The Company records net deferred tax assets to the extent the Company believes these assets will more likely than not be realized. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. In the event the Company determines that it would not be able to realize the deferred income tax assets in the future in excess of the net recorded amount, the Company establishes a valuation allowance which offsets the previously recognized income tax benefit. Deferred income taxes result from temporary differences between the carrying amounts of assets and liabilities of the TRSs for financial reporting purposes and the amounts used for income tax purposes. Significant components of the deferred tax assets and liabilities as of December 31, 2013 and 2012 consisted of deferred rent, depreciation and net operating loss carry forwards. As of December 31, 2013, the Company had a deferred tax asset of $0.6 million and a valuation allowance of $0.5 million. The Company did not have any deferred tax assets as of December 31, 2012.
The TRSs have federal and state net operating loss carry forwards as of December 31, 2013 and 2012 of $0.5 million, which will expire through 2034. The Company has concluded that it is more likely than not that the net operating loss carry forwards will not be utilized during the carry forward period and as such the Company has established a valuation allowance against these deferred tax assets.
As of December 31, 2013, the Company had no material uncertain income tax position. The tax years subsequent to and including the fiscal year ended December 31, 2010 remain open to examination by the major taxing jurisdictions to which the Company is subject.
Per Share Data
Net income (loss) attributed to stockholders per basic share of common stock is calculated by dividing net income (loss) by the weighted-average number of shares of common stock issued and outstanding during such period. Diluted net income (loss) attributed to stockholders per share of common stock considers the effect of potentially dilutive shares of common stock outstanding during the period and is calculated using the if-converted method whereby the Company assumes that dilutive securities are converted at the beginning of the fiscal period or at the time of issuance, whichever is later.

15

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Reportable Segments
The Company has determined that it has three reportable segments, from activities related to investing in medical office buildings and outpatient facilities; seniors housing communities; and hospitals, post-acute care and other facilities. Management evaluates the operating performance of the Company's investments in real estate and seniors housing communities on an individual property level.
Recently Issued Accounting Pronouncements
In December 2011, the Financial Accounting Standards Board ("FASB") issued guidance regarding disclosures about offsetting assets and liabilities, which requires entities to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The guidance was effective for fiscal years and interim periods beginning on or after January 1, 2013 with retrospective application for all comparative periods presented. The adoption of this guidance, which is related to disclosure only, did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
In July 2012, the FASB issued revised guidance intended to simplify how an entity tests indefinite-lived intangible assets for impairment. The amendments allow an entity to initially assess initially qualitative factors to determine whether it is necessary to perform a quantitative impairment test. An entity is no longer required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative test unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments were effective for annual and interim indefinite-lived intangible asset impairment tests performed for fiscal years beginning after September 15, 2012. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
In February 2013, the FASB issued guidance which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. The guidance was effective for annual and interim periods beginning after December 15, 2012. The adoption of this guidance, which is related to disclosure only, did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
In February 2013, the FASB issued new accounting guidance clarifying the accounting and disclosure requirements for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. The Company does not expect the adoption of this guidance to have a material impact on the Company's consolidated financial position, results of operations or cash flows.

16

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Note 3 — Real Estate Investments 
The following table presents the allocation of the assets acquired and liabilities assumed during the years ended December 31, 2013, 2012 and 2011.
 
 
Year Ended December 31,
(Dollar amounts in thousands)
 
2013
 
2012
 
2011
Real estate investments, at cost:
 
 
 
 
 
 
Land
 
$
59,310

 
$
38,193

 
$
10,216

Buildings, fixtures and improvements
 
811,596

 
421,572

 
130,594

Construction in progress
 
11,112

 

 

Total tangible assets
 
882,018

 
459,765

 
140,810

Acquired intangibles:
 
 
 
 
 
 
In-place leases
 
100,480

 
52,169

 
20,695

Above-market lease assets
 
5,371

 
744

 
3,536

Below-market lease liabilities
 
(4,272
)
 
(1,307
)
 
(556
)
            Total assets acquired, net
 
983,597

 
511,371

 
164,485

Mortgage notes payable assumed or used to acquire real estate investments
 
(59,727
)
 
(54,639
)
 
(110,741
)
Premium on mortgages assumed
 
(692
)
 
(3,218
)
 

Other liabilities assumed
 
(2,637
)
 
(968
)
 
(396
)
Cash paid for acquired real estate investments
 
$
920,541

 
$
452,546

 
$
53,348

Number of properties purchased
 
64

 
36

 
14

Land, buildings, fixtures and improvements and in-place lease intangibles of $122.3 million, are comprised of $9.4 million, $98.5 million and $14.4 million, respectively, which have been provisionally assigned to each class of asset, pending receipt of information being prepared by a third-party specialist. The following table reflects the number and related purchase prices of properties acquired, excluding land and related construction in progress, during the years ended December 31, 2013, 2012 and 2011:
 
Number of Properties
 
Base Purchase Price
 
 
 
(In thousands)
Year ended December 31, 2011
14
 
$
164,485

Year ended December 31, 2012
36
 
508,108

Year ended December 31, 2013
64
 
970,000

Total portfolio as of December 31, 2013
114
 
$
1,642,593

The following table presents unaudited pro forma information as if the acquisitions during the year ended December 31, 2013, had been consummated on January 1, 2011. Additionally, the unaudited pro forma net loss attributable to stockholders was adjusted to reclass acquisition and transaction related expenses of $15.6 million from the year ended December 31, 2013 to the year ended December 31, 2011.
 
 
Year Ended December 31,
(In thousands)
 
2013
 
2012
 
2011
Pro forma revenues
 
$
208,815

 
$
169,907

 
$
51,468

Pro forma net income attributable to stockholders
 
$
(6,568
)
 
$
(14,088
)
 
$
(20,563
)

17

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The following table presents future minimum base rental cash payments due to the Company over the next five years and thereafter.  These amounts exclude contingent rent payments, as applicable, that may be collected from certain tenants based on provisions related to sales thresholds and increases in annual rent based on exceeding certain economic indexes among other items.
(In thousands)
 
Future Minimum
Base Rental Cash Payments
2014
 
$
92,407

2015
 
93,373

2016
 
93,719

2017
 
92,314

2018
 
86,782

Thereafter
 
552,618

 
 
$
1,011,213

The following table lists the tenants (including for this purpose, all affiliates of such tenants) whose annualized rental income on a straight-line basis represented approximately 10% or greater of total annualized rental income for all portfolio properties on a straight-line basis as of December 31, 2013, 2012 and 2011:
 
 
December 31,
Tenant
 
2013
 
2012
 
2011
UnitedHealth Group Incorporated
 
9.9%
 
*
 
*
Reliant Rehabilitation
 
*
 
9.6%
 
22.9%
Carson Tahoe Regional Healthcare
 
*
 
*
 
11.4%
Global Rehabilitation Hospital
 
*
 
*
 
10.1%
_________________
*
Tenant's annualized rental income on a straight-line basis was not greater than 10% of total annualized rental income for all tenants as of the period specified.
The termination, delinquency or non-renewal of leases by one or more of the above tenants may have a material adverse effect on revenues. No other tenant represents approximately 10% or more of annualized rental income as of December 31, 2013, 2012 and 2011.
The following table lists the states where the Company has concentrations of properties where annualized rental income represented approximately 10% of or more consolidated annualized rental income as of December 31, 2013, 2012 and 2011:
 
 
December 31,
State
 
2013
 
2012
 
2011
Florida
 
10.2%
 
*
 
*
Georgia
 
18.2%
 
22.4%
 
*
Illinois
 
*
 
10.8%
 
14.5%
Nevada
 
*
 
*
 
31.1%
Oregon
 
10.3%
 
*
 
*
Texas
 
14.0%
 
21.3%
 
45.8%
_________________
*
State's annualized rental income on a straight-line basis was not 10% or more of total annualized rental income for all portfolio properties as of the period specified.


18

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Note 4 — Investment Securities
As of December 31, 2013, the Company had investments in common stock, redeemable preferred stock and a senior note with a fair value of $14.7 million. These investments are considered available-for-sale securities and therefore increases or decreases in the fair value of these investments are recorded in accumulated other comprehensive loss as a component of equity on the consolidated balance sheets unless the securities are considered to be permanently impaired, at which time the losses would be reclassified to expense.
The following table details the unrealized gains and losses on investment securities as of December 31, 2013. The Company did not have any such investments as of December 31, 2012.
 
 
December 31, 2013
(In thousands)
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Investment securities
 
$
17,580

 
$
202

 
$
(3,112
)
 
$
14,670

Unrealized losses as of December 31, 2013 were considered temporary and therefore no impairment was recorded during the year ended December 31, 2013. During the year ended December 31, 2013, the Company sold investments in common stock and senior notes with a cost basis of $2.0 million for $1.7 million, resulting in a realized loss on sale of investment securities of $0.3 million.
The Company's preferred stock investments are redeemable at the respective issuer's option after five years from issuance. The senior note matures in 29.2 years and has an interest rate of 5.5% as of December 31, 2013.
Note 5 — Credit Facility
On May 25, 2012, the Company entered into a senior revolving credit facility in the aggregate principal amount of $50.0 million, as amended, (the "Credit Facility") with KeyBank National Association ("Key Bank"). On October 25, 2012, the Company entered into an amendment, which increased the maximum commitments under the Credit Facility to $200.0 million with an "accordion" feature to increase aggregate commitments, subject to certain conditions, up to a maximum of $400.0 million.
Pursuant to the Credit Facility, the Company had the option, based on it's corporate leverage, to have the Credit Facility advances priced at either: (a) LIBOR, plus an applicable margin that ranges from 2.00% to 3.00%; or (b) the Base Rate, plus an applicable margin that ranges from 0.75% to 1.75%. Base Rate was defined in the Credit Facility as the greater of (i) the fluctuating annual rate of interest announced from time to time by KeyBank as its "prime rate" or (ii) 0.5% above the federal funds effective rate. The Credit Facility required an unused fee per annum of 0.3% and 0.2%, if the unused balance of the facility exceeded or was equal to or less than 50% of the available facility, respectively.
On July 24, 2013, the Company entered into an unsecured amended and restated credit agreement (the "Amended Facility") which allows for total borrowings of up to $755.0 million, comprised of a $500.0 million term loan component and a $255.0 million revolving loan component. The Amended Facility also contains a subfacility for letters of credit of up to $25.0 million. The Amended Facility contains an "accordion feature" to allow the Company, under certain circumstances, to increase the aggregate term loan borrowings under the Amended Facility to up to $750.0 million and the aggregate revolving loan borrowings to up to $450.0 million, or up to $1.2 billion of total borrowings. Availability of borrowings is based on a pool of eligible unencumbered real estate assets.
Pursuant to the Amended Facility, the Company has the option, based upon its corporate leverage, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 1.60% to 2.20%; or (b) the Base Rate, plus an applicable margin that ranges from 0.35% to 0.95%. Base Rate is defined in the Amended Facility as the greatest of (i) the fluctuating annual rate of interest announced from time to time by Key Bank as its "prime rate," (ii) 0.5% above the federal funds effective rate or (iii) 1.0% above the applicable one-month LIBOR. Upon such time as the Company receives an investment grade credit rating as determined by major credit rating agencies, the Company will have the option, based upon its credit rating, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 0.95% to 1.70%; or (b) the Base Rate, plus an applicable margin that ranges from 0.00% to 0.70%.

19

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The Amended Facility provides for monthly interest payments for each Base Rate loan and periodic payments for each LIBOR loan, based upon the applicable LIBOR loan period, with all principal outstanding being due on the maturity date. The term loan component of the Amended Facility matures in July 2018 and the revolving loan component of the Amended Facility matures in July 2016. The revolving loan component of the Amended Facility contains two, one-year extension options. The Amended Facility may be prepaid from time to time and at any time, in whole or in part, without premium or penalty, subject to reimbursement of certain costs and expenses. In the event of a default, the lenders have the right to terminate its obligations under the Amended Facility and to accelerate the payment on any unpaid principal amount of all outstanding loans.
As of December 31, 2012, the balance under the Credit Facility was $26.0 million. This balance was repaid in full in January 2013. There were no advances outstanding as of December 31, 2013. The Company's unused borrowing capacity was $315.3 million, based on the assets assigned to the Amended Facility as of December 31, 2013. Availability of borrowings is based on a pool of eligible unencumbered real estate assets.
The Credit Facility and Amended Facility requires the Company to meet certain financial covenants, including the maintenance of certain financial ratios (such as specified debt to equity and debt service coverage ratios) as well as the maintenance of a minimum net worth. As of December 31, 2013, the Company was in compliance with the financial covenants under the Amended Facility agreement.
Note 6 — Note Payable
In September 2011, the Company entered into an unsecured $4.5 million note payable with an unaffiliated third party investor. The note bore interest at a fixed rate of 8.0% per annum and was due to mature in September 2014. The note had two one-year extension options. The note required monthly interest payments with the principal balance due at maturity. The note could be repaid at any time, in whole or in part, without premium or penalty. Notwithstanding the foregoing, after the initial maturity date, the lender had a right to require the repayment in full of any outstanding principal and interest under the note upon 60 days' notice. The note was repaid in full in January 2013 at the Company's election.

20

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Note 7 — Mortgage Notes Payable
The Company's mortgage notes payable as of December 31, 2013 and 2012 consist of the following:
 
 
 
 
Outstanding Loan Amount
as of December 31,
 
Effective
 
 
 
 
Portfolio
 
Encumbered Properties
 
2013
 
2012
 
Interest Rate
 
Interest Rate
 
Maturity
 
 
 
 
(In thousands)
 
(In thousands)
 
 
 
 
 
 
Texarkana ASC - Texarkana, TX
 
1
 
$
2,143

 
$
2,187

 
5.58
%
 
Fixed
 
Jun. 2016
Carson Tahoe Specialty Medical Center - Carson City, NV (1)
 
3
 
21,751

 
21,751

 
5.08
%
 
Fixed
 
Sep. 2015
Durango Medical Plaza - Las Vegas, NV (1)
 
1
 
17,172

 
17,172

 
5.08
%
 
Fixed
 
Sep. 2015
CareMeridian Rehabilitation - Phoenix, AZ (1)
 
1
 
6,936

 
6,936

 
5.08
%
 
Fixed
 
Sep. 2015
Reliant Rehabilitation - Dallas, TX (1)
 
1
 
24,850

 
24,850

 
5.15
%
 
Fixed
 
Sep. 2015
Select Rehabilitation - San Antonio, TX (1)
 
1
 
12,714

 
12,714

 
5.15
%
 
Fixed
 
Sep. 2015
Spring Creek Medical Plaza - Tomball, TX (1)
 
1
 
7,477

 
7,477

 
5.15
%
 
Fixed
 
Sep. 2015
Odessa Regional MOB - Odessa, TX
 
1
 
4,047

 
4,047

 
4.09
%
(2) 
Fixed
 
Dec. 2016
Methodist North MOB - Peoria, IL
 
1
 
13,544

 
13,544

 
3.99
%
(2) 
Fixed
 
Dec. 2016
University of Wisconsin Health MOB - Monona, WI
 
1
 
5,039

 
5,039

 
4.00
%
 
Fixed
 
Apr. 2017
Reliant Rehabilitation - Houston, TX (1)
 
1
 
13,437

 
13,437

 
4.98
%
 
Fixed
 
Sep. 2015
Village Healthcare Center - Santa Ana (1)
 
1
 
1,906

 
1,906

 
4.98
%
 
Fixed
 
Sep. 2015
Sisters of Mercy Building - Springfield, MO
 
1
 
5,500

 
5,500

 
4.11
%
 
Fixed
 
Sep. 2017
East Pointe Medical Plaza - Lehigh Acres, FL
 
1
 
5,260

 
5,260

 
4.11
%
 
Fixed
 
Sep. 2017
Unitron Hearing Building - Plymouth, MN
 
1
 
4,000

 
4,000

 
4.11
%
 
Fixed
 
Sep. 2017
Carson Tahoe MOB West - Carson City, NV
 
1
 
4,675

 
4,675

 
3.88
%
(2) 
Fixed
 
Jun. 2017
Aurora Health Care Portfolio
 
3
 
49,600

 
49,600

 
5.60
%
 
Fixed
 
Jan. 2017
Princeton Village - Clackamas, OR
 
1
 
3,114

 

 
7.48
%
 
Fixed
 
Jan. 2031
Pelican Pointe - Klamath Falls, OR
 
1
 
12,460

 

 
5.16
%
 
Fixed
 
Apr. 2022
Fayette MOB - Fayetteville, GA
 
1
 
6,986

 

 
5.18
%
 
Fixed
 
Sep. 2015
Benton House - Anderson, SC
 
1
 
8,149

 

 
4.86
%
 
Fixed
 
Dec. 2018
Benton House - Covington, GA
 
1
 
8,121

 

 
5.26
%
 
Fixed
 
May 2019
Arbor Terrace - Asheville, SC
 
1
 
9,497

 

 
5.58
%
 
Fixed
 
Feb. 2018
Arbor Terrace - Decatur, GA
 
1
 
10,970

 

 
5.57
%
 
Fixed
 
Jan. 2018
Total
 
28
 
$
259,348

 
$
200,095

 
5.09
%
(3) 
 
 
 
_________________
(1)
These mortgages, aggregating $106.2 million, represent the first, second and third tranches of a multi-tranche mortgage loan agreement to provide funding for a portfolio of eight properties. The mortgages for each of the properties are cross-collateralized with one another and in the event that the Company defaults on one of the mortgages, the lender may look to the other properties as collateral.
(2)
Fixed as a result of entering into a swap agreement.
(3)
Calculated on a weighted average basis for all mortgages outstanding as of December 31, 2013.

21

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The following table summarizes the scheduled aggregate principal payments for the five years subsequent to December 31, 2013:
(In thousands)
 
Future Principal
Payments
2014
 
$
1,038

2015
 
113,975

2016
 
20,545

2017
 
75,041

2018
 
27,346

Thereafter
 
21,403

 
 
$
259,348

Some of the Company's mortgage notes payable agreements require the compliance of certain property-level financial covenants including debt service coverage ratios. As of December 31, 2013 and 2012, the Company was in compliance with financial covenants under its mortgage notes payable agreements.
Note 8 — Fair Value of Financial Instruments
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. This alternative approach also reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The guidance defines three levels of inputs that may be used to measure fair value:
Level 1 — Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset and liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.
Level 3 — Unobservable inputs that reflect the entity's own assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.
The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. However, the Company expects that changes in classifications between levels will be rare.
Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with those derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. However, as of December 31, 2013 and 2012, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of the Company's derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.
The valuation of derivative instruments is determined using a discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, as well as observable market-based inputs, including interest rate curves and implied volatilities. In addition, credit valuation adjustments, are incorporated into the fair values to account for the Company's potential nonperformance risk and the performance risk of the counterparties.

22

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The Company has investments in common stock, redeemable preferred stock and senior notes that are traded in active markets and therefore, due to the availability of quoted market prices in active markets, the Company has classified these investments as level 1 in the fair value hierarchy.
The following table presents information about the Company's assets and liabilities (including derivatives that are presented net) measured at fair value on a recurring basis as of December 31, 2013 and 2012, aggregated by the level in the fair value hierarchy within which those instruments fall.
(In thousands)
 
Quoted Prices in Active Markets
Level 1
 
Significant Other Observable Inputs
Level 2
 
Significant Unobservable Inputs
Level 3
 
Total
December 31, 2013
 
 
 
 
 
 
 
 
Interest rate swaps
 
$

 
$
(333
)
 
$

 
$
(333
)
Investment securities
 
$
14,670

 
$

 
$

 
$
14,670

December 31, 2012
 
 
 
 
 
 
 
 
Interest rate swaps
 
$

 
$
(643
)
 
$

 
$
(643
)
A review of the fair value hierarchy classification is conducted on a quarterly basis. Changes in the type of inputs may result in a reclassification for certain assets. There were no transfers between Level 1 and Level 2 of the fair value hierarchy during the years ended December 31, 2013 or 2012.
The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate that value. The fair value of short-term financial instruments such as cash and cash equivalents, restricted cash, other receivables, due to affiliates, accounts payable and distributions payable approximates their carrying value on the consolidated balance sheets due to their short-term nature. The fair values of the Company's remaining financial instruments that are not reported at fair value on the consolidated balance sheets are reported below.
 
 
 
 
Carrying Amount at
 
Fair Value at
 
Carrying Amount at
 
Fair Value at
(In thousands)
 
Level
 
December 31, 2013
 
December 31, 2013
 
December 31, 2012
 
December 31, 2012
Mortgage notes payable and premiums, net
 
3
 
$
262,117

 
$
266,242

 
$
202,998

 
$
209,906

Credit facility
 
3
 
$

 
$

 
$
26,000

 
$
26,000

Note payable
 
3
 
$

 
$

 
$
2,500

 
$
2,851

The fair value of the mortgage notes payable and note payable are estimated using a discounted cash flow analysis, based on the Advisor's experience with similar types of borrowing arrangements. Advances under the credit facility are considered to be reported at fair value, since its interest rate varies with changes in LIBOR.
Note 9 — Derivatives and Hedging Activities
Risk Management Objective of Using Derivatives
The Company may use derivative financial instruments, including interest rate swaps, caps, collars, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company's operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company, and its affiliates, may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

23

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Cash Flow Hedges of Interest Rate Risk
The Company's objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company may use interest rate swaps and collars as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with forecasted variable-rate debt. Interest rate collars designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract and payments of variable-rate amounts if interest rates fall below the floor strike rate on the contract.
The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings.
Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. During the next 12 months, the Company estimates that an additional $0.2 million will be reclassified from other comprehensive loss as an increase to interest expense.
As of December 31, 2013 and 2012, the Company had the following outstanding interest rate derivatives that were designated as a cash flow hedge of interest rate risk:
 
 
December 31, 2013
 
December 31, 2012
Interest Rate Derivative
 
Number of
Instruments
 
Notional Amount
 
Number of
Instruments
 
Notional Amount
 
 
 
 
(In thousands)
 
 
 
(In thousands)
Interest Rate Swaps
 
3
 
$
22,266

 
3
 
$
22,266

The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheets as of December 31, 2013 and 2012:
(In thousands)
 
Balance Sheet Location
 
December 31, 2013
 
December 31, 2012
Derivatives designated as hedging instruments:
 
 
 
 
 
 
Interest Rate Swaps
 
Derivatives, at fair value
 
$
(333
)
 
$
(643
)
Derivatives in Cash Flow Hedging Relationships
The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the years ended December 31, 2013 and 2012:
 
 
Year Ended December 31,
(In thousands)
 
2013
 
2012
 
2011
Amount of income (loss) recognized in accumulated other comprehensive loss from interest rate derivatives (effective portion)
 
$
62

 
$
(624
)
 
$
(246
)
Amount of loss reclassified from accumulated other comprehensive loss into income as interest expense (effective portion)
 
$
(248
)
 
$
(227
)
 
$

Amount of gain (loss) recognized in income on derivative instruments (ineffective portion and amount excluded from effectiveness testing)
 
$

 
$

 
$


24

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Offsetting Derivatives
The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2013 and 2012. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The table below provides the location that the fair value of derivative assets and liabilities are presented on the accompanying consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross Amounts Not Offset on the Balance Sheet
 
 
Derivatives (In thousands)
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset on the Balance Sheet
 
Net Amounts of Liabilities presented on the Balance Sheet
 
Financial Instruments
 
Cash Collateral Posted
 
Net Amount
December 31, 2013
 
$
(333
)
 
$

 
$
(333
)
 
$

 
$

 
$
(333
)
December 31, 2012
 
$
(643
)
 
$

 
$
(643
)
 
$

 
$

 
$
(643
)
Derivatives Not Designated as Hedges
Derivatives not designated as hedges are not speculative. These derivatives may be used to manage the Company's exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements to be classified as hedging instruments. The Company does not have any hedging instruments that do not qualify for hedge accounting.
Credit-risk-related Contingent Features
The Company has an agreement with its derivative counterparty that contains a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligation.
As of December 31, 2013, the fair value of derivatives in a liability position related to these agreements, including accrued interest, but excluding any adjustment for nonperformance risk related to these agreements, was $0.4 million. As of December 31, 2013, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreement at its aggregate termination value of $0.4 million at December 31, 2013.
Note 10 — Common Stock
As of December 31, 2013 and 2012, the Company had 180.5 million and 55.6 million shares of common stock outstanding, including DRIP issuances, from total proceeds of $1.8 billion and $553.0 million, respectively.
On December 10, 2011, the board of directors authorized, and the Company declared, its current distribution rate, which is calculated based on stockholders of record each day during the applicable period, at a rate of $0.0018630137 per day or $0.68 annually per share of common stock beginning January 1, 2012. The Company's distributions are payable by the 5th day following each month end to stockholders of record at the close of business each day during the prior month. Distribution payments are dependent on the availability of funds. The board of directors may reduce the amount of distributions paid or suspend distribution payments at any time and therefore distribution payments are not assured.

25

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Note 11 — Commitments and Contingencies
Future Minimum Lease Payments
The Company entered into lease agreements related to certain acquisitions under leasehold interests arrangements. The following table reflects the minimum base cash rental payments due from the Company over the next five years and thereafter.  These amounts exclude contingent rent payments, as applicable, that may be payable based on provisions related to increases in annual rent based on exceeding certain economic indexes among other items.
(In thousands)
 
Future Minimum Base Cash Rental Payments Due
2014
 
$
613

2015
 
620

2016
 
626

2017
 
633

2018
 
656

Thereafter
 
23,109

 
 
$
26,257

Purchase Commitments
In July 2013, the Company entered into a construction advance agreement and purchase and sale agreement to initially fund the construction of, and subsequently purchase upon construction completion and rent commencement, a medical office building in Kenosha, Wisconsin for $24.5 million. As of December 31, 2013, the Company has funded $1.7 million and $11.1 million for the land and construction in progress, respectively.
Litigation
In the ordinary course of business, the Company may become subject to litigation or claims. There are no material legal proceedings pending or known to be contemplated against the Company or its properties.
Environmental Matters
In connection with the ownership and operation of real estate, the Company may potentially be liable for costs and damages related to environmental matters. As of December 31, 2013, the Company has not been notified by any governmental authority of any non-compliance, liability or other claim, and is not aware of any other environmental condition that it believes will have a material adverse effect on the results of operations.
Property Damages
On October 20, 2013, an electrical transformer malfunctioned at the Company's Michiana Oncology property located in Mishiwaka, Indiana, resulting in significant electrical damage within a portion of the building. The tenant completed the work necessary to repair the damage in December 2013. The tenant's property and other insurance absorbed the cost of fixing the damage. The Company does not expect any insurance or legal claims to arise from this incident. The tenant remained current with their rental obligations, and no loss of revenue was incurred by the Company.
Note 12 — Related Party Transactions and Arrangements
American Realty Capital Healthcare Special Limited Partnership, LLC, an entity wholly owned by the Sponsor, owned 20,000 shares of the Company's outstanding common stock as of December 31, 2013 and 2012.
Fees Paid in Connection with the IPO
The Dealer Manager was entitled to receive fees and compensation in connection with the sale of the Company's common stock in the IPO. The Dealer Manager received a selling commission of up to 7.0% of gross offering proceeds before reallowance of commissions earned by participating broker-dealers. In addition, the Dealer Manager received up to 3.0% of the gross proceeds, from the sale of common stock, before reallowance to participating broker-deals, as a dealer-manager fee. The

26

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Dealer Manager was permitted to reallow its dealer-manager fee to such participating broker-dealers, based on such factors as the volume of shares sold by respective participating broker-dealers and marketing support incurred as compared to those of other participating broker-dealers. The following table details total selling commissions and dealer manager fees incurred from and due to the Dealer Manager as of and for the periods presented:
 
 
Year Ended December 31,
 
Payable as of December 31,
(In thousands)
 
2013
 
2012
 
2011
 
2013
 
2012
Total commissions and fees from the Dealer Manager (1)
 
$
117,343

 
$
47,412

 
$
6,733

 
$
(18
)
 
$
625

_________________
(1)
Includes reimbursements received for selling commissions and dealer manager fees as a result of share purchase cancellations related to common stock sales prior to the close of the IPO.
The Advisor and its affiliates received compensation and reimbursement for services relating to the IPO. Effective March 1, 2013, the Company utilized transfer agent services provided by an affiliate of the Dealer Manager. All offering costs incurred by the Company, or its affiliated entities, on behalf of the Company were charged to additional paid-in capital on the accompanying consolidated balance sheets during the IPO. The following table details offering costs and reimbursements incurred from and due to the Advisor and Dealer Manager as of and for the periods presented:
 
 
Year Ended December 31,
 
Payable as of December 31,
(In thousands)
 
2013
 
2012
 
2011
 
2013
 
2012
Fees and expense reimbursements from the Advisor and Dealer Manager
 
$
1,901

 
$
13,717

 
$
2,997

 
$

 
$
73

The Company was responsible for offering and related costs from the IPO, excluding selling commissions and dealer manager fees, up to a maximum of 1.5% of gross proceeds received from the IPO, measured at the end of the IPO. Offering costs in excess of the 1.5% cap as of the end of the IPO were to be the Advisor's responsibility. As of the end of the IPO, offering and related costs, excluding selling commissions and dealer manager fees, did not exceed 1.5% of gross proceeds received from the IPO. In aggregate, offering costs including selling commissions and dealer manager fees are the Company's responsibility up to a maximum of 11.5% of the gross proceeds received from the IPO as determined at the end of our IPO. As of the end of the IPO in April 2013, offering costs were less than 11.5% of the gross proceeds received in the IPO.
Fees Paid in Connection With the Operations of the Company
The Advisor receives an acquisition fee of 1.0% of the contract purchase price of each acquired property and 1.0% of the amount advanced for a loan or other investment and is reimbursed for acquisition costs incurred in the process of acquiring properties, which is expected to be approximately 0.5% of the contract purchase price. In no event will the total of all acquisition fees and acquisition expenses (including any financing coordination fee) payable with respect to a particular investment exceed 4.5% of the contract purchase price. Once the proceeds from the IPO have been fully invested, the aggregate amount of acquisition fees and financing coordination fees (as described below) shall not exceed 1.5% of the contract purchase price and the amount advanced for a loan or other investment, as applicable for all the assets acquired.
If the Advisor provides services in connection with the origination or refinancing of any debt that the Company obtains and uses to acquire properties or to make other permitted investments, or that is assumed, directly or indirectly, in connection with the acquisition of properties, the Company will pay the Advisor a financing coordination fee equal to 1.0% of the amount available and/or outstanding under such financing, subject to certain limitations.
In connection with providing strategic advisory services related to certain portfolio acquisitions, the Company has entered into arrangements in which the investment banking division of the Dealer Manager receives a transaction fee of 0.25% of the Transaction Value for such portfolio acquisition transactions. Pursuant to such arrangements to date, the Transaction Value has been defined as: (i) the value of the consideration paid or to be paid for all the equity securities or assets in connection with the sale transaction or acquisition transaction (including consideration payable with respect to convertible or exchangeable securities and option, warrants or other exercisable securities and including dividends or distributions and equity security

27

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


repurchases made in anticipation of or in connection with the sale transaction or acquisition transaction), or the implied value for all the equity securities or assets of the Company or acquisition target, as applicable, if a partial sale or purchase is undertaken, plus (ii) the aggregate value of any debt, capital lease and preferred equity security obligations (whether consolidated, off-balance sheet or otherwise) of the Company or acquisition target, as applicable, outstanding at the closing of the sale transaction or acquisition transaction), plus (iii) the amount of any fees, expenses and promote paid by the buyer(s) on behalf of the Company or the acquisition target, as applicable. Should the Dealer Manager provide strategic advisory services related to additional portfolio acquisition transactions, the Company will enter into new arrangements with the Dealer Manager on such terms as may be agreed upon between the two parties.
Until October 1, 2012, the Company paid the Advisor a fee of 0.75% per annum of average invested assets to provide asset management services.  Average invested assets is defined as the average of the aggregate book value of assets invested, directly or indirectly, in properties, mortgage loans and other debt financing investments and other real estate-related investments secured by real estate before reserves for depreciation or bad debts or other similar non-cash reserves. However, the asset management fee was reduced by any amounts payable to the Property Manager as an oversight fee (as described below), such that the aggregate of the asset management fee and the oversight fee did not exceed 0.75% per annum of average invested assets. Such asset management fee was payable on a monthly basis, at the discretion of the Company's board, in cash, common stock or restricted stock grants, or any combination thereof.  The asset management fee was reduced to the extent, if any, that the Company's funds from operations, as adjusted, during the six months ending on the last calendar quarter immediately preceding the date the asset management fee was payable was less than the distributions declared with respect to such six month period.
Effective October 1, 2012, the payment of asset management fees in monthly installments in cash, shares or restricted stock grants, or any combination thereof to the Advisor was eliminated. Instead the Company issues (subject to periodic approval by the board of directors) to the Advisor performance-based restricted partnership units of the OP designated as "Class B units," which are intended to be profit interests and will vest, and no longer be subject to forfeiture, at such time as: (x) the value of the OP's assets plus all distributions made equals or exceeds the total amount of capital contributed by investors plus a 6% cumulative, pre-tax, non-compounded annual return thereon (the "economic hurdle"); (y) any one of the following occurs: (1) the termination of the advisory agreement by an affirmative vote of a majority of the Company's independent directors without cause; (2) a listing; or (3) another liquidity event; and (z) the Advisor is still providing advisory services to the Company (the "performance condition"). Such Class B units will be forfeited immediately if: (a) the advisory agreement is terminated other than by an affirmative vote of a majority of the Company's independent directors without cause; or (b) the advisory agreement is terminated by an affirmative vote of a majority of the Company's independent directors without cause before the economic hurdle has been met.
The calculation of the asset management fees has also been revised to pay a fee equal to: (i) the excess of (A) the product of (y) the cost of assets multiplied by (z) 0.1875% over (B) any amounts payable as an oversight fee (as described below) for such calendar quarter; divided by (ii) the value of one share of common stock as of the last day of such calendar quarter. When and if approved by the board of directors, the Class B units are expected to be issued to the Advisor quarterly in arrears pursuant to the terms of the limited partnership agreement of the OP. As of December 31, 2013, the Company cannot determine the probability of achieving the performance condition. The value of issued Class B units will be determined and expensed when the Company deems the achievement of the performance condition to be probable. The Advisor receives distributions on unvested Class B units equal to the distribution rate received on the Company's common stock. Such distributions on issued Class B units are included in general and administrative expenses in the consolidated statement of operations and comprehensive loss until the performance condition is considered probable to occur. During the year ended December 31, 2013, the board of directors approved the issuance of 709,180 Class B Units to the Advisor in connection with this arrangement. There were no such Class B Units issued as of December 31, 2012.
Unless the Company contracts with a third party, the Company will pay the Property Manager a property management fee of up to 1.5% of gross revenues from the Company's stand-alone single-tenant net leased properties and up to 2.5% of gross revenues from all other types of properties, respectively, plus market-based leasing commission applicable to the geographic location of each property.  The Company will also reimburse the affiliate for property level expenses. If the Company contracts directly with third parties for such services, the Company will pay them customary market fees and will pay the Property Manager an oversight fee of up to 1.0% of the gross revenues of the property managed. In no event will the Company pay the Property Manager or any affiliate both a property management fee and an oversight fee with respect to any particular property.

28

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Effective March 1, 2013, the Company entered into an agreement with the Dealer Manager to provide strategic advisory and investment banking services required in the ordinary course of the Company's business, such as performing financial analysis, evaluating publicly traded comparable companies and assisting in developing a portfolio composition strategy, a capitalization structure to optimize future liquidity options and structuring operations. Strategic advisory fees were amortized over the term of the IPO and included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. The Dealer Manager and its affiliates also provide transfer agency services, as well as transaction management and other professional services. These fees are also included in general and administrative expenses on the consolidated statement of operations and comprehensive loss during the period the service was provided.
The following table details amounts incurred, forgiven and payable to related parties in connection with the Company's operations-related services described above as of and for the periods presented:
 
 
Year Ended December 31,
 
 
 
 
 
 
2013
 
2012
 
2011
 
Payable as of December 31,
(In thousands)
 
Incurred
 
Forgiven
 
Incurred
 
Forgiven
 
Incurred
 
Forgiven
 
2013
 
2012
One-time fees and reimbursements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisition fees and related cost reimbursements, net(1)
 
$
5,909

 
$

 
$
7,851

 
$

 
$
2,699

 
$

 
$

 
$
143

Transaction fee
 
306

 

 

 

 

 

 

 

Financing coordination fees
 
8,166

 

 
2,882

 

 
1,279

 

 

 

Other expense reimbursements
 

 

 
149

 

 

 

 

 

Ongoing fees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset management fees(2)
 

 

 
987

 
597

 

 
154

 

 

Property management
 

 
1,394

 

 
446

 

 
39

 

 

Transfer agent and other professional fees
 
1,475

 

 

 

 

 

 
235

 

Strategic advisory fees
 
920

 

 

 

 

 

 

 

Distributions on Class B Units
 
220

 

 

 

 

 

 

 

Total related party operation fees and reimbursements
 
$
16,996

 
$
1,394

 
$
11,869

 
$
1,043

 
$
3,978

 
$
193

 
$
235

 
$
143

_________________
(1) During the year ended December 31, 2013, the Advisor reimbursed the Company $4.7 million for acquisition expenses and legal reimbursements incurred.
(2) Effective October 1, 2012, the Company issues (subject to approval by the board of directors) to the Advisor restricted performance based Class B units for asset management services, which will be forfeited immediately if certain conditions occur.
The Company will reimburse the Advisor's costs of providing administrative services, subject to the limitation that it will not reimburse the Advisor for any amount by which its operating expenses (including the asset management fee) at the end of the four preceding fiscal quarters exceeds the greater of (a) 2% of average invested assets, or (b) 25% of net income other than any additions to reserves for depreciation, bad debt or other similar non-cash reserves and excluding any gain from the sale of assets for that period. Additionally, the Company will not reimburse the Advisor for personnel costs in connection with services for which the Advisor receives acquisition fees or real estate commissions. No reimbursement was incurred from the Advisor for providing administrative services for the years ended December 31, 2013, 2012 or 2011.
In order to improve operating cash flows and the ability to pay distributions from operating cash flows, the Advisor and the Property Manager agreed to waive certain fees including asset management and property management fees. Because the Advisor and the Property Manager waived certain fees, cash flows from operations that would have been paid to the Advisor and the Property Manager were available to pay distributions to stockholders.  The fees that were forgiven are not deferrals and accordingly, will not be paid to the Advisor or the Property Manager in any subsequent periods. In certain instances, to improve the Company's working capital, the Advisor may elect to absorb a portion of the Company's general and administrative costs. For the years ended December 31, 2013 and 2012, the Advisor absorbed $0.3 million and $0.2 million of the Company's general and administrative costs. There were no general and administrative costs absorbed by the Advisor during the year ended December 31, 2011. These costs are presented net in the accompanying consolidated statements of operations and

29

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


comprehensive loss. The Company did not have a receivable due from the Advisor related to the absorbed general and administrative costs as of December 31, 2013 and 2011. As of December 31, 2012, the Company had a receivable of $0.2 million due from the Advisor related to absorbed general and administrative costs as presented on the accompanying consolidated balance sheets.
As the Company's real estate portfolio matures, the Company expects cash flows from operations (reported in accordance with GAAP) to cover a more significant portion of distributions and over time to cover the entire distribution. As the cash flows from operations become more significant, the Advisor and/or the Property Manager may discontinue their past practice of forgiving fees and may charge the full fees owed to them in accordance with the Company's agreements with such parties.
Fees Paid in Connection with the Liquidation or Listing of the Company's Real Estate Assets
In December 2013, the Company entered into a transaction management agreement with RCS Advisory Services, LLC, an entity owned by the Dealer Manager, to provide strategic alternatives transaction management services through the occurrence of a liquidity event and a-la-carte services thereafter. The Company agreed to pay $3.0 million pursuant to this agreement. As of December 31, 2013, the Company has incurred an aggregate of $1.5 million of expenses pursuant to this agreement, which includes amounts for services provided as of that date, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss and in accounts payable and accrued expenses on the accompanying consolidated balance sheet.
In December 2013, the Company entered into an information agent and advisory services agreement with Realty Capital Securities and American National Stock Transfer, entities owned by the Dealer Manager, to provide in connection with a liquidity event, advisory services, educational services to external and internal wholesalers, communication support as well as proxy, tender offer or redemption and solicitation services. The Company agreed to pay $1.9 million pursuant to this agreement. As of December 31, 2013, the Company has incurred an aggregate of $0.6 million of expenses pursuant to this agreement, which includes amounts for services provided as of that date, and is included in acquisition and transaction related costs on the accompanying consolidated statement of operations and comprehensive loss and in accounts payable and accrued expenses on the accompanying consolidated balance sheet.
The investment banking division of the Dealer Manager provides the Company with strategic and financial advice and assistance in connection with (i) a possible sale transaction involving the Company (ii) the possible listing of the Company's securities on a national securities exchange, and (iii) a possible acquisition transaction involving the Company. The Dealer Manager will receive a listing advisory fee equal to the greatest of (i) an amount equal to 0.25% of Transaction Value (as defined above), (ii) $1.0 million and (iii) the highest fee payable to any co-bookrunner (or comparable person) in connection with the listing. If one of the above events does not occur, the Dealer Manager will receive a base advisory services fee of $1.0 million on the earlier of (a) the date the Dealer Manager resigns or is terminated for cause and (b) 18 months from the date of any other termination of this agreement by the Company. No such amounts were incurred during years ended December 31, 2013, 2012 or 2011. 
The Company will pay a brokerage commission on the sale of property, not to exceed the lesser of 2.0% of the contract sale price of the property and 50.0% of the total brokerage commission paid if a third party broker is also involved; provided, however, that in no event may the real estate commissions paid to the Advisor, its affiliates and unaffiliated third parties exceed the lesser of 6.0% of the contract sales price and a reasonable, customary and competitive real estate commission, in light of the size, type and location of the property, in each case, payable to the Advisor if the Advisor or its affiliates, as determined by a majority of the independent directors. No such fees were incurred during the years ended December 31, 2013, 2012 or 2011.
The Company will pay a subordinated participation in the net sales proceeds of the sale of real estate assets of 15.0% of remaining net sale proceeds after return of capital contributions to investors plus payment to investors of an annual 6.0% cumulative, pre-tax non-compounded return on the capital contributed by investors.  The Company cannot assure that it will provide this 6.0% return, but the Advisor will not be entitled to the subordinated participation in net sale proceeds unless the Company's investors have received a 6% cumulative non-compounded return on their capital contributions. No such amounts were incurred during the years ended December 31, 2013, 2012 or 2011.
If the Company is listed on an exchange, the Company will pay a subordinated incentive listing distribution of 15.0% of the amount by which the sum of the adjusted market value of real estate assets plus distributions exceeds the aggregate capital contributed by investors plus an amount equal to a 6.0% cumulative, pre-tax non-compounded annual return to investors.  The

30

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Company cannot assure that it will provide this 6.0% return, but the Advisor will not be entitled to the subordinated incentive listing fee unless investors have received a 6.0% cumulative, pre-tax non-compounded return on their capital contributions. No such amounts were incurred during years ended December 31, 2013, 2012, or 2011. Neither the Advisor nor any of its affiliates can earn both the subordination participation in the net proceeds and the subordinated incentive listing distribution. The subordinated incentive listing distribution will be paid in the form of a non-interest bearing promissory note that will be repaid from the net sale proceeds of each sale of a property, loan or other investment after the date of the listing.
Upon termination or non-renewal of the advisory agreement, the Advisor will receive distributions from the Company payable in the form of a non-interest bearing promissory note. In addition, the Advisor may elect to defer its right to receive a subordinated distribution upon termination until either a listing on a national securities exchange or other liquidity event occurs.
Note 13 — Economic Dependency
Under various agreements, the Company has engaged or will engage the Advisor and its affiliates and entities under common ownership with our Advisor, to provide certain services that are essential to the Company, including asset management services, supervision of the management and leasing of properties owned by the Company, asset acquisition and disposition decisions, transfer agency services, as well as other administrative responsibilities for the Company including accounting services, transaction management services and investor relations.
As a result of these relationships, the Company is dependent upon the Advisor and its affiliates. In the event that these companies are unable to provide the Company with the respective services, the Company will be required to find alternative providers of these services.
Note 14 — Share-Based Compensation
Stock Option Plan
The Company has a stock option plan (the "Plan") which authorizes the grant of nonqualified stock options to the Company's independent directors, officers, advisors, consultants and other personnel subject to the absolute discretion of the board of directors and the applicable limitations of the Plan. The exercise price for all stock options granted under the Plan is fixed at $10.00 per share. Once the Company begins calculating a fair market value of the common stock, the exercise price for stock options granted to the independent directors will be equal to the fair market value of a share on the last business day preceding the annual meeting of stockholders. A total of 0.5 million shares have been authorized and reserved for issuance under the Plan. As of December 31, 2013 and 2012, no stock options were issued under the Plan.
Restricted Share Plan
The Company has an employee and director incentive restricted share plan (the "RSP"), which provides for the automatic grant of 3,000 restricted shares of common stock to each of the independent directors, without any further action by the Company's board of directors or the stockholders, on the date of initial election to the board of directors and on the date of each annual stockholder's meeting. Restricted stock issued to independent directors will vest over a five-year period following the first anniversary of the date of grant in increments of 20% per annum. The RSP provides the Company with the ability to grant awards of restricted shares to the Company's directors, officers and employees (if the Company ever has employees), employees of the Advisor and its affiliates, employees of entities that provide services to the Company, directors of the Advisor or of entities that provide services to the Company, certain consultants to the Company and the Advisor and its affiliates or to entities that provide services to the Company. The total number of common shares granted under the RSP shall not exceed 5.0% of the Company's shares of common stock on a fully diluted basis at any time, and in any event will not exceed 7.5 million shares (as such number may be adjusted for stock splits, stock dividends, combinations and similar events).

31

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


Restricted share awards entitle the recipient to receive shares of common stock from the Company under terms that provide for vesting over a specified period of time. Such awards would typically be forfeited with respect to the unvested shares upon the termination of the recipient's employment or other relationship with the Company. Restricted shares may not, in general, be sold or otherwise transferred until restrictions are removed and the shares have vested. Holders of restricted shares may receive cash distributions prior to the time that the restrictions on the restricted shares have lapsed. Any distributions payable in shares of common stock shall be subject to the same restrictions as the underlying restricted shares. The following table reflects restricted share award activity for the years ended December 31, 2013, 2012, and 2011:
 
Number of Common Shares
 
Weighted-Average Issue Price
Unvested, January 1, 2011

 
$

Granted
9,000

 
10.00

Unvested, December 31, 2011
9,000

 
10.00

Granted
12,000

 
9.25

Vested
(1,800
)
 
10.00

Forfeitures
(2,400
)
 
10.00

Unvested, December 31, 2012
16,800

 
9.46

Granted
12,000

 
9.00

Vested
(10,800
)
 
9.28

Unvested, December 31, 2013
18,000

 
$
9.23

As of December 31, 2013, the Company had $0.1 million of unrecognized compensation cost related to unvested restricted share awards granted under the Company's RSP. That cost is expected to be recognized over a weighted average period of 3.9 years.
The fair value of the restricted shares, based on the price per share in the IPO, excluding commissions, is being expensed over the vesting period of five years. Compensation expense related to restricted stock was $0.1 million, $27,000 and $16,000 for the years ended December 31, 2013, 2012 and 2011, respectively.
Other Share-Based Compensation
The Company may issue common stock in lieu of cash to pay fees earned by the Company's directors at the respective director's election. There are no restrictions on the shares issued. The following table reflects the shares of common stock issued to directors in lieu of cash compensation for the years ended December 31, 2013, 2012, and 2011:
 
Year Ended December 31,
 
2013
 
2012
 
2011
Shares issued in lieu of cash
1,667

 
10,972

 
4,556

Value of shares issued in lieu of cash (in thousands)
$
15

 
$
99

 
$
41

Note 15 — Net Loss Per Share
The following is a summary of the basic and diluted net loss per share computation for the years ended December 31, 2013, 2012 and 2011:  
 
Year Ended December 31,
 
2013
 
2012
 
2011
Net loss attributable to stockholders (in thousands)
$
(22,230
)
 
$
(10,635
)
 
$
(4,085
)
Basic and diluted weighted average common shares outstanding
151,683,551

 
25,008,063

 
1,649,649

Basic and diluted net loss per share attributable to stockholders
$
(0.15
)
 
$
(0.43
)
 
$
(2.48
)

32

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The Company had the following common share equivalents as of December 31, 2013, 2012 and 2011, which were excluded from the calculation of diluted loss per share attributable to stockholders as the effect would have been antidilutive:
 
December 31,
 
2013
 
2012
 
2011
Unvested restricted stock
18,000

 
16,800

 
9,000

OP Units
202

 
202

 
202

Class B Units
709,180

 

 

Total common share equivalents
727,382

 
17,002

 
9,202

Note 16 — Non-Controlling Interests
The Company is the sole general partner and holds a majority of all of the units of limited partner interests in the OP ("OP Units"). As of December 31, 2013 and 2012, the Advisor, a limited partner, held 202 OP Units, which represents a nominal percentage of the aggregate OP ownership. A holder of OP Units has the right to convert OP Units for the cash value of a corresponding number of shares of common stock or, at the option of the OP, a corresponding number of shares of common stock of the Company, in accordance with the limited partnership agreement of the OP. The remaining rights of the holders of OP Units are limited, however, and do not include the ability to replace the general partner or to approve the sale, purchase or refinancing of the OP's assets.
The Company has investment arrangements with unaffiliated third parties whereby such investors receive an ownership interest in certain of the Company's property-owning subsidiaries and are entitled to receive a proportionate share of the net operating cash flow derived from the subsidiaries' property. Upon disposition of a property subject to non-controlling interest, the investor will receive a proportionate share of the net proceeds from the sale of the property. The investor has no recourse to any other assets of the Company. Due to the nature of the Company's involvement with each of the arrangements described in the table below and the significance of its investment in relation to the investment of the third parties, the Company has determined that it controls each entity in each of these arrangements and therefore the entities related to these arrangements are consolidated within the Company's financial statements. A non-controlling interest is recorded for each investors' ownership interest in the property.
The following table summarizes the activity related to investment arrangements with unaffiliated third parties:
 
 
 
 
 
 
 
 
As of December 31, 2013
 
As of December 31, 2012
 
Distributions
 
 
 
 
 Net Investment
 
 Non-Controlling Ownership
 
Net Real Estate Assets Subject to
 
Mortgage Payables
Subject to
 
Net Real Estate Assets
Subject to
 
Mortgage Payables
Subject to
 
Year Ended December 31,
Property Name (Dollar amounts in thousands)
 
Investment
Date
 
Amount as of December 31, 2013
 
Percentage as of December 31, 2013
 
Investment
Arrangement
 
Investment
Arrangement
 
Investment
Arrangement
 
Investment
Arrangement
 
2013
 
2012
Reliant Rehabilitation - Dallas, TX
 
Nov. 2011
 
$
2,000

 
20%
 
$
31,735

 
$
24,850

 
$
32,981

 
$
24,850

 
$
162

 
$
166

Odessa Regional MOB - Odessa, TX (1)
 
Dec. 2011
 

 
—%
 

 

 
7,036

 
4,047

 
7

 

Methodist North MOB - Peoria, IL (1)
 
Dec. 2011
 

 
—%
 

 

 
23,795

 
13,544

 
24

 

University of Wisconsin Health MOB - Monona, WI
 
Mar. 2012
 
2,300

 
25%
 
8,739

 
5,039

 
8,993

 
5,039

 
187

 
195

Total
 
 
 
$
4,300

 
 
 
$
40,474

 
$
29,889

 
$
72,805

 
$
47,480

 
$
380

 
$
361

_________________
(1) During the year ended December 31, 2013, the Company fully redeemed the third parties' interest in Odessa Regional MOB and Methodist North MOB for an aggregate of $0.1 million.
Note 17 — Segment Reporting
During the years ended December 31, 2013 and 2012, the Company operated in three reportable business segments for management and internal financial reporting purposes: medical office buildings and outpatient facilities; seniors housing communities; and hospitals, post-acute care and other facilities. The Company did not own any seniors housing communities and therefore, operated in two reportable business segments during the year ended December 31, 2011.


33

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


These operating segments are the segments of the Company for which separate financial information is available and for which segment results are evaluated in deciding how to allocate resources and in assessing performance. The medical office buildings and outpatient facilities segment primarily consists of investing in medical office buildings and leasing those properties to healthcare-related tenants under long-term leases, which may require such tenants to pay property-related expenses. The seniors housing communities segment primarily consists of investments in seniors housing communities located in the United States which we lease or engage independent third-party managers. The hospital, post-acute care and other facilities primarily consists of investments in hospitals and inpatient rehabilitation facilities under long-term leases, which require such tenants to pay property-related expenses. The Company evaluates performance of the combined properties in each segment based on net operating income. Net operating income is defined as total revenues less property operating and maintenance expenses. There are no intersegment sales or transfers. The Company uses net operating income to evaluate the operating performance of real estate investments and to make decisions concerning the operation of the property. The Company believes that net operating income is useful to investors in understanding the value of income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as operating fees to affiliates, acquisition and transaction related expenses, general and administrative expenses, depreciation and amortization expense and interest expense. Additionally, net operating income as defined by the Company may not be comparable to net operating income as defined by other REITs or companies.
The following tables reconcile the segment activity to consolidated net income for the years ended December 31, 2013, 2012 and 2011:
 
 
Year Ended December 31, 2013
(In thousands)
 
Medical Office Buildings and Outpatient Facilities
 
Seniors Housing Communities
 
Hospitals, Post-Acute Care and Other Facilities
 
Consolidated
Revenues:
 
 
 
 
 
 
 
 
Rental income
 
$
45,917

 
$
41,890

 
$
19,947

 
$
107,754

Operating expense reimbursements
 
8,352

 

 
2,796

 
11,148

Resident services and fee income
 

 
6,451

 

 
6,451

Total revenues
 
54,269

 
48,341

 
22,743

 
125,353

 
 
 
 
 
 
 
 
 
Property operating and maintenance
 
10,235

 
33,152

 
3,278

 
46,665

Net operating income
 
$
44,034

 
$
15,189

 
$
19,465

 
78,688

Operating fees to affiliate
 
 
 
 
 
 
 

Acquisition and transaction related
 
 
 
 
 
 
 
13,606

General and administrative
 
 
 
 
 
 
 
4,613

Depreciation and amortization
 
 
 
 
 
 
 
67,456

Interest expense
 
 
 
 
 
 
 
15,843

Income from investments
 
 
 
 
 
 
 
(869
)
Other income
 
 
 
 
 
 
 
(89
)
Loss on sale of investment securities
 
 
 
 
 
 
 
300

Net loss attributable to non-controlling interests
 
 
 
 
 
 
 
58

Net loss attributable to stockholders
 
 
 
 
 
 
 
$
(22,230
)

34

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


 
 
Year Ended December 31, 2012
(In thousands)
 
Medical Office Buildings and Outpatient Facilities
 
Seniors Housing Communities
 
Hospitals, Post-Acute Care and Other Facilities
 
Consolidated
Revenues:
 
 
 
 
 
 
 
 
Rental income
 
$
15,839

 
$
1,740

 
$
12,800

 
$
30,379

Operating expense reimbursements
 
2,520

 

 
2,674

 
5,194

Resident services and fee income
 

 
165

 

 
165

Total revenues
 
18,359

 
1,905

 
15,474

 
35,738

 
 
 
 
 
 
 
 
 
Property operating and maintenance
 
2,734

 
1,101

 
2,729

 
6,564

Net operating income
 
$
15,625

 
$
804

 
$
12,745

 
29,174

Operating fees to affiliate
 
 
 
 
 
 
 
987

Acquisition and transaction related
 
 
 
 
 
 
 
9,433

General and administrative
 
 
 
 
 
 
 
905

Depreciation and amortization
 
 
 
 
 
 
 
19,320

Interest expense
 
 
 
 
 
 
 
9,184

Income from investments
 
 
 
 
 
 
 

Other income
 
 
 
 
 
 
 
(18
)
Loss on sale of investment securities
 
 
 
 
 
 
 

Net loss attributable to non-controlling interests
 
 
 
 
 
 
 
(2
)
Net loss attributable to stockholders
 
 
 
 
 
 
 
$
(10,635
)

 
 
Year Ended December 31, 2011
(In thousands)
 
Medical Office Buildings and Outpatient Facilities
 
Seniors Housing Communities
 
Hospitals, Post-Acute Care and Other Facilities
 
Consolidated
Revenues:
 
 
 
 
 
 
 
 
Rental income
 
$
1,086

 
$

 
$
1,475

 
$
2,561

Operating expense reimbursements
 
173

 

 
580

 
753

Resident services and fee income
 

 

 

 

Total revenues
 
1,259

 

 
2,055

 
3,314

 
 
 
 
 
 
 
 
 
Property operating and maintenance
 
280

 

 
583

 
863

Net operating income
 
$
979

 
$

 
$
1,472

 
2,451

Operating fees to affiliate
 
 
 
 
 
 
 

Acquisition and transaction related
 
 
 
 
 
 
 
3,415

General and administrative
 
 
 
 
 
 
 
429

Depreciation and amortization
 
 
 
 
 
 
 
1,535

Interest expense
 
 
 
 
 
 
 
1,191

Income from investments
 
 
 
 
 
 
 

Other income
 
 
 
 
 
 
 
(2
)
Loss on sale of investment securities
 
 
 
 
 
 
 

Net loss attributable to non-controlling interests
 
 
 
 
 
 
 
(32
)
Net loss attributable to stockholders
 
 
 
 
 
 
 
$
(4,085
)

35

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


The following table reconciles the segment activity to consolidated total assets as of December 31, 2013 and 2012:
 
 
December 31,
 
December 31,
(In thousands)
 
2013
 
2012
Assets
 
 
 
 
Investments in real estate:
 
 
 
 
Medical office buildings and outpatient facilities
 
$
779,228

 
$
407,062

Seniors housing communities
 
442,863

 
85,249

Hospitals, post-acute care and other facilities
 
354,512

 
164,016

Total reportable segments, net
 
1,576,603

 
656,327

Cash
 
103,447

 
13,869

Restricted cash
 
1,381

 
127

Investment securities, at fair value
 
14,670

 

Receivable for sale of common stock
 

 
6,943

Prepaid expenses and other assets
 
17,431

 
5,826

Due from affiliate
 

 
190

Deferred costs, net
 
21,041

 
7,386

Total assets
 
$
1,734,573

 
$
690,668

Note 18 – Quarterly Results (Unaudited)
Presented below is a summary of the unaudited quarterly financial information for the years ended December 31, 2013, 2012 and 2011:
 
 
Quarters Ended
(In thousands, except for share amounts)
 
March 31, 2013
 
June 30, 2013
 
September 30, 2013
 
December 31, 2013
Total revenues
 
$
18,678

 
$
23,937

 
$
34,147

 
$
48,591

Net loss attributable to stockholders
 
$
(3,606
)
 
$
(3,258
)
 
$
(5,475
)
 
$
(9,891
)
Basic and diluted weighted average common shares outstanding
 
77,029,025

 
170,124,871

 
178,231,121

 
179,929,602

Basic and diluted net loss per share attributable to stockholders
 
$
(0.05
)
 
$
(0.02
)
 
$
(0.03
)
 
$
(0.05
)
 
 
Quarters Ended
(In thousands, except for share amounts)
 
March 31, 2012
 
June 30, 2012
 
September 30, 2012
 
December 31, 2012
Total revenues
 
$
4,707

 
$
6,875

 
$
10,194

 
$
13,962

Net loss attributable to stockholders
 
$
(1,424
)
 
$
(3,456
)
 
$
(2,061
)
 
$
(3,694
)
Basic and diluted weighted average common shares outstanding
 
9,742,753

 
18,017,661

 
28,039,574

 
43,990,171

Basic and diluted net loss per share attributable to stockholders
 
$
(0.15
)
 
$
(0.19
)
 
$
(0.07
)
 
$
(0.08
)

36

AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2013


 
 
Quarters Ended
(In thousands, except for share amounts)
 
March 31, 2011
 
June 30, 2011
 
September 30, 2011
 
December 31, 2011
Total revenues
 
$

 
$
12

 
$
436

 
$
2,866

Net loss attributable to stockholders
 
$
(35
)
 
$
(277
)
 
$
(1,118
)
 
$
(2,655
)
Basic and diluted weighted average common shares outstanding
 
20,000

 
230,133

 
1,510,422

 
4,787,183

Basic and diluted net loss per share attributable to stockholders
 
NM

 
$
(1.20
)
 
$
(0.74
)
 
$
(0.55
)
_________________
NM - Not Meaningful
Note 19 — Subsequent Events
The Company has evaluated subsequent events through the filing of this Annual Report on Form 10-K, and determined that there have not been any events that have occurred that would require adjustments to disclosures in the consolidated financial statements except for the following transactions:
Acquisitions
The following table presents certain information about the properties that the Company acquired from January 1, 2014 to February 26, 2014:
 
Number of Properties
 
Rentable
Square Feet
 
Base
Purchase Price
(1)
 
 
 
 
 
(In thousands)
Total portfolio as of December 31, 2013
114

 
5,830,271

 
$
1,642,593

Acquisitions
6

 
393,264

 
129,525

Total portfolio as of February 26, 2014
120

 
6,223,535

 
$
1,772,118

_________________
(1)    Contract purchase price, excluding acquisition related costs.

37

American Realty Capital Healthcare Trust, Inc.

Real Estate and Accumulated Depreciation
Schedule III
December 31, 2013
(dollar amounts in thousands)

 
 
 
 
 
 
 
 
Initial Costs
 
Subsequent to Acquisition
 
 
 
 
Property
 
State
 
Acquisition
Date
 
Encumbrances at
December 31, 2013
 
Land
 
Building and
Improvements
 
Building and Improvements
 
Gross Amount at
December  31, 2013 
(1) (2)
 
Accumulated
Depreciation 
(3) (4)
Texarkana ASC - Texarkana
 
TX
 
6/21/2011
 
$
2,143

 
$
786

 
$
3,143

 
$

 
$
3,929

 
$
468

DaVita Dialysis - Marked Tree
 
AR
 
6/30/2011
(5) 

 
64

 
1,219

 

 
1,283

 
180

DaVita Dialysis - Rockford
 
IL
 
7/25/2011
(5) 

 

 
1,797

 

 
1,797

 
204

Carson Tahoe Specialty Medical Center - Carson City
 
NV
 
9/19/2011
 
21,751

 
2,205

 
22,934

 

 
25,139

 
3,349

Durango Medical Plaza - Las Vegas
 
NV
 
9/19/2011
 
17,172

 
2,389

 
16,065

 
56

 
18,428

(6) 
2,604

CareMeridian Rehabilitation - Phoenix
 
AZ
 
9/15/2011
 
6,936

 
804

 
7,236

 

 
8,040

 
923

Reliant Rehabilitation - Dallas
 
TX
 
11/22/2011
 
24,850

 
1,422

 
27,024

 

 
28,446

 
3,190

Select Rehabilitation - San Antonio
 
TX
 
11/22/2011
 
12,714

 
1,447

 
13,027

 

 
14,474

 
1,538

Spring Creek Medical Plaza - Tomball
 
TX
 
11/22/2011
 
7,477

 
705

 
7,314

 
1

 
7,490

(6) 
875

Odessa Regional MOB- Odessa
 
TX
 
12/19/2011
 
4,047

 

 
6,463

 

 
6,463

 
797

Methodist North MOB - Peoria
 
IL
 
12/19/2011
 
13,544

 

 
21,917

 

 
21,917

 
2,131

Cooper Health MOB I - Willingboro
 
NJ
 
12/29/2011
(5) 

 
394

 
2,455

 
62

 
2,911

 
288

Village Healthcare Center - Santa Ana
 
CA
 
1/13/2012
 
1,906

 
1,584

 
2,376

 

 
3,960

 
269

BioLife Sciences Building - Denton
 
TX
 
1/20/2012
(5) 

 
1,027

 
4,109

 

 
5,136

 
370

University of Wisconsin Health MOB - Monona
 
WI
 
3/6/2012
 
5,039

 
816

 
7,344

 

 
8,160

 
628

Carson Tahoe MOB West - Carson City
 
NV
 
3/8/2012
 
4,675

 

 
7,111

 

 
7,111

 
823

Henry Ford Dialysis Center - Southfield
 
MI
 
3/15/2012
(5) 

 
126

 
2,402

 

 
2,528

 
207

Sisters of Mercy Building - Springfield
 
MO
 
4/10/2012
 
5,500

 
490

 
9,311

 

 
9,801

 
760

East Pointe Medical Plaza - Lehigh Acres
 
FL
 
4/18/2012
 
5,260

 
473

 
8,980

 

 
9,453

 
698

DaVita Dialysis - Paoli
 
IN
 
5/4/2012
(5) 

 
167

 
1,503

 

 
1,670

 
118

Reliant Rehabilitation - Houston
 
TX
 
5/9/2012
 
13,437

 
1,330

 
25,262

 

 
26,592

 
2,386

PAPP Clinic - Newnan
 
GA
 
5/14/2012
(5) 

 
955

 
3,821

 
65

 
4,841

 
297

Unitron Hearing Building - Plymouth
 
MN
 
5/15/2012
 
4,000

 
822

 
7,394

 

 
8,216

 
656

Cooper Health MOB II - Willingboro
 
NJ
 
5/22/2012
(5) 

 
158

 
3,923

 

 
4,081

 
368

Fresenius Medical - Metairie
 
LA
 
5/23/2012
(5) 

 
660

 
2,642

 

 
3,302

 
197

Sunnyvale Medical Plaza - Sunnyvale
 
TX
 
5/31/2012
(5) 

 
951

 
10,290

 

 
11,241

 
1,053

Texas Clinic at Arlington - Arlington
 
TX
 
5/31/2012
(5) 

 
2,689

 
16,833

 
143

 
19,665

 
1,559

Pinnacle Health - Harrisburg
 
PA
 
6/12/2012
(5) 

 
485

 
10,797

 

 
11,282

 
1,028

Cancer Care Partners - Mishawaka
 
IN
 
6/15/2012
(5) 

 
1,188

 
22,578

 

 
23,766

 
1,668

Aurora Health Care - Hartford
 
WI
 
7/26/2012
 
19,120

 
2,295

 
20,659

 

 
22,954

 
1,366

Aurora Health Care - Neenah
 
WI
 
7/26/2012
 
7,840

 
470

 
8,932

 

 
9,402

 
591

Aurora Health Care - Two Rivers
 
WI
 
7/26/2012
 
22,640

 
1,359

 
25,816

 

 
27,175

 
1,707

Baylor Institute for Rehabilitation - Fort Worth
 
TX
 
8/22/2012
(5) 

 
1,413

 
12,720

 

 
14,133

 
961

Bronson Lakeview - Paw Paw
 
MI
 
9/27/2012
(5) 

 
1,362

 
25,871

 

 
27,233

 
1,509


38

American Realty Capital Healthcare Trust, Inc.

Real Estate and Accumulated Depreciation
Schedule III
December 31, 2013
(dollar amounts in thousands)

 
 
 
 
 
 
 
 
Initial Costs
 
Subsequent to Acquisition
 
 
 
 
Property
 
State
 
Acquisition
Date
 
Encumbrances at
December 31, 2013
 
Land
 
Building and
Improvements
 
Building and Improvements
 
Gross Amount at
December  31, 2013 
(1) (2)
 
Accumulated
Depreciation 
(3) (4)
Benton Village - Palm Coast
 
FL
 
11/21/2012
(5) 

 
1,053

 
15,446

 

 
16,499

 
607

Benton House - Douglasville
 
GA
 
11/21/2012
(5) 

 
1,201

 
13,104

 

 
14,305

 
519

Benton Village - Stockbridge
 
GA
 
11/21/2012
(5) 

 
1,770

 
14,303

 
20

 
16,093

 
592

Benton House - Sugar Hill
 
GA
 
11/21/2012
(5) 

 
1,337

 
14,216

 

 
15,553

 
566

Benton House - Newnan
 
GA
 
12/4/2012
(5) 

 
1,023

 
18,505

 

 
19,528

 
659

Advocate Beverly Center - Chicago
 
IL
 
11/28/2012
(5) 

 
1,971

 
12,451

 

 
14,422

 
700

Rush Copley POB I - Aurora
 
IL
 
11/29/2012
(5) 

 

 
23,236

 

 
23,236

 
1,331

CareMeridian Rehabilitation - La Mesa
 
CA
 
12/14/2012
(5) 

 
1,313

 
3,938

 

 
5,251

 
242

Wellmont Blue Ridge MOB - Bristol
 
TN
 
12/27/2012
(5) 

 
218

 
4,143

 

 
4,361

 
193

Albany Medical Center MOB - Albany
 
NY
 
12/28/2012
(5) 

 
3,693

 
9,534

 

 
13,227

 
507

Michiana Oncology - Mishawaka
 
IN
 
12/28/2012
(5) 

 
1,794

 
17,137

 

 
18,931

 
810

Metro Health - Wyoming
 
MI
 
12/28/2012
(5) 

 
826

 
4,682

 

 
5,508

 
218

Rush Copley POB II - Aurora
 
IL
 
12/28/2012
(5) 

 

 
23,553

 

 
23,553

 
1,398

North Valley Orthopedic Surgery Center - Phoenix
 
AZ
 
12/31/2012
(5) 

 
1,174

 
6,652

 

 
7,826

 
310

Scott & White Healthcare - Kingsland
 
TX
 
2/21/2013
(5) 

 
196

 
3,733

 

 
3,929

 
145

Salem Medical - Woodstown
 
NJ
 
3/1/2013
(5) 

 
162

 
3,086

 

 
3,248

 
120

Northside East Cobb Medical Campus - Marietta
 
GA
 
3/22/2013
(5) 

 
764

 
16,165

 
196

 
17,125

 
863

Rex Wellness Center - Garner
 
NC
 
3/27/2013
(5) 

 
790

 
7,110

 

 
7,900

 
249

Princeton Village - Clackamas
 
OR
 
3/28/2013
 
3,114

 
766

 
5,813

 

 
6,579

 
148

Pelican Pointe - Klamath Falls
 
OR
 
3/28/2013
 
12,460

 
357

 
19,179

 

 
19,536

 
461

Lakeview Terrace - Lake Havasu
 
AZ
 
4/3/2013
(5) 

 
369

 
7,009

 

 
7,378

 
260

Crystal Lakes Medical Arts - Crystal Lake
 
IL
 
4/30/2013
(5) 

 
1,577

 
15,349

 

 
16,926

 
555

St. Francis Cancer Center - Midlothian
 
VA
 
5/2/2013
(5) 

 

 
16,578

 

 
16,578

 
707

Advocate Good Shepard - Crystal Lake
 
IL
 
5/2/2013
(5) 

 
471

 
6,628

 

 
7,099

 
410

Dakota Ridge Medical Center - Littleton
 
CO
 
5/2/2013
(5) 

 
553

 
6,332

 

 
6,885

 
418

Pheasant Pointe - Molalla
 
OR
 
5/3/2013
(5) 

 
621

 
6,627

 

 
7,248

 
145

Cedar Village - Salem
 
OR
 
5/3/2013
(5) 

 
617

 
10,148

 

 
10,765

 
210

Ocean Ridge - Coos Bay
 
OR
 
5/3/2013
(5) 

 
1,621

 
11,127

 
6

 
12,754

 
288

Spectrum Health MOB - Wyoming
 
MI
 
5/15/2013
(5) 

 
1,504

 
13,538

 

 
15,042

 
421

Memorial Hermann MOB - Houston
 
TX
 
6/4/2013
(5) 

 
602

 
11,430

 

 
12,032

 
311

UC Davis MOB - Folsom
 
CA
 
6/17/2013
(5) 

 
707

 
7,553

 
29

 
8,289

 
207

Wyndcrest - Rochester
 
IL
 
7/1/2013
(5) 

 
276

 
4,587

 

 
4,863

 
76

Fayette MOB - Fayetteville
 
GA
 
7/16/2013
 
6,986

 

 
15,326

 

 
15,326

 
364

Garden House - Anderson
 
SC
 
7/26/2013
 
8,149

 
520

 
12,187

 

 
12,707

 
170

Arbor Terrace - Athens
 
GA
 
7/31/2013
(5) 

 
1,265

 
15,877

 
33

 
17,175

 
196

Arbor Terrace of Cascade - Atlanta
 
GA
 
7/31/2013
(5) 

 
1,762

 
6,890

 
13

 
8,665

 
120

Arbor Terrace - Decatur (Land)
 
GA
 
7/31/2013
 

 
1,788

 

 

 
1,788

 

Arbor Terrace - Largo
 
FL
 
7/30/2013
(5) 

 
1,052

 
6,691

 
2

 
7,745

 
102


39

American Realty Capital Healthcare Trust, Inc.

Real Estate and Accumulated Depreciation
Schedule III
December 31, 2013
(dollar amounts in thousands)

 
 
 
 
 
 
 
 
Initial Costs
 
Subsequent to Acquisition
 
 
 
 
Property
 
State
 
Acquisition
Date
 
Encumbrances at
December 31, 2013
 
Land
 
Building and
Improvements
 
Building and Improvements
 
Gross Amount at
December  31, 2013 
(1) (2)
 
Accumulated
Depreciation 
(3) (4)
Arbor - Terrace of Knoxville
 
TN
 
7/31/2013
(5) 

 
364

 
16,292

 

 
16,656

 
213

Barrington Terrace - Fort Myers
 
FL
 
7/31/2013
(5) 

 
1,522

 
14,359

 

 
15,881

 
239

Barrington Terrace - Naples
 
FL
 
7/31/2013
(5) 

 
1,684

 
20,181

 
24

 
21,889

 
305

Clearwater Springs - Vancouver
 
WA
 
8/1/2013
(5) 

 
740

 
9,799

 

 
10,539

 
141

Redwood Heights - Salem
 
OR
 
8/1/2013
(5) 

 
1,070

 
10,077

 

 
11,147

 
145

Ocean Crest - Coos Bay
 
OR
 
8/1/2013
(5) 

 
235

 
3,453

 

 
3,688

 
56

Benton House - Covington
 
GA
 
8/2/2013
 
8,121

 
1,025

 
12,115

 

 
13,140

 
173

Via Christi Clinic - Wichita
 
KS
 
8/20/2013
 

 
705

 
6,341

 

 
7,046

 
99

United Healthcare - Cypress
 
CA
 
9/24/2013
 

 
310

 
47,879

 

 
48,189

 
578

United Healthcare - Indianapolis
 
IN
 
9/24/2013
 

 
4,160

 
28,037

 

 
32,197

 
338

United Healthcare - Onlaska
 
WI
 
9/24/2013
 

 
700

 
7,268

 

 
7,968

 
88

United Healthcare - Wawatosa
 
WI
 
9/24/2013
 

 
4,270

 
15,274

 

 
19,544

 
184

Athens Medical Complex - Athens
 
GA
 
9/27/2013
 

 
1,476

 
14,402

 

 
15,878

 
214

Restora Hospital - Sun City
 
AZ
 
9/27/2013
 

 
860

 
16,352

 

 
17,212

 
232

Restora Hospital - Mesa
 
AZ
 
9/27/2013
 

 
861

 
16,345

 

 
17,206

 
232

West Valley Medical Center - Buckeye
 
AZ
 
9/27/2013
 

 
1,535

 
6,140

 

 
7,675

 
72

Lutheran Medical Arts - Ft. Wayne
 
IN
 
9/27/2013
 

 

 
11,165

 

 
11,165

 
162

DuPont Road MOB - Ft. Wayne
 
IN
 
9/27/2013
 

 

 
8,124

 
46

 
8,170

 
121

Crozer-Keystone I - Springfield
 
PA
 
9/27/2013
 

 
2,423

 
46,043

 

 
48,466

 
537

Crozer-Keystone II - Springfield
 
PA
 
9/27/2013
 

 
1,696

 
9,610

 

 
11,306

 
112

Aventura Medical Plaza - Aventura
 
FL
 
9/27/2013
 

 
667

 
13,875

 

 
14,542

 
273

Spartanburg Regional MOB - Spartanburg
 
SC
 
9/27/2013
 

 

 
17,824

 

 
17,824

 
231

Virginia Urology Center - Richmond
 
VA
 
9/27/2013
 

 
1,757

 
15,813

 

 
17,570

 
184

St. Peter's Recovery Center - Guilderland
 
NY
 
9/27/2013
 

 
404

 
7,682

 

 
8,086

 
97

Capital Regional MOB - Tallahassee
 
FL
 
9/30/2013
 

 

 
8,210

 

 
8,210

 
172

Arbor Terrace - Asheville
 
NC
 
10/4/2013
 
9,497

 
832

 
16,080

 
11

 
16,923

 
121

Arbor Terrace - Decatur
 
GA
 
10/4/2013
 
10,970

 
872

 
20,491

 

 
21,363

 
144

Gardens at Westlake - Westlake
 
OH
 
10/31/2013
 

 
1,591

 
19,390

 

 
20,981

 
99

Baylor Orthopedic & Spine - Arlington
 
TX
 
11/5/2013
 

 

 
23,914

 

 
23,914

 
237

Trinity Health Medical Arts - Minot
 
ND
 
11/6/2013
 

 
572

 
10,867

 

 
11,439

 
85

TriSun Care Center - San Antonio
 
TX
 
11/21/2013
 

 
1,044

 
9,392

 

 
10,436

 
44

Allina Health - Elk River
 
MN
 
11/25/2013
 

 
544

 
5,991

 

 
6,535

 
19

Riverdale MOB - Riverdale
 
GA
 
12/6/2013
 

 
438

 
8,721

 

 
9,159

 
36

Wellington ALF - Minot
 
ND
 
12/16/2013
 

 
1,480

 
8,388

 

 
9,868

 

Spartanburg ASC - Spartanburg
 
SC
 
12/24/2013
 

 
600

 
11,398

 

 
11,998

 

Solana at Cinco Ranch - Katy
 
TX
 
12/30/2013
 

 
2,786

 
65,340

 

 
68,126

 

Aurora Healthcare - Kenosha
 
WI
 
7/1/2013
 

 
1,747

 

 

 
1,747

 


40

American Realty Capital Healthcare Trust, Inc.

Real Estate and Accumulated Depreciation
Schedule III
December 31, 2013
(dollar amounts in thousands)

 
 
 
 
 
 
 
 
Initial Costs
 
Subsequent to Acquisition
 
 
 
 
Property
 
State
 
Acquisition
Date
 
Encumbrances at
December 31, 2013
 
Land
 
Building and
Improvements
 
Building and Improvements
 
Gross Amount at
December  31, 2013 
(1) (2)
 
Accumulated
Depreciation 
(3) (4)
 
 
 
 
 
 
$
259,348

 
$
107,719

 
$
1,363,763

 
$
707

 
$
1,471,577

 
$
57,347

_________________
(1)
Acquired intangible lease assets allocated to individual properties in the amount of $181.3 million are not reflected in the table above.
(2)
The tax basis of aggregate land, buildings and improvements as of December 31, 2013 is $1.6 billion.
(3)
The accumulated depreciation column excludes $30.0 million of amortization associated with acquired intangible lease assets.
(4)
Depreciation is computed using the straight-line method over the estimated useful lives of up to 40 years for buildings, 15 years for land improvements and five years for fixtures.
(5)
These properties collateralize the credit facility which had no advances outstanding as of December 31, 2013.
(6)
Gross amount is net of tenant improvement write-offs $0.6 million due to early tenant lease terminations.
ALF — Assisted Living Facility
ASC — Ambulatory Surgery Center
MOB — Medical Office Building
POB — Physicians Office Building


41

American Realty Capital Healthcare Trust, Inc.

Real Estate and Accumulated Depreciation
Schedule III
December 31, 2013
(dollar amounts in thousands)

A summary of activity for real estate and accumulated depreciation for the years ended December 31, 2013, 2012 and December 31, 2011:

 
 
December 31,
 
 
2013
 
2012
 
2011
Real estate investments, at cost:
 
 
 
 
 
 
Balance at beginning of year
 
$
600,494

 
$
140,810

 
$

Additions - Acquisitions
 
871,612

 
459,765

 
140,810

Disposals
 
(529
)
 
(81
)
 

Balance at end of the year
 
$
1,471,577

 
$
600,494

 
$
140,810

 
 
 
 
 
 
 
Accumulated depreciation and amortization:
 
 
 
 
 
 
Balance at beginning of year
 
$
16,178

 
$
1,174

 
$

Depreciation expense
 
41,232

 
15,010

 
1,174

Disposals
 
(63
)
 
(6
)
 

Balance at end of the year
 
$
57,347

 
$
16,178

 
$
1,174



42


Exhibit 99.3

VENTAS, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
As of and For the Six Months Ended June 30, 2014 and For the Year Ended December 31, 2013
 
On June 2, 2014, Ventas, Inc. (“Ventas” or the “Company”) announced that it had entered into a definitive agreement to acquire all of the outstanding shares of American Realty Capital Healthcare Trust, Inc. (“HCT”) in a stock and cash transaction valued at $2.9 billion, or $11.33 per HCT share, including investments expected to be made by HCT prior to completion of the acquisition, the majority of which have now been completed.
 
The following unaudited pro forma condensed consolidated financial information sets forth:
 
The historical consolidated financial information of Ventas as of and for the six months ended June 30, 2014, derived from Ventas’s unaudited consolidated financial statements, and the historical consolidated statement of income information of Ventas for the year ended December 31, 2013, derived from Ventas’s audited consolidated financial statements;

Pro forma adjustments to give effect to Ventas’s August 2014 acquisition of 29 independent living seniors housing communities located in Canada on Ventas’s consolidated balance sheet as of June 30, 2014, as if the acquisition closed on June 30, 2014;

Pro forma adjustments to give effect to Ventas’s 2014 and 2013 acquisitions and other investments, dispositions and significant debt activity (including the August 2014 acquisition of 29 independent living seniors housing communities located in Canada and the April 2014 issuance and sale of $700 million aggregate principal amount of senior notes) on Ventas’s consolidated statements of income for the six months ended June 30, 2014 and for the year ended December 31, 2013, as if these transactions occurred on January 1, 2013;

The historical consolidated financial information of HCT as of and for the six months ended June 30, 2014, derived from HCT’s unaudited consolidated financial statements, and the historical consolidated statement of income information of HCT for the year ended December 31, 2013, derived from HCT’s audited consolidated financial statements;

Pro forma adjustments to give effect to HCT’s 2014 and 2013 acquisitions and other investments, dispositions and significant debt activity on HCT’s consolidated statements of income for the six months ended June 30, 2014 and for the year ended December 31, 2013, as if these transactions occurred on January 1, 2013;

Pro forma adjustments to give effect to Ventas’s acquisition of HCT on Ventas’s consolidated balance sheet as of June 30, 2014, as if the acquisition closed on June 30, 2014; and

Pro forma adjustments to give effect to Ventas’s acquisition of HCT on Ventas’s consolidated statements of income for the six months ended June 30, 2014 and for the year ended December 31, 2013, as if the acquisition closed on January 1, 2013.
 
These unaudited pro forma condensed consolidated financial statements have been prepared for informational purposes only and are based on assumptions and estimates considered appropriate by Ventas’s management; however, they are not necessarily indicative of what Ventas’s consolidated financial condition or results of operations actually would have been assuming the transactions had been consummated as of the dates indicated, nor do they purport to represent Ventas’s consolidated financial position or results of operations for future periods. These unaudited pro forma condensed consolidated financial statements do not include the impact of any synergies that may be achieved in the transactions or any strategies that management may consider in order to continue to efficiently manage Ventas’s operations.  This pro forma condensed consolidated financial information should be read in conjunction with:
 
Ventas’s unaudited consolidated financial statements and the related notes thereto as of and for the six months ended June 30, 2014 included in the Company’s Quarterly Report on Form 10-Q for the quarter then ended, filed with the Securities and Exchange Commission (“SEC”) on August 11, 2014;

Ventas’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2013 included in the Company’s Annual Report on Form 10-K for the year then ended, filed with the SEC on February 18, 2014, as amended by Amendment No. 1 to the Company’s Annual Report on Form 10-K/A, filed with the SEC on September 4, 2014;



HCT’s unaudited consolidated financial statements and the related notes thereto as of and for the six months ended June 30, 2014 included in HCT’s Quarterly Report on Form 10-Q for the quarter then ended, filed with the SEC on August 12, 2014; and

HCT’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2013 included in HCT’s Annual Report on Form 10-K for the year then ended, filed with the SEC on February 26, 2014.
 
The acquisition of HCT will be accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification Topic 805, Business Combinations.  The total purchase price of approximately $2.9 billion will be allocated to the assets ultimately acquired and liabilities ultimately assumed based upon their respective fair values.  The allocations of the purchase price reflected in these unaudited pro forma condensed consolidated financial statements have not been finalized and are based upon preliminary estimates of these fair values, which is the best available information at the current time. A final determination of the fair values of the assets acquired and liabilities assumed, which cannot be made prior to the completion of the acquisition, will be based on the actual valuations of the tangible and intangible assets and liabilities that exist as of the date of completion of the acquisition. Consequently, amounts preliminarily allocated to identifiable tangible and intangible assets and liabilities could change significantly from those used in the unaudited pro forma condensed consolidated financial statements and could result in a material change in depreciation and amortization of tangible and intangible assets and liabilities.
 
The completion of the valuation, the allocation of purchase price, the impact of ongoing integration activities, the timing of completion of the acquisition and other changes in tangible and intangible assets and liabilities that occur prior to completion of the acquisition could cause material differences in the information presented herein.




VENTAS, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
As of June 30, 2014
(In thousands)

 
Ventas Historical
 
Ventas 2014 Transactions Adjustments (A)
 
Pro Forma for Ventas 2014 Transactions
 
HCT Historical (B)
 
HCT Acquisition Adjustments (C)
 
 
 
Total Pro Forma
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
Net real estate investments
$
18,389,744

 
$
1,004,635

 
$
19,394,379

 
$
1,972,317

 
$
738,501

 
(D)
 
$
22,105,197

Cash and cash equivalents
86,635

 
43,669

 
130,304

 
28,695

 

 
 
 
158,999

Escrow deposits and restricted cash
75,514

 

 
75,514

 
2,135

 

 
 
 
77,649

Deferred financing costs, net
63,399

 
4,701

 
68,100

 
19,287

 
(19,287
)
 
(E)
 
68,100

Other assets
1,175,494

 
(36,287
)
 
1,139,207

 
55,091

 
82,300

 
(F)
 
1,276,598

Total assets
$
19,790,786

 
$
1,016,718

 
$
20,807,504

 
$
2,077,525

 
$
801,514

 
 
 
$
23,686,543

Liabilities and equity
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Senior notes payable and other debt
$
9,602,439

 
$
923,641

 
$
10,526,080

 
$
815,707

 
$
198,783

 
(G)
 
$
11,540,570

Accrued interest
56,722

 

 
56,722

 
1,540

 

 
 
 
58,262

Accounts payable and other liabilities
975,282

 
11,644

 
986,926

 
95,634

 
(37,676
)
 
(H)
 
1,044,884

Deferred income taxes
256,392

 
107,026

 
363,418

 

 

 
 
 
363,418

Total liabilities
10,890,835

 
1,042,311

 
11,933,146

 
912,881

 
161,107

 
 
 
13,007,134

Redeemable OP unitholder and noncontrolling interests
169,292

 

 
169,292

 

 
79,959

 
(I)
 
249,251

Commitments and contingencies
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity:
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Ventas stockholders' equity
8,655,110

 
(25,593
)
 
8,629,517

 
1,150,157

 
574,935

 
(J)
 
10,354,609

Noncontrolling interest
75,549

 

 
75,549

 
14,487

 
(14,487
)
 
(K)
 
75,549

Total equity
8,730,659

 
(25,593
)
 
8,705,066

 
1,164,644

 
560,448

 
 
 
10,430,158

Total liabilities and equity
$
19,790,786

 
$
1,016,718

 
$
20,807,504

 
$
2,077,525

 
$
801,514

 
 
 
$
23,686,543

See accompanying notes to unaudited pro forma condensed consolidated financial statements.




VENTAS, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME
For the six months ended June 30, 2014
(In thousands, except per share amounts)
 
Ventas Historical
 
Ventas 2014 Transactions Adjustments (L)
 
Pro Forma for Ventas 2014 Transactions
 
HCT Historical (B)
 
HCT 2014 Transactions Adjustments (L)
 
Pro Forma for HCT 2014 Transactions
 
HCT Acquisition Adjustments (C)
 
 
 
Total Pro Forma
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rental income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Triple-net leased
$
480,572

 
$
4,136

 
$
484,708

 
$
13,218

 
$
4,823

 
$
18,041

 
$
131

 
(M)
 
$
502,880

Medical office buildings
230,113

 
(209
)
 
229,904

 
48,939

 
964

 
49,903

 
(162
)
 
(M)
 
279,645

 
710,685

 
3,927

 
714,612

 
62,157

 
5,787

 
67,944

 
(31
)
 
 
 
782,525

Resident fees and services
745,534

 
58,218

 
803,752

 
58,214

 
11,321

 
69,535

 

 
 
 
873,287

Medical office building and other services revenue
10,667

 

 
10,667

 

 

 

 

 
 
 
10,667

Income from loans and investments
25,392

 
2,059

 
27,451

 
1,130

 

 
1,130

 
(12
)
 
(N)
 
28,569

Interest and other income
446

 

 
446

 

 

 

 

 
 
 
446

Total revenues
1,492,724

 
64,204

 
1,556,928

 
121,501

 
17,108

 
138,609

 
(43
)
 
 
 
1,695,494

Expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest
179,342

 
13,760

 
193,102

 
12,651

 
359

 
13,010

 
(1,788
)
 
(O)
 
204,324

Depreciation and amortization
384,412

 
29,424

 
413,836

 
60,656

 
7,303

 
67,959

 
(18,520
)
 
(P)
 
463,275

Property-level operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Senior living
497,719

 
28,628

 
526,347

 
41,532

 
7,650

 
49,182

 

 
 
 
575,529

Medical office buildings
78,680

 
(39
)
 
78,641

 
10,150

 
290

 
10,440

 

 
 
 
89,081

 
576,399

 
28,589

 
604,988

 
51,682

 
7,940

 
59,622

 

 
 
 
664,610

Medical office building services costs
4,997

 

 
4,997

 

 

 

 

 
 
 
4,997

General, administrative and professional fees
64,172

 

 
64,172

 
4,057

 

 
4,057

 

 
 
 
68,229

Loss (gain) on extinguishment of debt, net
2,665

 
(243
)
 
2,422

 

 

 

 

 
 
 
2,422

Merger-related expenses and deal costs
20,359

 
(8,398
)
 
11,961

 
25,878

 
(6,428
)
 
19,450

 

 
 
 
31,411

Other
10,092

 

 
10,092

 
71,067

 

 
71,067

 
(71,067
)
 
(Q)
 
10,092

Total expenses
1,242,438

 
63,132

 
1,305,570

 
225,991

 
9,174

 
235,165

 
(91,375
)
 
 
 
1,449,360

Income (loss) before income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest
250,286

 
1,072

 
251,358

 
(104,490
)
 
7,934

 
(96,556
)
 
91,332

 
 
 
246,134

Income from unconsolidated entities
596

 
36

 
632

 

 

 

 

 
 
 
632

Income tax expense
(6,707
)
 

 
(6,707
)
 
(642
)
 

 
(642
)
 

 
 
 
(7,349
)
Income from continuing operations
244,175

 
1,108

 
245,283

 
(105,132
)
 
7,934

 
(97,198
)
 
91,332

 
 
 
239,417

Gain (loss) on real estate dispositions, net
12,889

 
(14,771
)
 
(1,882
)
 

 

 

 

 
 
 
(1,882
)
Income (loss) from continuing operations, including real estate dispositions
257,064

 
(13,663
)
 
243,401

 
(105,132
)
 
7,934

 
(97,198
)
 
91,332

 
 
 
237,535

Net income (loss) attributable to noncontrolling interest
395

 

 
395

 
(808
)
 

 
(808
)
 
808

 
(R)
 
395

Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions
$
256,669

 
$
(13,663
)
 
$
243,006

 
$
(104,324
)
 
$
7,934

 
$
(96,390
)
 
$
90,524

 
 
 
$
237,140

Income (loss) from continuing operations attributable to common stockholders per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.87

 
$

 
$
0.83

 
$
(0.58
)
 
$

 
$
(0.54
)
 
N/A
 
 
 
$
0.74

Diluted
$
0.87

 
$

 
$
0.82

 
$
(0.58
)
 
$

 
$
(0.54
)
 
N/A
 
 
 
$
0.73

Weighted average shares used in computing earnings per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
293,932

 

 
293,932

 
178,357

 

 
178,357

 
25,723

 
(S)
 
319,655

Diluted
296,369

 

 
296,369

 
178,357

 

 
178,357

 
26,914

 
(S)
 
323,283

See accompanying notes to unaudited pro forma condensed consolidated financial statements.



VENTAS, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME
For the year ended December 31, 2013
(In thousands, except per share amounts)
 
Ventas Historical
 
Ventas 2014 and 2013 Transactions Adjustments (L)
 
Pro Forma for Ventas 2014 and 2013 Transactions
 
HCT Historical (B)
 
HCT 2014 and 2013 Transactions Adjustments (L)
 
Pro Forma for HCT 2014 and 2013 Transactions
 
HCT Acquisition Adjustments (C)
 
 
 
Total Pro Forma
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rental income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Triple-net leased
$
875,877

 
$
63,404

 
$
939,281

 
$
12,880

 
$
15,600

 
$
28,480

 
$
261

 
(M)
 
$
968,022

Medical office buildings
450,107

 
5,208

 
455,315

 
64,075

 
31,314

 
95,389

 
(258
)
 
(M)
 
550,446

 
1,325,984

 
68,612

 
1,394,596

 
76,955

 
46,914

 
123,869

 
3

 
 
 
1,518,468

Resident fees and services
1,406,005

 
180,806

 
1,586,811

 
47,698

 
67,768

 
115,466

 

 
 
 
1,702,277

Medical office building and other services revenue
17,809

 
596

 
18,405

 

 

 

 

 
 
 
18,405

Income from loans and investments
58,208

 
(2,573
)
 
55,635

 
569

 

 
569

 
(13
)
 
(N)
 
56,191

Interest and other income
2,047

 
1

 
2,048

 
89

 

 
89

 

 
 
 
2,137

Total revenues
2,810,053

 
247,442

 
3,057,495

 
125,311

 
114,682

 
239,993

 
(10
)
 
 
 
3,297,478

Expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest
334,484

 
65,650

 
400,134

 
15,843

 
2,884

 
18,727

 
1,459

 
(O)
 
420,320

Depreciation and amortization
721,959

 
108,216

 
830,175

 
67,456

 
60,583

 
128,039

 
4,960

 
(P)
 
963,174

Property-level operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Senior living
956,684

 
94,666

 
1,051,350

 
33,151

 
42,137

 
75,288

 

 
 
 
1,126,638

Medical office buildings
152,948

 
3,069

 
156,017

 
12,814

 
5,013

 
17,827

 

 
 
 
173,844

 
1,109,632

 
97,735

 
1,207,367

 
45,965

 
47,150

 
93,115

 

 
 
 
1,300,482

Medical office building services costs
8,315

 

 
8,315

 

 

 

 

 
 
 
8,315

General, administrative and professional fees
115,106

 
(5
)
 
115,101

 
4,089

 

 
4,089

 

 
 
 
119,190

Loss on extinguishment of debt, net
1,201

 
243

 
1,444

 

 

 

 

 
 
 
1,444

Merger-related expenses and deal costs
21,634

 
(7,276
)
 
14,358

 
13,606

 
(15,239
)
 
(1,633
)
 

 
 
 
12,725

Other
18,732

 

 
18,732

 

 

 

 

 
 
 
18,732

Total expenses
2,331,063

 
264,563

 
2,595,626

 
146,959

 
95,378

 
242,337

 
6,419

 
 
 
2,844,382

Income (loss) before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest
478,990

 
(17,121
)
 
461,869

 
(21,648
)
 
19,304

 
(2,344
)
 
(6,429
)
 
 
 
453,096

(Loss) income from unconsolidated entities
(508
)
 
493

 
(15
)
 

 

 

 

 
 
 
(15
)
Income tax benefit (expense)
11,828

 

 
11,828

 
(524
)
 

 
(524
)
 

 
 
 
11,304

Income (loss) from continuing operations
490,310

 
(16,628
)
 
473,682

 
(22,172
)
 
19,304

 
(2,868
)
 
(6,429
)
 
 
 
464,385

Gain on real estate dispositions, net

 
14,771

 
14,771

 

 

 

 
 
 
 
 
14,771

Income (loss) from continuing operations, including real estate dispositions
490,310

 
(1,857
)
 
488,453

 
(22,172
)
 
19,304

 
(2,868
)
 
(6,429
)
 
 
 
479,156

Net income attributable to noncontrolling interest
1,380

 
143

 
1,523

 
58

 

 
58

 
(58
)
 
(R)
 
1,523

Income (loss) from continuing operations attributable to common stockholders
$
488,930

 
$
(2,000
)
 
$
486,930

 
$
(22,230
)
 
$
19,304

 
$
(2,926
)
 
$
(6,371
)
 
 
 
$
477,633

Income (loss) from continuing operations attributable to common stockholders per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
$
1.67

 
$

 
$
1.66

 
$
(0.15
)
 
$

 
$
(0.02
)
 
N/A
 
 
 
$
1.50

Diluted
$
1.66

 
$

 
$
1.65

 
$
(0.15
)
 
$

 
$
(0.02
)
 
N/A
 
 
 
$
1.48

Weighted average shares used in computing earnings per common share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
292,654

 

 
292,654

 
151,684

 

 
151,684

 
25,723

 
(S)
 
318,377

Diluted
295,110

 

 
295,110

 
151,684

 

 
151,684

 
26,914

 
(S)
 
322,024

See accompanying notes to unaudited pro forma condensed consolidated financial statements.



VENTAS, INC.
 NOTES AND MANAGEMENT’S ASSUMPTIONS TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
NOTE 1 - BASIS OF PRO FORMA PRESENTATION
 
Ventas, Inc. (“Ventas” or the “Company”) is a real estate investment trust (“REIT”) with a geographically diverse portfolio of seniors housing and healthcare properties in the United States, Canada and the United Kingdom.  The historical consolidated financial statements of Ventas include the accounts of the Company and its wholly owned subsidiaries and joint venture entities over which it exercises control.
 
On June 2, 2014, Ventas announced that it had entered into a definitive agreement to acquire all of the outstanding shares of American Realty Capital Healthcare Trust, Inc. (“HCT”) in a stock and cash transaction valued at $2.9 billion, or $11.33 per HCT share, including investments expected to be made by HCT prior to the acquisition, the majority of which have now been completed.

NOTE 2 - ADJUSTMENTS TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

(A) Adjustments reflect the effect on Ventas’s historical consolidated balance sheet of its August 2014 acquisition of 29 independent living seniors housing communities located in Canada, a portion of which was funded through borrowings under a new CAD 791 million unsecured term loan, as if this transaction closed on June 30, 2014.

(B) Reflects historical consolidated financial condition or results of operations of HCT as of or for the six months ended June 30, 2014 or for the year ended December 31, 2013.  Certain amounts have been reclassified to conform to Ventas’s presentation.

(C) Reflects adjustments to record the acquisition of HCT by Ventas based upon the estimated purchase price of approximately $2.9 billion.  The calculation of the estimated purchase price to be allocated is as follows (in millions, except per share amounts):

Equity to be issued (26.9 million shares at $67.13 per share)
$
1,806

Cash to be paid (assumed to be funded with borrowings under Ventas’s unsecured revolving credit facility)
192

Assumption or repayment of net debt
930

Estimated purchase price
$
2,928

 
 

(D) Reflects adjustment to record the estimated increase over HCT’s historical investment in real estate based upon the preliminary estimated fair value for the tangible and intangible real estate assets to be acquired.  These estimated values are as follows (in millions):

Land and improvements
 
$
266

Buildings and improvements
 
2,219

Acquired lease intangibles
 
225

Estimated fair value of net real estate investments
 
$
2,710

 
 
 

(E) Reflects the write-off of HCT’s historical deferred financing costs, which were not assigned any value in the preliminary purchase price allocation.

(F) Reflects adjustments to eliminate assets of HCT included in the historical consolidated financial information that Ventas is not acquiring as part of the working capital consideration, net of other acquired assets, primarily consisting of approximately $150 million of other intangible assets.




(G) Reflects the following adjustments (in millions):

Write-off of HCT’s historical fair value of debt adjustments
 
$
(4
)
Fair value of debt adjustment recorded in connection with the acquisition
 
11

HCT debt anticipated to be repaid at closing
 
(508
)
Anticipated borrowings under Ventas’s unsecured revolving credit facility
 
708

Pro forma adjustment to debt
 
$
207

 
 
 

(H) Reflects adjustments to eliminate historical other liabilities of HCT that were not assigned any value in the preliminary purchase price allocation and the recording of approximately $31 million of various lease intangibles, which were recorded based on preliminary fair value calculations.

(I) Reflects the adjustment to record the fair value of the redeemable OP unitholder interests, which are valued at a price of $11.33 per unit (the acquisition value of each share of HCT common stock at the time the acquisition was announced).

(J) Reflects the write-off of HCT’s historical equity, net of the issuance of 26.9 million shares of Ventas common stock in connection with the HCT acquisition, which are valued at $1.8 billion

(K) Reflects the adjustment to record the reclassification of HCT’s historical noncontrolling interest value to redeemable OP unitholder interests.

NOTE 3 - ADJUSTMENTS TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(L) Adjustments reflect the effect on Ventas’s and HCT’s historical consolidated statements of income of Ventas’s and HCT’s respective significant 2014 and 2013 transactions, as if those transactions were consummated on January 1, 2013.  With respect to Ventas, these adjustments primarily relate to certain acquisitions and dispositions (including its August 2014 acquisition of 29 independent living seniors housing communities located in Canada) and debt repayments and issuances.  With respect to HCT, these adjustments primarily relate to various asset acquisitions.

(M) Reflects the net amortization of above and below market lease intangibles recorded by Ventas as a result of the HCT acquisition and the elimination of HCT’s historical amortization related to above and below market lease intangibles.

(N) Reflects the elimination of HCT’s historical revenues attributable to assets that Ventas is not acquiring as part of the acquisition.

(O) Reflects the following adjustments (in millions):

 
 
For the Six Months Ended June 30, 2014
 
For the Year Ended December 31, 2013
Write-off of HCT’s historical fair value of debt adjustments
 
$
1

 
$
1

Fair value of debt adjustment recorded in connection with the acquisition
 
(2
)
 
(4
)
HCT debt anticipated to be repaid at closing
 
(3
)
 
(1
)
Anticipated borrowings under Ventas’s unsecured revolving credit facility
 
5

 
10

Write-off of HCT’s deferred financing costs
 
(3
)
 
(4
)
Pro forma adjustment to interest expense
 
$
(2
)
 
$
2





(P) Based on the preliminary purchase price allocation, Ventas expects to allocate $266 million to land and $2.2 billion to buildings and improvements. Depreciation expense is calculated on a straight-line basis based on Ventas’s purchase price allocation and using a 35-year life for buildings and permanent structural improvements, a five-year life for furniture and equipment and a ten-year life for land improvements. Additionally, Ventas’s purchase price allocation includes $180 million of acquired in-place lease intangibles. Further, the adjustment reflects the elimination of historical depreciation and amortization expense.

(Q) Reflects the elimination of costs and fees directly attributable to the merger and fees associated with the ultimate disposition of HCT’s assets.

(R) Reflects the elimination of HCT’s noncontrolling interest that Ventas is not acquiring as part of the acquisition.

(S) Reflects the issuance of 26.9 million shares of Ventas common stock upon consummation of the HCT acquisition, including the impact of redeemable OP units issued on the acquisition date.






NOTE 4 - FUNDS FROM OPERATIONS AND NORMALIZED FUNDS FROM OPERATIONS
 
Ventas’s historical and pro forma funds from operations (“FFO”) and normalized FFO for the six months ended June 30, 2014 and the year ended December 31, 2013 are summarized as follows (in thousands):

VENTAS, INC.
UNAUDITED PRO FORMA FFO AND NORMALIZED FFO
For the six months ended June 30, 2014
(In thousands, except per share amounts)
 
Ventas Historical
 
Ventas 2014 Transactions Adjustments
 
Pro Forma for Ventas 2014 Transactions
 
HCT Historical
 
HCT 2014 Transactions Adjustments
 
Pro Forma for HCT 2014 Transactions
 
HCT Acquisition Adjustments
 
Total Pro Forma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations attributable to common stockholders
$
256,669

 
$
(13,663
)
 
$
243,006

 
$
(104,324
)
 
$
7,934

 
$
(96,390
)
 
$
90,524

 
$
237,140

Discontinued operations
2,776

 
(854
)
 
1,922

 

 

 

 

 
1,922

Net income (loss) attributable to common stockholders
259,445

 
(14,517
)
 
244,928

 
(104,324
)
 
7,934

 
(96,390
)
 
90,524

 
239,062

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real estate depreciation and amortization
381,262

 
29,424

 
410,686

 
60,523

 
7,303

 
67,826

 
(18,520
)
 
459,992

Real estate depreciation related to noncontrolling interest
(5,305
)
 

 
(5,305
)
 

 

 

 

 
(5,305
)
Real estate depreciation related to unconsolidated entities
2,989

 

 
2,989

 

 

 

 

 
2,989

(Gain) loss on real estate dispositions, net
(12,889
)
 
14,771

 
1,882

 

 

 

 

 
1,882

Discontinued operations:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gain on real estate dispositions, net
(1,483
)
 
1,058

 
(425
)
 

 

 

 

 
(425
)
Depreciation on real estate assets
1,528

 
(159
)
 
1,369

 

 

 

 

 
1,369

FFO
625,547

 
30,577

 
656,124

 
(43,801
)
 
15,237

 
(28,564
)
 
72,004

 
699,564

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in fair value of financial instruments
41

 

 
41

 

 

 

 

 
41

Income tax expense
6,407

 

 
6,407

 

 

 

 

 
6,407

Loss on extinguishment of debt, net
2,114

 
(243
)
 
1,871

 

 

 

 

 
1,871

Merger-related expenses and deal costs
20,363

 
(8,398
)
 
11,965

 
25,878

 
(6,428
)
 
19,450

 

 
31,415

Amortization of other intangibles
511

 

 
511

 

 

 

 

 
511

Normalized FFO
$
654,983

 
$
21,936

 
$
676,919

 
$
(17,923
)
 
$
8,809

 
$
(9,114
)
 
$
72,004

 
$
739,809




Ventas’s historical and pro forma FFO and normalized FFO per diluted share outstanding for the six months ended June 30, 2014 follows (in thousands, except per share amounts) (1):
 
Ventas Historical
 
Total Pro Forma
 
 
 
 
Income from continuing operations attributable to common stockholders
$
0.87

 
$
0.73

Discontinued operations
0.01

 
0.01

Net income attributable to common stockholders
0.88

 
0.74

Adjustments:
 
 
 
Real estate depreciation and amortization
1.29

 
1.42

Real estate depreciation related to noncontrolling interest
(0.02
)
 
(0.02
)
Real estate depreciation related to unconsolidated entities
0.01

 
0.01

(Gain) loss on real estate dispositions, net
(0.04
)
 
0.01

Discontinued operations:
 
 
 
Gain on real estate dispositions, net
(0.01
)
 
(0.00
)
Depreciation on real estate assets
0.01

 
0.00

FFO
2.11

 
2.16

Adjustments:
 
 
 
Change in fair value of financial instruments
0.00

 
0.00

Income tax expense
0.02

 
0.02

Loss on extinguishment of debt, net
0.01

 
0.01

Merger-related expenses and deal costs
0.07

 
0.10

Amortization of other intangibles
0.00

 
0.00

Normalized FFO
$
2.21

 
$
2.29

 
 
 
 
Dilutive shares outstanding used in computing FFO and normalized FFO per common share
296,369

 
323,283

 
 
(1) Per share amounts may not add due to rounding.



VENTAS, INC.
UNAUDITED PRO FORMA FFO AND NORMALIZED FFO
For the year ended December 31, 2013
(In thousands, except per share amounts)
 
Ventas Historical
 
Ventas 2014 and 2013 Transactions Adjustments
 
Pro Forma for Ventas 2014 and 2013 Transactions
 
HCT Historical
 
HCT 2014 and 2013 Transactions Adjustments
 
Pro Forma for HCT 2014 and 2013 Transactions
 
HCT Acquisition Adjustments
 
Total Pro Forma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations attributable to common stockholders
$
488,930

 
$
(2,000
)
 
$
486,930

 
$
(22,230
)
 
$
19,304

 
$
(2,926
)
 
$
(6,371
)
 
$
477,633

Discontinued operations
(35,421
)
 
2,154

 
(33,267
)
 

 

 

 

 
(33,267
)
Net income (loss) attributable to common stockholders
453,509

 
154

 
453,663

 
(22,230
)
 
19,304

 
(2,926
)
 
(6,371
)
 
444,366

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real estate depreciation and amortization
716,412

 
108,216

 
824,628

 
66,975

 
60,583

 
127,558

 
4,960

 
957,146

Real estate depreciation related to noncontrolling interest
(10,512
)
 

 
(10,512
)
 

 

 

 

 
(10,512
)
Real estate depreciation related to unconsolidated entities
6,543

 

 
6,543

 

 

 

 

 
6,543

Gain on re-measurement of equity interest upon acquisition, net
(1,241
)
 

 
(1,241
)
 

 

 

 

 
(1,241
)
Gain on real estate dispositions, net

 
(14,771
)
 
(14,771
)
 

 

 

 

 
(14,771
)
Discontinued operations:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Gain on real estate dispositions, net
(4,059
)
 
1,262

 
(2,797
)
 

 

 

 

 
(2,797
)
Depreciation on real estate assets
47,806

 
(2,892
)
 
44,914

 

 

 

 

 
44,914

FFO
1,208,458

 
91,969

 
1,300,427

 
44,745

 
79,887

 
124,632

 
(1,411
)
 
1,423,648

Adjustments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in fair value of financial instruments
449

 

 
449

 

 

 

 

 
449

Income tax benefit
(11,828
)
 

 
(11,828
)
 

 

 

 

 
(11,828
)
Loss on extinguishment of debt, net
1,048

 
243

 
1,291

 

 

 

 

 
1,291

Merger-related expenses and deal costs
21,560

 
(7,276
)
 
14,284

 
13,606

 
(15,239
)
 
(1,633
)
 

 
12,651

Amortization of other intangibles
1,022

 

 
1,022

 

 

 

 

 
1,022

Normalized FFO
$
1,220,709

 
$
84,936

 
$
1,305,645

 
$
58,351

 
$
64,648

 
$
122,999

 
$
(1,411
)
 
$
1,427,233




Ventas’s historical and pro forma FFO and normalized FFO per diluted share outstanding for the year ended December 31, 2013 follows (in thousands, except per share amounts) (1):
 
Ventas Historical
 
Total Pro Forma
 
 
 
 
Income from continuing operations attributable to common stockholders
$
1.66

 
$
1.48

Discontinued operations
(0.12
)
 
(0.10
)
Net income attributable to common stockholders
1.54

 
1.38

Adjustments:
 
 
 
Real estate depreciation and amortization
2.43

 
2.97

Real estate depreciation related to noncontrolling interest
(0.04
)
 
(0.03
)
Real estate depreciation related to unconsolidated entities
0.02

 
0.02

Gain on re-measurement of equity interest upon acquisition, net
(0.00
)
 
(0.00
)
Gain on real estate dispositions, net

 
(0.05
)
Discontinued operations:
 
 
 
Gain on real estate dispositions, net
(0.01
)
 
(0.01
)
Depreciation on real estate assets
0.16

 
0.14

FFO
4.09

 
4.42

Adjustments:
 
 
 
Change in fair value of financial instruments
0.00

 
0.00

Income tax benefit
(0.04
)
 
(0.04
)
Loss on extinguishment of debt, net
0.00

 
0.00

Merger-related expenses and deal costs
0.07

 
0.04

Amortization of other intangibles
0.00

 
0.00

Normalized FFO
$
4.14

 
$
4.43

 
 
 
 
Dilutive shares outstanding used in computing FFO and normalized FFO per common share
295,110

 
322,024

 
 
(1) Per share amounts may not add due to rounding.









Unaudited pro forma FFO and normalized FFO are presented herein for informational purposes only and are based on available information and assumptions that the Company’s management believes to be reasonable; however, they are not necessarily indicative of what Ventas’s FFO or normalized FFO actually would have been assuming the transactions had occurred as of the dates indicated.
 
Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time.  However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  To overcome this problem, Ventas considers FFO and normalized FFO to be appropriate measures of operating performance of an equity REIT.  In particular, Ventas believes that normalized FFO is useful because it allows investors, analysts and Ventas management to compare Ventas’s operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items and other events such as transactions and litigation.  In some cases, Ventas provides information about identified non-cash components of FFO and normalized FFO because it allows investors, analysts and Ventas management to assess the impact of those items on Ventas’s financial results.

Ventas uses the National Association of Real Estate Investment Trusts (“NAREIT”) definition of FFO.  NAREIT defines FFO as net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, including gain on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis.  Ventas defines normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) merger-related costs and expenses, including amortization of intangibles, transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to the Company’s acquisition lawsuits; (b) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company’s debt; (c) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company’s consolidated statements of income; (d) the impact of future acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions; (e) the financial impact of contingent consideration, severance-related costs, charitable donations made to the Ventas Charitable Foundation, gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments; and (f) expenses related to the re-audit and re-review of the Company’s historical financial statements and related matters.
 
FFO and normalized FFO presented herein may not be identical to FFO and normalized FFO presented by other real estate companies due to the fact that not all real estate companies use the same definitions.  FFO and normalized FFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of Ventas’s financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of Ventas’s liquidity, nor is FFO and normalized FFO necessarily indicative of sufficient cash flow to fund all of Ventas’s needs.  Ventas believes that in order to facilitate a clear understanding of Ventas’s consolidated historical operating results, FFO and normalized FFO should be examined in conjunction with net income as presented in the unaudited pro forma condensed consolidated financial statements.


(MM) (NASDAQ:HCT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more (MM) Charts.
(MM) (NASDAQ:HCT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more (MM) Charts.